<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chlorhexidine mouthrinse as an adjunctive treatment for gingival health - James, P - 2017 | Cochrane Library</title> <meta content="Chlorhexidine mouthrinse as an adjunctive treatment for gingival health - James, P - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008676.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chlorhexidine mouthrinse as an adjunctive treatment for gingival health - James, P - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008676.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008676.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chlorhexidine mouthrinse as an adjunctive treatment for gingival health" name="citation_title"/> <meta content="Patrice James" name="citation_author"/> <meta content="Cork University Dental School and Hospital" name="citation_author_institution"/> <meta content="p.james@ucc.ie" name="citation_author_email"/> <meta content="Helen V Worthington" name="citation_author"/> <meta content="Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester" name="citation_author_institution"/> <meta content="Carmel Parnell" name="citation_author"/> <meta content="HSE Louth Meath Dental Service" name="citation_author_institution"/> <meta content="Mairead Harding" name="citation_author"/> <meta content="Cork University Dental School and Hospital (UCC), Wilton, Cork, and HSE South (CHO 4)" name="citation_author_institution"/> <meta content="Thomas Lamont" name="citation_author"/> <meta content="University of Dundee" name="citation_author_institution"/> <meta content="Andrea Cheung" name="citation_author"/> <meta content="Cork University Dental School and Hospital (UCC)" name="citation_author_institution"/> <meta content="Helen Whelton" name="citation_author"/> <meta content="School of Dentistry, University of Leeds" name="citation_author_institution"/> <meta content="Philip Riley" name="citation_author"/> <meta content="Division of Dentistry, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD008676.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008676.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008676.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008676.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chemotherapy, Adjuvant; Chlorhexidine [adverse effects, *therapeutic use]; Dental Plaque [complications, *drug therapy]; Dental Plaque Index; Dental Prophylaxis; Gingivitis [*drug therapy, etiology]; Mouthwashes [adverse effects, *therapeutic use]; Oral Hygiene; Publication Bias; Randomized Controlled Trials as Topic; Time Factors; Tooth Discoloration [chemically induced]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008676.pub2&amp;doi=10.1002/14651858.CD008676.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008676\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008676\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","ko","ms","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008676.pub2",title:"Chlorhexidine mouthrinse as an adjunctive treatment for gingival health",firstPublishedDate:"Mar 31, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Oral Health Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008676.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008676.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008676.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008676.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008676.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008676.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008676.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008676.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008676.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008676.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>32493 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008676.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0096"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-sec-0090"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/appendices#CD008676-sec-0101"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/table_n/CD008676StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/table_n/CD008676StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chlorhexidine mouthrinse as an adjunctive treatment for gingival health</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Patrice James</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0005">Helen V Worthington</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0006">Carmel Parnell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0007">Mairead Harding</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0008">Thomas Lamont</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0009">Andrea Cheung</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0010">Helen Whelton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information#CD008676-cr-0011">Philip Riley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information/en#CD008676-sec-0112">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008676.pub2">https://doi.org/10.1002/14651858.CD008676.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008676-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008676-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008676-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008676-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008676-abs-0006">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008676-abs-0001" lang="en"> <section id="CD008676-sec-0001"> <h3 class="title" id="CD008676-sec-0001">Background</h3> <p>Dental plaque associated gingivitis is a reversible inflammatory condition caused by accumulation and persistence of microbial biofilms (dental plaque) on the teeth. It is characterised by redness and swelling of the gingivae (gums) and a tendency for the gingivae to bleed easily. In susceptible individuals, gingivitis may lead to periodontitis and loss of the soft tissue and bony support for the tooth. It is thought that chlorhexidine mouthrinse may reduce the build‐up of plaque thereby reducing gingivitis. </p> </section> <section id="CD008676-sec-0002"> <h3 class="title" id="CD008676-sec-0002">Objectives</h3> <p>To assess the effectiveness of chlorhexidine mouthrinse used as an adjunct to mechanical oral hygiene procedures for the control of gingivitis and plaque compared to mechanical oral hygiene procedures alone or mechanical oral hygiene procedures plus placebo/control mouthrinse. Mechanical oral hygiene procedures were toothbrushing with/without the use of dental floss or interdental cleaning aids and could include professional tooth cleaning/periodontal treatment. </p> <p>To determine whether the effect of chlorhexidine mouthrinse is influenced by chlorhexidine concentration, or frequency of rinsing (once/day versus twice/day). </p> <p>To report and describe any adverse effects associated with chlorhexidine mouthrinse use from included trials. </p> </section> <section id="CD008676-sec-0003"> <h3 class="title" id="CD008676-sec-0003">Search methods</h3> <p>Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 28 September 2016); the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 8) in the Cochrane Library (searched 28 September 2016); MEDLINE Ovid (1946 to 28 September 2016); Embase Ovid (1980 to 28 September 2016); and CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to 28 September 2016). We searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the <a href="http://apps.who.int/trialsearch/" target="_blank">World Health Organization International Clinical Trials Registry Platform</a> for ongoing trials. No restrictions were placed on the language or date of publication when searching the electronic databases. </p> </section> <section id="CD008676-sec-0004"> <h3 class="title" id="CD008676-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials assessing the effects of chlorhexidine mouthrinse used as an adjunct to mechanical oral hygiene procedures for at least 4 weeks on gingivitis in children and adults. Mechanical oral hygiene procedures were toothbrushing with/without use of dental floss or interdental cleaning aids and could include professional tooth cleaning/periodontal treatment. We included trials where participants had gingivitis or periodontitis, where participants were healthy and where some or all participants had medical conditions or special care needs. </p> </section> <section id="CD008676-sec-0005"> <h3 class="title" id="CD008676-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened the search results extracted data and assessed the risk of bias of the included studies. We attempted to contact study authors for missing data or clarification where feasible. For continuous outcomes, we used means and standard deviations to obtain the mean difference (MD) and 95% confidence interval (CI). We combined MDs where studies used the same scale and standardised mean differences (SMDs) where studies used different scales. For dichotomous outcomes, we reported risk ratios (RR) and 95% CIs. Due to anticipated heterogeneity we used random‐effects models for all meta‐analyses. </p> </section> <section id="CD008676-sec-0006"> <h3 class="title" id="CD008676-sec-0006">Main results</h3> <p>We included 51 studies that analysed a total of 5345 participants. One study was assessed as being at unclear risk of bias, with the remaining 50 being at high risk of bias, however, this did not affect the quality assessments for gingivitis and plaque as we believe that further research is very unlikely to change our confidence in the estimate of effect. </p> <p><i><b>Gingivitis</b> </i> </p> <p>After 4 to 6 weeks of use, chlorhexidine mouthrinse reduced gingivitis (Gingival Index (GI) 0 to 3 scale) by 0.21 (95% CI 0.11 to 0.31) compared to placebo, control or no mouthrinse (10 trials, 805 participants with mild gingival inflammation (mean score 1 on the GI scale) analysed, high‐quality evidence). A similar effect size was found for reducing gingivitis at 6 months. There were insufficient data to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 (moderate or severe levels of gingival inflammation). </p> <p><i><b>Plaque</b> </i> </p> <p>Plaque was measured by different indices and the SMD at 4 to 6 weeks was 1.45 (95% CI 1.00 to 1.90) standard deviations lower in the chlorhexidine group (12 trials, 950 participants analysed, high‐quality evidence), indicating a large reduction in plaque. A similar large reduction was found for chlorhexidine mouthrinse use at 6 months. </p> <p><i><b>Extrinsic tooth staining</b> </i> </p> <p>There was a large increase in extrinsic tooth staining in participants using chlorhexidine mouthrinse at 4 to 6 weeks. The SMD was 1.07 (95% CI 0.80 to 1.34) standard deviations higher (eight trials, 415 participants analysed, moderate‐quality evidence) in the chlorhexidine mouthrinse group. There was also a large increase in extrinsic tooth staining in participants using chlorhexidine mouthrinse at 7 to 12 weeks and 6 months. </p> <p><i><b>Calculus</b> </i> </p> <p>Results for the effect of chlorhexidine mouthrinse on calculus formation were inconclusive.</p> <p><i><b>Effect of concentration and frequency of rinsing</b> </i> </p> <p>There were insufficient data to determine whether there was a difference in effect for either chlorhexidine concentration or frequency of rinsing. </p> <p><i><b>Other adverse effects</b> </i> </p> <p>The adverse effects most commonly reported in the included studies were taste disturbance/alteration (reported in 11 studies), effects on the oral mucosa including soreness, irritation, mild desquamation and mucosal ulceration/erosions (reported in 13 studies) and a general burning sensation or a burning tongue or both (reported in nine studies). </p> </section> <section id="CD008676-sec-0007"> <h3 class="title" id="CD008676-sec-0007">Authors' conclusions</h3> <p>There is high‐quality evidence from studies that reported the Löe and Silness Gingival Index of a reduction in gingivitis in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 GI scale) that was not considered to be clinically relevant. There is high‐quality evidence of a large reduction in dental plaque with chlorhexidine mouthrinse used as an adjunct to mechanical oral hygiene procedures for 4 to 6 weeks and 6 months. There is no evidence that one concentration of chlorhexidine rinse is more effective than another. There is insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation. Rinsing with chlorhexidine mouthrinse for 4 weeks or longer causes extrinsic tooth staining. In addition, other adverse effects such as calculus build up, transient taste disturbance and effects on the oral mucosa were reported in the included studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008676-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008676-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008676-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008676-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008676-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008676-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008676-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008676-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD008676-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008676-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008676-abs-0002" lang="en"> <h3>Chlorhexidine mouthrinse to reduce gingivitis and plaque build‐up</h3> <p><b>Review question</b> </p> <p>Does the use of chlorhexidine mouthrinse (a broad spectrum antiseptic) in addition to other conventional tooth cleaning help to control and improve gingivitis (inflammation of the gums)? Does the frequency of rinsing or the concentration of the solution affect the result and are there any undesirable side effects? </p> <p><b>Background</b> </p> <p>Gingivitis is a reversible condition when gums become red, swollen and can bleed easily. Gingivitis is also very common ‐ studies suggest that as many as 50% to 90% of adults in the UK and USA suffer from it. In susceptible people gingivitis may lead to periodontitis, which is not reversible. In periodontitis inflammation is accompanied by loss of ligaments and bone supporting the teeth. If untreated it may eventually lead to tooth loss. Severe periodontitis is the sixth most widespread disease globally. </p> <p>It is recognised that maintaining a high standard of oral hygiene is important for the prevention and treatment of gingivitis. Toothbrushing is the main method for maintaining good oral hygiene. Other cleaning methods commonly used include dental floss, interdental brushes and scaling and polishing carried out by a dental professional. Some people have difficulty controlling plaque build‐up and preventing gingivitis using only conventional tooth cleaning. Therefore people sometimes use mouthrinses containing chlorhexidine in addition to conventional tooth cleaning. These mouthrinses are readily available over the counter; prescriptions generally not being required outside the USA. </p> <p><b>Study characteristics</b> </p> <p>We included 51 studies that analysed a total of 5345 participants. The evidence in this review is up to date as of 28 September 2016. Generally study participants were children and adults who had gingivitis or periodontitis, were able to use usual tooth cleaning methods and were healthy. We did not exclude studies where some or all participants had medical conditions or special care needs as we considered the use of mouthrinses with chlorhexidine to be particularly relevant to them. The included studies assessed the effects of chlorhexidine mouthrinse used for at least 4 weeks in addition to conventional tooth cleaning on gingivitis in children and adults. </p> <p><b>Key results</b> </p> <p>There is high‐quality evidence that the use of mouthrinses containing chlorhexidine in addition to usual toothbrushing and cleaning for 4 to 6 weeks or 6 months leads to a large reduction in the build‐up of plaque. There is also high‐quality evidence of a moderate reduction in gingivitis in people with a mild level of it, although because the level of disease was already low this is not considered clinically important. The nature of the available evidence does not allow us to determine the level of reduction of gingivitis in people with moderate to severe levels of it. </p> <p>There was no evidence that one concentration or strength of chlorhexidine rinse was more effective than another. </p> <p>Rinsing for 4 weeks or longer causes tooth staining, which requires scaling and polishing carried out by a dental professional. Other side effects have been reported, including build‐up of calculus (tartar), temporary taste disturbance and temporary shedding of/damage to the lining of the mouth. </p> <p><b>Quality of the evidence</b> </p> <p>One study was assessed as being at unclear risk of bias, with the remaining 50 being at high risk of bias, however this did not affect the quality assessments for gingivitis and plaque as we believe that further research is very unlikely to change our confidence in the estimate of effect. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008676-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008676-sec-0096"></div> <h3 class="title" id="CD008676-sec-0097">Implications for practice</h3> <section id="CD008676-sec-0097"> <p>This review found high‐quality evidence of a large reduction in dental plaque with chlorhexidine mouthrinse used as an adjunct to mechanical oral hygiene procedures for 4 to 6 weeks and 6 months. We also found high‐quality evidence from studies that reported the Löe and Silness Gingival Index of a reduction in gingivitis in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 Gingival Index (GI) scale), that was not considered to be clinically relevant. There was no evidence that one concentration of chlorhexidine mouthrinse was more effective than another. There was insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation. Rinsing with chlorhexidine mouthrinse for 4 weeks or longer causes extrinsic tooth staining. In addition, other adverse effects such as calculus build‐up, transient taste disturbance and effects on the oral mucosa were reported in the included studies.Chlorhexidine mouthrinse is indicated in particular clinical situations for short periods of time. Using chlorhexidine mouthrinse for longer periods of time in individuals with special care needs who cannot maintain an adequate level of plaque control using mechanical cleaning methods alone must be carefully weighed against the adverse effects associated with its use. </p> </section> <h3 class="title" id="CD008676-sec-0098">Implications for research</h3> <section id="CD008676-sec-0098"> <p>The majority of the studies included in the main analysis of the Gingival Index at 4 to 6 weeks and 6 months involved healthy participants with low levels of gingivitis.There was insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation. Some of the studies included in the meta‐analyses of gingival bleeding at 4 to 6 weeks and 6 months included participants with a high proportion of sites with bleeding on probing. However, due to the variety of different gingival bleeding indices employed, we were unable to determine the mean reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with moderate or severe levels of gingival inflammation. Further well‐conducted randomised controlled trials are needed to investigate the effect size for adjunctive chlorhexidine mouthrinse use in individuals with moderate or severe levels of gingival inflammation. Agreement among the experts about which indices are most appropriate for measuring gingivitis in studies evaluating antimicrobial mouthrinses would facilitate future evidence syntheses. Evidence‐based guidance regarding patient selection for chlorhexidine mouthrinse use would help to provide clarity regarding the 'particular clinical situations' in which short‐term use of chlorhexidine mouthrinse is recommended. </p> <p>Only five studies evaluating 0.05% or 0.06% chlorhexidine mouthrinse met the inclusion criteria for this review. These studies demonstrated a reduction in plaque but the effect of these low‐concentration mouthrinses on gingivitis was not clear or consistent. As low‐concentration chlorhexidine mouthrinse is currently marketed for long‐term daily use, well‐conducted randomised controlled trials are needed to investigate the effect of these mouthrinses on gingivitis and to record any adverse effects associated with their use. </p> <p>Due to the unavoidable influence of extrinsic tooth staining associated with use of chlorhexidine mouthrinse on blinding of participants, personnel and outcome assessors, particular attention must be given to robust study design and rigorous reporting of the other domains in the Cochrane 'Risk of bias' tool. In particular, estimates of effect should be fully reported with a measure of variance so that data can be included in meta‐analyses. Evidence of adverse effects should also be fully reported for each study arm. The CONSORT Statement (<a href="./references#CD008676-bbs2-0175" title="SchulzKF , AltmanDG , MoherD , Group C. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology2010;63(8):834-40.">Schulz 2010</a>) should be used to optimise reporting in future studies. The appropriateness of using studies with cross‐over design that include chlorhexidine mouthrinse warrants further investigation. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008676-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008676-sec-0008"></div> <div class="table" id="CD008676-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Chlorhexidine mouthrinse compared with placebo/control mouthrinse/no mouthrinse for gingival health</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with gingivitis </p> <p><b>Settings:</b> any </p> <p><b>Intervention:</b> chlorhexidine mouthrinse </p> <p><b>Comparison:</b> placebo/control mouthrinse or no mouthrinse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gingival Index 4 to 6 weeks</b> (Löe and Silness Gingival Index) (0 to 3 on an increasing scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean gingivitis scores ranged across control groups from 0.17 to 1.40<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean gingivitis score in the chlorhexidine group was 0.21 lower (0.11 to 0.31 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805</p> <p>(10 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>2,3</sup><br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect size at 6 months was similar</p> <p>Insufficient evidence for differences in effect size for different chlorhexidine concentration or frequency of use </p> <p>Insufficient evidence to determine the effect size in individuals with moderate or severe levels of gingival inflammation on average (mean GI scores 1.1 to 3) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Plaque 4 to 6 weeks</b> </p> <p>(various increasing scales including Plaque Index (0 to 3 scale) and Turesky Modification of the Quigley and Hein Index (0 to 5 scale)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Plaque Index ranged from 0.75 to 1.06</p> <p>Turesky Modification of the Quigley and Hein Index ranged from 1.2 to 3.3</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The SMD was 1.45 lower in the chlorhexidine group indicating a large reduction in plaque from 1.00 to 1.90 standard deviations </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>950</p> <p>(12 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>2,3</sup><br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect for the Plaque Index (4 trials; 223 participants) was 0.58 (95% CI 0.39 to 0.78) lower </p> <p>The effect for the Turesky Modification of the Quigley and Hein Index (5 trials; 546 participants) was 0.78 (95% CI 0.70 to 0.85) lower </p> <p>There were also large effects for the plaque at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tooth staining 4 to 6 weeks</b> </p> <p>(various increasing scales)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tooth staining score was measured on different scales</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The SMD for tooth staining in the chlorhexidine group was<br/>1.07 (0.80 to 1.34) standard deviations higher </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>415</p> <p>(8 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>4</sup><br/><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data have not been converted to original scale as many different scales are used. The SMD effect size is considered large </p> <p>There were also 2 trials presenting dichotomous data showing large significant effect RR 5.41 (95% CI 2.03 to 14.47) </p> <p>There was also a large effect for tooth staining for chlorhexidine at 7 to 12 weeks and 6 months </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>22 trials reported at least 1 adverse effect apart from extrinsic tooth staining and calculus formation in the chlorhexidine rinse arms. The adverse effects most commonly reported were taste disturbance/alteration (reported in 11 trials), effects on the oral mucosa including mucosal irritation, soreness, mild desquamation, mucosal ulceration/erosions, oral mucosal lesions (reported in 13 trials) and a general burning sensation and/or a burning tongue (reported in 9 trials) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across trials) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval; <b>GI:</b> Gingival Index; <b>RR:</b> risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The mean gingivitis score for the control group was 0.93 (median is 1.0).<br/><sup>2</sup>Although most trials included in the meta‐analyses were assessed as at high risk of bias we did not downgrade the GRADE assessments for this reason because we believe that further research is very unlikely to change our confidence in the estimate of effect.<br/><sup>3</sup>Not downgraded for high heterogeneity as results consistent.<br/><sup>4</sup>Downgraded as 8 trials at high risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008676-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008676-sec-0009"></div> <section id="CD008676-sec-0010"> <h3 class="title" id="CD008676-sec-0010">Description of the condition</h3> <p>Plaque‐associated periodontal disease involves the inflammation of the gingivae (gums) and the supporting structures of the teeth. The first stage of the disease is plaque‐associated gingivitis (inflammation of the gingivae), which is a reversible inflammatory condition characterised by redness and swelling of the gingivae and a tendency for the gingivae to bleed easily. It is caused by the accumulation and persistence of microbial biofilms (dental plaque) on the teeth (<a href="./references#CD008676-bbs2-0146" title="LöeH , TheiladeE , JensenSB . Experimental gingivitis in man. Journal of Periodontology1965;36:177-87.">Löe 1965</a>). Gingivitis is very common with studies suggesting that as many as 50% to 90% of adults in the UK and USA suffer from gingivitis (<a href="./references#CD008676-bbs2-0163" title="NICE. National Institute for Health and Care Excellence (NICE). NICE Clinical Knowledge Summaries. Gingivitis and Periodontitis, 2012. cks.nice.org.uk/gingivitis-and-periodontitis#!backgroundsub:10 (accessed March 2015).">NICE 2012</a>). In susceptible individuals, gingivitis may lead to the second stage of periodontal disease, periodontitis. Periodontitis is an irreversible condition, where inflammation of the gingivae is accompanied by connective tissue destruction and loss of the periodontal ligament and alveolar bone supporting the tooth. If untreated, periodontitis may ultimately lead to tooth loss. Severe periodontitis is the sixth most prevalent disease of man with a global age‐standardised prevalence of 11.2% (<a href="./references#CD008676-bbs2-0136" title="KassebaumNJ , BernabéE , DahiyaM , BhandariB , MurrayCJ , MarcenesW . Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. Journal of Dental Research2014;93(11):1045-53.">Kassebaum 2014</a>). It has a negative impact on oral‐health‐related quality of life (<a href="./references#CD008676-bbs2-0101" title="Al-HarthiLS , CullinanMP , LeichterJW , ThomsonWM . The impact of periodontitis on oral health-related quality of life: a review of the evidence from observational studies. Australian Dental Journal2013;58(3):274-7.">Al‐Harthi 2013</a>; <a href="./references#CD008676-bbs2-0154" title="MarcenesW , KassebaumNJ , BernabeE , FlaxmanA , NaghaviM , LopezA , et al. Global burden of oral conditions in 1990-2010: a systematic analysis. Journal of Dental Research2013;92(7):592-7.">Marcenes 2013</a>; <a href="./references#CD008676-bbs2-0160" title="NeedlemanI , McGrathC , FloydP , BiddleA . Impact of oral health on the life quality of periodontal patients. Journal of Clinical Periodontology2004;31(6):454-7.">Needleman 2004</a>; <a href="./references#CD008676-bbs2-0182" title="TonettiMS , ChappleILC , JepsenS , SanzM . Primary and secondary prevention of periodontal and peri-implant diseases - Introduction to, and objectives of the 11th European workshop on periodontology consensus conference. Journal of Clinical Periodontology2015;42(16):S1-S4.">Tonetti 2015</a>), affecting both physical function and social interaction (<a href="./references#CD008676-bbs2-0116" title="Cunha-CruzJ , HujoelPP , KressinNR . Oral health-related quality of life of periodontal patients. Journal of Periodontal Research2007;42(2):169-76.">Cunha‐Cruz 2007</a>; <a href="./references#CD008676-bbs2-0162" title="NgSK , LeungWK . Oral health-related quality of life and periodontal status. Community Dentistry and Oral Epidemiology2006;34(2):114-22.">Ng 2006</a>). The response of the individual to gingival irritation by the microbial biofilm is modulated by local, systemic and genetic factors, and it is recognised that gingivitis will only progress to periodontitis in some individuals and at some sites. However as the microbial biofilm is a prerequisite for both conditions, gingival inflammation is considered a key risk factor in the initiation of periodontitis (<a href="./references#CD008676-bbs2-0112" title="ChappleIL , van derWeijdenF , DoerferC , HerreraD , ShapiraL , PolakD , et al. Primary prevention of periodontitis: managing gingivitis. Journal of Clinical Periodontology2015;42 Suppl 16:S71-6.">Chapple 2015</a>; <a href="./references#CD008676-bbs2-0139" title="LangNP , SchätzleMA , LöeH . Gingivitis as a risk factor in periodontal disease. Journal of Clinical Periodontology2009;36 Suppl 10:3-8.">Lang 2009</a>). Indeed, consistent inflammation of the gingivae and gingival bleeding are predictive of future attachment loss and tooth loss (<a href="./references#CD008676-bbs2-0174" title="SchatzleM , LoeH , LangNP , BurginW , AnerudA , BoysenH . The clinical course of chronic periodontitis. Journal of Clinical Periodontology2004;31(12):1122-7.">Schatzle 2004</a>). </p> <p>Although it is not possible to identify those individuals who will go on to develop severe periodontitis, the importance of maintaining a high standard of oral hygiene in the prevention and treatment of periodontal diseases is well recognised (<a href="./references#CD008676-bbs2-0102" title="AxelssonP , NystromB , LindheJ . The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. Journal of Clinical Periodontology2004;31(9):749-57.">Axelsson 2004</a>; <a href="./references#CD008676-bbs2-0165" title="OhrnK , SanzM . Prevention and therapeutic approaches to gingival inflammation. Journal of Clinical Periodontology2009;36 Suppl 10:20-6.">Ohrn 2009</a>; <a href="./references#CD008676-bbs2-0187" title="van derWeijdenF , SlotDE . Oral hygiene in the prevention of periodontal diseases: the evidence. Periodontology 20002011;55(1):104-23.">van der Weijden 2011</a>). Furthermore, the most important predictor of periodontal diseases, regardless of age is poor oral hygiene (<a href="./references#CD008676-bbs2-0095" title="AbdellatifHM , BurtBA . An epidemiological investigation into the relative importance of age and oral hygiene status as determinants of periodontitis. Journal of Dental Research1987;66(1):13-8.">Abdellatif 1987</a>). Thus, the population approach to prevention of periodontal diseases should promote adequate plaque control and removal of the microbial biofilm for all individuals. </p> </section> <section id="CD008676-sec-0011"> <h3 class="title" id="CD008676-sec-0011">Description of the intervention</h3> <p>Mechanical disruption and removal of the microbial biofilm is commonly achieved by toothbrushing and interdental cleaning (<a href="./references#CD008676-bbs2-0104" title="BerchierCE , SlotDE , HapsS , Van der WeijdenGA . The efficacy of dental floss in addition to a toothbrush on plaque and parameters of gingival inflammation: a systematic review. International Journal of Dental Hygiene2008;6(4):265-79.">Berchier 2008</a>). However, adequate removal of the microbial biofilm with mechanical methods alone can be difficult for some, with many individuals finding it difficult to maintain an effective level of plaque control (<a href="./references#CD008676-bbs2-0156" title="MarshPD . Microbiological aspects of the chemical control of plaque and gingivitis. Journal of Dental Research1992;71(7):1431-8.">Marsh 1992</a>; <a href="./references#CD008676-bbs2-0171" title="SalzerS , SlotDE , Van der WeijdenFA , DorferCE . Efficacy of inter-dental mechanical plaque control in managing gingivitis - a meta-review. Journal of Clinical Periodontology2015;42:S92-S105.">Salzer 2015</a>; <a href="./references#CD008676-bbs2-0179" title="SlotDE , WiggelinkhuizenL , RosemaNA , van derWeijdenGA . The efficacy of manual toothbrushes following a brushing exercise: a systematic review. International Journal of Dental Hygiene2012;10(3):187-97.">Slot 2012</a>; <a href="./references#CD008676-bbs2-0185" title="van derWeijdenGA , HioeKP . A systematic review of the effectiveness of self-performed mechanical plaque removal in adults with gingivitis using a manual toothbrush. Journal of Clinical Periodontology2005;32:214-28.">van der Weijden 2005</a>; <a href="./references#CD008676-bbs2-0187" title="van derWeijdenF , SlotDE . Oral hygiene in the prevention of periodontal diseases: the evidence. Periodontology 20002011;55(1):104-23.">van der Weijden 2011</a>; <a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a>). For these individuals, the level of plaque control that is achieved by regular mechanical cleaning alone may not be sufficient to prevent the onset or recurrence of periodontal diseases (<a href="./references#CD008676-bbs2-0176" title="SerranoJ , EscribanoM , RoldánS , MartínC , HerreraD . Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. Journal of Clinical Periodontology2015;42(16):S106-38.">Serrano 2015</a>).Therefore chemical methods of removing the microbial biofilm such as antimicrobial mouthrinses have been recommended for use as either an adjunct to, or in some limited situations, a replacement for mechanical removal of the microbial biofilm. </p> <p>Chlorhexidine is a broad spectrum bisbiguanide antiseptic which was first introduced into clinical medicine in 1953 in the form of an antiseptic cream (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0124" title="FoulkesDM . Some toxicological observations on chlorhexidine. Journal of Periodontal Research Supplement1973;12:55-60.">Foulkes 1973</a>). It is a strong base and is practically insoluble in water (<a href="./references#CD008676-bbs2-0135" title="KarpinskiTM , SzkaradkiewiczAK . Chlorhexidine - pharmaco-biological activity and application. European Review for Medical and Pharmacological Sciences2015;19(7):1321-6.">Karpinski 2015</a>). In clinical medicine its water soluble salts, in particular chlorhexidine digluconate, are most commonly used (<a href="./references#CD008676-bbs2-0124" title="FoulkesDM . Some toxicological observations on chlorhexidine. Journal of Periodontal Research Supplement1973;12:55-60.">Foulkes 1973</a>; <a href="./references#CD008676-bbs2-0135" title="KarpinskiTM , SzkaradkiewiczAK . Chlorhexidine - pharmaco-biological activity and application. European Review for Medical and Pharmacological Sciences2015;19(7):1321-6.">Karpinski 2015</a>). In dentistry, chlorhexidine is used in a variety of formulations and vehicles, such as mouthrinses, gels, sprays and varnishes. Problems can be encountered when delivering chlorhexidine as a gel or a toothpaste as the chlorhexidine may bind to ingredients in the products reducing its activity (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>). Although considerable advances have been made in recent years in the formulation of these and other chlorhexidine vehicles, mouthrinses have the advantage of having a long history of use for oral health. They are already accepted as part of a normal oral hygiene regimen, used following normal mechanical tooth cleaning (<a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a>). Chlorhexidine‐containing mouthrinses are marketed worldwide under a number of trade names and are in widespread use for chemical plaque control. This family of rinses are mainly indicated for use as adjuncts to mechanical cleaning, in specific clinical situations where mechanical oral hygiene is difficult, such as postsurgery, in individuals with intermaxillary fixation, in fixed appliance orthodontic therapy and in individuals with intellectual and physical disabilities (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>). Chlorhexidine mouthrinse is mainly available in concentrations of 0.1%, 0.12% or 0.2% chlorhexidine digluconate as well as in low concentration (≤ 0.06%) rinse. The effect of chlorhexidine on the microbial biofilm is dose‐dependant (<a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). The optimum dose of chlorhexidine in a mouthrinse is considered to be 20 mg twice daily (<a href="./references#CD008676-bbs2-0148" title="LöeH , SchiottCR . The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. Journal of Periodontal Research1970;5(2):79-83.">Löe 1970</a>) equivalent to 10 mL of 0.2% chlorhexidine mouthrinse (20 mg) or 15 mL of 0.12% chlorhexidine mouthrinse (18 mg) (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). A rinse time of 30 seconds appears to be effective and acceptable although 60‐second rinse times are also advocated (<a href="./references#CD008676-bbs2-0107" title="BonesvollP , LokkenP , RollaG . Influence of concentration, time, temperature and pH on the retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(11):1025-9.">Bonesvoll 1974</a>; <a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). </p> </section> <section id="CD008676-sec-0012"> <h3 class="title" id="CD008676-sec-0012">How the intervention might work</h3> <p>The action of chlorhexidine mouthrinse as a treatment adjunct in managing inflammation of the gingivae involves its antimicrobial properties, which reduce the bacterial load of the microbial biofilm and should therefore reduce levels of inflammation and help prevent primary and secondary plaque‐associated periodontal disease. Chlorhexidine digluconate has the ability to kill a wide variety of micro‐organisms including gram‐positive and gram‐negative bacteria (aerobes and anaerobes) (<a href="./references#CD008676-bbs2-0121" title="EmilsonCG . Susceptibility of various microorganisms to chlorhexidine. Scandinavian Journal of Dental Research1977;85(4):255-65.">Emilson 1977</a>) as well as fungi including yeasts (<a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>; <a href="./references#CD008676-bbs2-0168" title="Puig SillaM , Montiel CompanyJM , Almerich SillaJM . Use of chlorhexidine varnishes in preventing and treating periodontal disease. A review of the literature. Medicina Oral, Patología Oral y Cirugía Bucal2008;13(4):E257-60.">Puig Silla 2008</a>). When chlorhexidine mouthrinse is used, the positively charged (cationic) chlorhexidine molecule binds to the negatively charged microbial cell wall and interferes with the osmotic equilibrium of the micro‐organism. Depending on the dose, chlorhexidine can have a bacteriostatic or bacteriocidal effect. At low concentrations, chlorhexidine is bacteriostatic causing leakage of low molecular weight substances from the microbial cell and inhibiting reproduction. At higher concentrations chlorhexidine is bacteriocidal and causes cell death by precipitating the cytoplasmic contents of the microbial cell (<a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>; <a href="./references#CD008676-bbs2-0168" title="Puig SillaM , Montiel CompanyJM , Almerich SillaJM . Use of chlorhexidine varnishes in preventing and treating periodontal disease. A review of the literature. Medicina Oral, Patología Oral y Cirugía Bucal2008;13(4):E257-60.">Puig Silla 2008</a>). This ability of chlorhexidine to adsorb and adhere to negatively charged surfaces is central to its success as an antimicrobial agent. The chlorhexidine molecule has the ability to adsorb to anionic (negatively charged) substrates such as hydroxyapatite, pellicle, salivary glycoproteins and mucous membranes exerting an immediate bacteriocidal effect. When slowly released over time from the pellicle‐coated enamel surface, it provides a prolonged bacteriostatic effect in vivo (<a href="./references#CD008676-bbs2-0107" title="BonesvollP , LokkenP , RollaG . Influence of concentration, time, temperature and pH on the retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(11):1025-9.">Bonesvoll 1974</a>; <a href="./references#CD008676-bbs2-0108" title="BonesvollP , LokkenP , RollaG , PausPN . Retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(3):209-12.">Bonesvoll 1974a</a>; <a href="./references#CD008676-bbs2-0109" title="BonesvollP , GjermoP . A comparison between chlorhexidine and some quaternary ammonium compounds with regard to retention, salivary concentration and plaque-inhibiting effect in the human mouth after mouth rinses. Arch Oral Biol1978;23(4):289-94. [0003-9969: (Print)]">Bonesvoll 1978</a>; <a href="./references#CD008676-bbs2-0133" title="JenkinsS , AddyM , WadeW . The mechanism of action of chlorhexidine. A study of plaque growth on enamel inserts in vivo. Journal of Clinical Periodontology1988;15(7):415-24.">Jenkins 1988</a>; <a href="./references#CD008676-bbs2-0170" title="RollaG , LoeH , SchiottCR . Retention of chlorhexidine in the human oral cavity. Archives of Oral Biology1971;16(9):1109-16.">Rolla 1971</a>). This property of chlorhexidine is known as its substantivity and is what sets chlorhexidine apart from many other antimicrobial agents. </p> <p>Chlorhexidine mouthrinse use is associated with a number of local adverse effects the most common being the formation of brown staining on the teeth and oral tissues, particularly the tongue (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>). Several theories have been put forward to explain the cause of this characteristic staining, however most evidence points to the staining being a result of precipitation of anionic dietary chromogens (e.g. from tea, coffee, tannins from wine) onto adsorbed chlorhexidine cations (<a href="./references#CD008676-bbs2-0096" title="AddyM , MoranJ . Extrinsic tooth discoloration by metals and chlorhexidine. 2. Clinical staining produced by chlorhexidine, iron and tea. British Dental Journal1985;159(10):331-4.">Addy 1985</a>; <a href="./references#CD008676-bbs2-0097" title="AddyM , MoranJ , GriffithsAA , WillswoodNJ . Extrinsic tooth discoloration by metals and chlorhexidine. 1. Surface protein denaturation or dietary precipitation. British Dental Journal1985;159(9):281-5.">Addy 1985a</a>; <a href="./references#CD008676-bbs2-0191" title="WattsA , AddyM . Tooth discolouration and staining: a review of the literature. British Dental Journal2001;190(6):309-16.">Watts 2001</a>). Other less common local adverse effects have also been reported including supragingival calculus accumulation (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0152" title="MandelID . Antimicrobial mouthrinses: overview and update. Journal of the American Dental Association1994;125 Suppl 2:2S-10S.">Mandel 1994</a>; <a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>), oral mucosal lesions (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>; <a href="./references#CD008676-bbs2-0123" title="FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25.">Flotra 1971</a>; <a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>), and altered taste perception (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>; <a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0155" title="MarinoneMG , SavoldiE . Chlorhexidine and taste. Influence of mouthwashes concentration and of rinsing time. Minerva Stomatologica2000;49(5):221-6.">Marinone 2000</a>; <a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>). The occurrence of side effects tends to be reduced with lower chlorhexidine concentrations (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>; <a href="./references#CD008676-bbs2-0115" title="CummingBR , LöeH . Optimal dosage and method of delivering chlorhexidine solutions for the inhibition of dental plaque. Journal of Periodontal Research1973;8(2):57-62.">Cumming and Löe 1973</a>; <a href="./references#CD008676-bbs2-0123" title="FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25.">Flotra 1971</a>; <a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). With the exception of extrinsic staining of the teeth and calculus accumulation which require removal by professional tooth cleaning, the adverse effects are transient and resolve once chlorhexidine mouthrinse use has ceased (<a href="./references#CD008676-bbs2-0123" title="FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25.">Flotra 1971</a>; <a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>). These local adverse effects limit the use of chlorhexidine to short or moderate term use in specific clinical circumstances (<a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a>). Chlorhexidine is poorly absorbed by the oral tissues and the gastrointestinal tract and is considered to have very low toxicity (<a href="./references#CD008676-bbs2-0124" title="FoulkesDM . Some toxicological observations on chlorhexidine. Journal of Periodontal Research Supplement1973;12:55-60.">Foulkes 1973</a>; <a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>). Parotid gland swelling has been reported following chlorhexidine mouthrinse use (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>; <a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0186" title="van derWeijdenGA , ten HeggelerJMAG , SlotDE , RosemaNAM , van derVeldenU . Parotid gland swelling following mouthrinse use. International Journal of Dental Hygiene2010;8(4):276-9.">van der Weijden 2010</a>). There have been rare reports of type 1 hypersensitivity reactions to chlorhexidine used in the mouth or on the lips (<a href="./references#CD008676-bbs2-0166" title="PembertonMN , GibsonJ . Chlorhexidine and hypersensitivity reactions in dentistry. British Dental Journal2012;213(11):547-50.">Pemberton 2012</a>) but severe reactions such as anaphylaxis do not appear to have occurred as a result of using chlorhexidine mouthrinse to maintain periodontal health. </p> </section> <section id="CD008676-sec-0013"> <h3 class="title" id="CD008676-sec-0013">Why it is important to do this review</h3> <p>Chlorhexidine mouthrinse is readily available and a prescription is generally not required outside the USA (<a href="./references#CD008676-bbs2-0158" title="MoranJM . Home-use oral hygiene products: mouthrinses. Periodontology 20002008;48:42-53.">Moran 2008</a>). Its efficacy in controlling plaque and gingivitis in humans in the absence of active oral hygiene was first demonstrated over 40 years ago by Harald Löe and colleagues (<a href="./references#CD008676-bbs2-0148" title="LöeH , SchiottCR . The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. Journal of Periodontal Research1970;5(2):79-83.">Löe 1970</a>). Nowadays chlorhexidine mouthrinse is mostly used as an adjunct to regular mechanical oral hygiene and is commonly regarded as the gold standard against which other antiplaque agents are measured (<a href="./references#CD008676-bbs2-0134" title="JonesCG . Chlorhexidine: is it still the gold standard?Periodontology 20001997;15:55-62.">Jones 1997</a>; <a href="./references#CD008676-bbs2-0156" title="MarshPD . Microbiological aspects of the chemical control of plaque and gingivitis. Journal of Dental Research1992;71(7):1431-8.">Marsh 1992</a>). The last decade has seen the publication of two meta‐analyses (<a href="./references#CD008676-bbs2-0129" title="GunsolleyJC . A meta-analysis of six-month studies of antiplaque and antigingivitis agents. Journal of the American Dental Association2006;137(12):1649-57.">Gunsolley 2006</a>; <a href="./references#CD008676-bbs2-0130" title="GunsolleyJC . Clinical efficacy of antimicrobial mouthrinses. Journal of Dentistry2010;38 Suppl 1:S6-10.">Gunsolley 2010</a>) and a number of systematic reviews (including one metareview) of the effectiveness of chlorhexidine mouthrinse (<a href="./references#CD008676-bbs2-0110" title="BoyleP , KoechlinA , AutierP . Mouthwash use and the prevention of plaque, gingivitis and caries. Oral Disease2014;20 Suppl 1:1-68.">Boyle 2014</a>; <a href="./references#CD008676-bbs2-0176" title="SerranoJ , EscribanoM , RoldánS , MartínC , HerreraD . Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. Journal of Clinical Periodontology2015;42(16):S106-38.">Serrano 2015</a>; <a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a>; <a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>). In most of these publications chlorhexidine mouthrinse was one of a number of antiplaque chemical agents under review. The one dedicated review of the effectiveness of chlorhexidine mouthrinse compared to placebo, control or regular oral hygiene employed slightly different inclusion criteria to this review but included tooth staining as an outcome in addition to gingivitis and plaque (<a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>). However, the search for this review was conducted in April 2011 and adverse effects other than extrinsic tooth staining were not prespecified outcomes in the review. </p> <p>Given the numerous clinical indications for the use of chlorhexidine mouthrinse for gingivitis and plaque control, and the ready availability of chlorhexidine mouthrinse over‐the‐counter in many parts of the world, it is important to conduct a Cochrane systematic review of chlorhexidine mouthrinse as an adjunctive treatment for gingival health in order to provide, rigorous, up‐to‐date evidence for patients, oral health practitioners and policy makers. This should take into account the risk of bias of the studies that have been conducted, as well as assessing the possible adverse effects of the chlorhexidine mouthrinse. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008676-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008676-sec-0014"></div> <p>To assess the effectiveness of chlorhexidine mouthrinse used as an adjunct to mechanical oral hygiene procedures for the control of gingivitis and plaque compared to mechanical oral hygiene procedures alone or mechanical oral hygiene procedures plus placebo/control mouthrinse. Mechanical oral hygiene procedures were toothbrushing with/without the use of dental floss or interdental cleaning aids and could include professional tooth cleaning/periodontal treatment. </p> <p>To determine whether the effect of chlorhexidine mouthrinse is influenced by chlorhexidine concentration, or frequency of rinsing (once/day versus twice/day). </p> <p>To report and describe any adverse effects associated with chlorhexidine mouthrinse use (reporting of adverse effects is limited to those detailed in the included trials). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008676-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008676-sec-0015"></div> <section id="CD008676-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008676-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included parallel‐group randomised controlled trials (RCTs) irrespective of language or publication status where the duration of mouthrinsing was at least 4 weeks.The minimum duration of rinsing was selected to reflect the 'real life' use of chlorhexidine as a short‐term adjunct to mechanical oral hygiene procedures. Studies where the duration of mouthrinsing was less than 4 weeks were excluded. Cross‐over studies were excluded due to concerns that chlorhexidine could exert an effect beyond the washout period. It would not be possible to conduct a split‐mouth study of mouthrinse use, however split‐mouth studies comparing different scaling and root planing regimens and different periodontal surgical techniques often incorporate a chlorhexidine and placebo/control comparison. Such study designs were considered inappropriate to answer the question posed by this review and were excluded. We would have included properly designed cluster‐RCTs if any such studies had met the inclusion criteria. </p> </section> <section id="CD008676-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included RCTs involving children or adults with gingivitis or periodontitis provided they were capable of performing normal mechanical oral hygiene procedures (in accordance with other Cochrane reviews, we classified all participants aged 16 years or less as children and those older than 16 years as adults). We included trials where some or all of the participants had medical conditions or special care needs as we considered the intervention to be particularly relevant to these individuals/groups. </p> </section> <section id="CD008676-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Experimental intervention: chlorhexidine mouthrinse (used at any concentration, volume, frequency or duration of rinsing) used in conjunction with mechanical oral hygiene procedures (toothbrushing with/without the use of dental floss or interdental cleaning aids and could include professional tooth cleaning/periodontal treatment). </p> <p>Comparator interventions: mechanical oral hygiene alone (toothbrushing with/without the use of dental floss or interdental cleaning aids and could include professional tooth cleaning/periodontal treatment), or mechanical oral hygiene used in conjunction with placebo/control mouthrinse. </p> <p>We included studies:</p> <p> <ul id="CD008676-list-0001"> <li> <p>where the chlorhexidine mouthrinse also contained fluoride;</p> </li> <li> <p>where gum care or antigingivitis dentifrices (that did not contain chlorhexidine) were used for mechanical oral hygiene provided that they were used in both experimental and comparator arms; </p> </li> <li> <p>with and without baseline prophylaxis (scale and polish) but all study arms had to have the same treatment. </p> </li> </ul> </p> <p>We excluded studies:</p> <p> <ul id="CD008676-list-0002"> <li> <p>where chlorhexidine mouthrinse was used as a monotherapy in the absence of mechanical oral hygiene procedures; </p> </li> <li> <p>where the chlorhexidine mouthrinse formed part of a combined intervention with other agents (such as other chlorhexidine vehicles, e.g. dentifrice‐containing chlorhexidine, or other antimicrobial agents (e.g. cetylpyridinium chloride (CPC)) that the comparator arm/s did not receive because we would have been unable to separate the effect of the chlorhexidine from the effect of the other active agents; </p> </li> <li> <p>where the mechanical oral hygiene procedures were not the same in both the chlorhexidine mouthrinse and the comparator arms e.g. studies or study arms where experimental or comparator arms received more intensive or more frequent professional mechanical cleaning or used additional mechanical cleaning aids e.g. dental floss as part of the intervention that was different from the other study arms; </p> </li> <li> <p>where chlorhexidine mouthrinse was applied locally e.g. with a brush or via subgingival irrigation. </p> </li> </ul> </p> </section> <section id="CD008676-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD008676-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>Gingivitis measured using any appropriate index/scale.</p> <p>Only trials that reported gingivitis as an outcome were considered for inclusion in the review. The clinical features of gingivitis can be assessed non‐invasively by visual assessment of colour, contour and gingival bleeding or invasively using an instrument to provoke bleeding or both (<a href="./references#CD008676-bbs2-0151" title="LorenzK , BruhnG , NetuschilL , HeumannC , HoffmannT . How to select study designs and parameters to investigate the effect of mouthrinses? Part I: rationale and background. Journal of Physiology and Pharmacology2009;60 Suppl 8:77-83.">Lorenz 2009</a>). The Gingival Index of Löe and Silness (GI) utilises both visual assessment and assessment of bleeding on provocation. It can be measured at specific sites using six index teeth (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>) or all teeth (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>). Each site is scored on a 0 to 3 increasing scale and an average score can be calculated for each tooth assessed. The mean score for an individual represents an average score for the areas examined. The Modified Gingival Index (MGI) (<a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>) can be used as a full‐mouth index or applied to selected teeth and is measured non‐invasively on a 0 to 4 increasing scale i.e. there is no attempt to use pressure to elicit bleeding. Many indices measure gingivitis solely by assessing bleeding on provocation but the techniques used to elicit bleeding can vary between indices. The Gingival Bleeding Index (<a href="./references#CD008676-bbs2-0100" title="AinamoJ , BayI . Problems and proposals for recording gingivitis and plaque. International Dental Journal1975;25(4):229-35.">Ainamo and Bay 1975</a>) uses a blunt pocket probe to gently probe the orifice of the gingival crevice. If bleeding occurs within about 10 seconds after testing, a positive finding is recorded. The percentage of sites with gingival bleeding are calculated for the individual. </p> <p>It is not uncommon for multiple measures of gingivitis to be presented within one study. Therefore the following hierarchy was developed to simplify data extraction. </p> <p> <ul id="CD008676-list-0003"> <li> <p>Where gingival inflammation and gingival bleeding were reported within the same study we extracted data on both outcomes. </p> </li> <li> <p>Where gingival inflammation was reported using more than one index within a study, the GI (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>) was chosen over other indices and the MGI (<a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>) was chosen next if the gingival index was not reported. </p> </li> <li> <p>Where gingival bleeding was reported within a study as bleeding on probing (BOP) (<a href="./references#CD008676-bbs2-0100" title="AinamoJ , BayI . Problems and proposals for recording gingivitis and plaque. International Dental Journal1975;25(4):229-35.">Ainamo and Bay 1975</a>) and the proportion of sites with BOP using the GI (i.e. GI scores 2 or 3) (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>), BOP was chosen over the proportion of sites with BOP (GI scores 2 or 3). </p> </li> </ul> </p> <p>Within the gingival index, the severity (the average extent of the disease) was considered a measure of gingival inflammation and occurrence (the proportion of sites with BOP i.e. GI scores 2 or 3) was considered a measure of gingival bleeding. </p> <p>Outcome data at 4 to 6 weeks, 7 to 12 weeks, 13 weeks to 6 months and greater than 6 months were collected and reported but the primary analysis of the gingivitis data was concerned with short‐term use (4 to 6 weeks), along with a longer term measure at 6 months. </p> </section> <section id="CD008676-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>Data on the following secondary outcomes were extracted from eligible trials that also reported gingivitis as an outcome. </p> <p> <ul id="CD008676-list-0004"> <li> <p>Dental plaque measured using any appropriate index/scale. Although dental plaque can be measured using a variety of different indices, the Plaque Index (<a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) and the Turesky modification of the Quigley and Hein index (TQH) (<a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>) are commonly used to measure dental plaque. Both use an increasing scale to quantify the amount of plaque present. The Plaque Index uses a 0 to 3 increasing scale to quantify the amount of plaque on each surface (buccal, lingual, mesial and distal) of six index teeth. An average score for each tooth and for the individual can then be calculated. The TQH uses a 0 to 5 increasing scale to quantify the amount of plaque on the buccal and lingual surfaces of the teeth. An average score for the individual can then be calculated. Where dental plaque was measured using more than one index within a study; the Plaque Index (<a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) was chosen over other indices and the TQH (<a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>) was chosen next if the Plaque Index was not reported. </p> </li> <li> <p>Calculus measured using any appropriate index/scale.</p> </li> <li> <p>Tooth staining measured using any appropriate index/scale.</p> </li> <li> <p>Adverse effects (e.g. mucosal desquamation, taste disturbances, allergic reactions).</p> </li> </ul> </p> </section> </section> </section> <section id="CD008676-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008676-sec-0024"> <h4 class="title">Electronic searches</h4> <p>Cochrane Oral Health's Information Specialist conducted systematic searches in the following databases for randomised controlled trials and controlled clinical trials without language or publication status restrictions: </p> <p> <ul id="CD008676-list-0005"> <li> <p>Cochrane Oral Health's Trials Register (searched 28 September 2016) (<a href="./appendices#CD008676-sec-0102">Appendix 1</a>); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 8) in the Cochrane Library (searched 28 September 2016) (<a href="./appendices#CD008676-sec-0103">Appendix 2</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 28 September 2016) (<a href="./appendices#CD008676-sec-0104">Appendix 3</a>); </p> </li> <li> <p>Embase Ovid (1980 to 28 September 2016) (<a href="./appendices#CD008676-sec-0105">Appendix 4</a>); </p> </li> <li> <p>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature; 1937 to 28 September 2016) (<a href="./appendices#CD008676-sec-0106">Appendix 5</a>). </p> </li> </ul> </p> <p>Subject strategies were modelled on the search strategy designed for MEDLINE Ovid. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 6 (<a href="./references#CD008676-bbs2-0142" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins PJ, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Lefebvre 2011</a>). </p> </section> <section id="CD008676-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the following trial registries for ongoing studies:</p> <p> <ul id="CD008676-list-0006"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; searched 28 September 2016) (<a href="./appendices#CD008676-sec-0107">Appendix 6</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>; searched 28 September 2016) (<a href="./appendices#CD008676-sec-0108">Appendix 7</a>). </p> </li> </ul> </p> <p>We searched the reference lists of included studies and relevant systematic reviews for further studies. We attempted to contact companies that manufacture chlorhexidine mouthrinse (Colgate Palmolive (Periogard), 3M (Peridex), GlaxoSmithKline (Corsodyl)) and companies that manufacture other types of mouthrinse (Johnson &amp; Johnson (Listerine), P&amp;G (Oral B brand)) to identify unpublished and ongoing studies. </p> <p>We did not perform a separate search for adverse effects of interventions. Only the adverse effects that were described in the included studies were considered. </p> </section> </section> <section id="CD008676-sec-0026"> <h3 class="title" id="CD008676-sec-0026">Data collection and analysis</h3> <section id="CD008676-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently and in duplicate screened the titles and abstracts of the list of studies identified by the searching process against the inclusion criteria for the review to identify eligible and potentially eligible studies. We obtained full‐text copies of all the potentially eligible studies, and also of studies with insufficient information in the title/abstract to make a decision on eligibility. The review authors were not blinded to the journal name, authors, institution, results or sources of funding when assessing eligibility of the identified studies. Two review authors independently and in duplicate assessed the full‐text copies to identify those that met the inclusion criteria. We contacted study authors for clarification or missing information relating to eligibility where necessary and feasible. We linked multiple reports of the same study together under one single study title. We resolved any disagreements on eligibility through discussion but, if this was not possible, an experienced member of the Cochrane Oral Health editorial team (H Worthington) was consulted to achieve consensus. We recorded any studies failing to meet the inclusion criteria, along with reasons for exclusion.<br/>The eligibility of the non‐English language reports were assessed by two review authors independently and in duplicate. Relevant sections of the reports were translated with the assistance of Cochrane Oral Health. Non‐English language reports that met the inclusion criteria for the review were translated in full. </p> <p>This process is summarised in the 'Study flow diagram' (<a href="#CD008676-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD008676-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD008676-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD008676-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently and in duplicate extracted data from the included studies using a customised Excel spreadsheet that was piloted on a small sample of studies. We contacted study authors for clarification or missing information where necessary and feasible. We resolved any disagreements through discussion and where agreement could not be reached, an experienced member of the Cochrane Oral Health editorial team (H Worthington) was consulted to achieve consensus. </p> <p>We recorded the following data for each included study, which were then tabulated in the '<a href="./references#CD008676-sec-0119" title="">Characteristics of included studies</a>' tables. </p> <p> <ul id="CD008676-list-0007"> <li> <p>Trial design, location/setting, number of centres, study duration.</p> </li> <li> <p>Details of the participants including demographic characteristics, criteria for inclusion and exclusion, and relevant information on gingivitis levels at baseline, numbers randomised to each study arm, and numbers analysed in each arm. </p> </li> <li> <p>Details of the type of experimental/comparator intervention, concentration and volume of mouthrinse, frequency and duration of rinsing, baseline prophylaxis (scale and polish), details of oral hygiene instruction (OHI), supervision of mouthrinsing, timing of mouthrinsing in relation to toothbrushing and postrinsing instructions. </p> </li> <li> <p>Details of the outcomes reported, including method and timing of assessment.</p> </li> <li> <p>Sample size calculations, source of study funding, information about adverse effects, proportion of smokers in the studies/study arms and declarations/conflicts of interest. </p> </li> <li> <p>Outcome data: For gingivitis and plaque we extracted outcome data from the end point of each study with the exception of studies where the duration of rinsing was longer than 6 months. In this situation interim data for gingivitis and plaque at 6 months were extracted in addition to data at the end point of the study. We considered interim data on extrinsic tooth staining and calculus formation important in determining the time of onset of these adverse effects. Therefore, where they were reported, data on extrinsic tooth staining and calculus formation were extracted at interim time points as well as at the end point of each study. Outcome data were grouped according the following time intervals: 4 to 6 weeks, 7 to 12 weeks, 13 weeks to 6 months and greater than 6 months. Where data on extrinsic tooth staining or calculus were reported twice within one time interval, the later results were data extracted. Where an outcome was measured after rinsing has ceased, we considered the time point that rinsing ceased as the primary end point. Studies that measured gingivitis and plaque outcomes only after cessation of rinsing were included in a separate analysis of the long‐term effects of rinsing with chlorhexidine mouthrinse on gingivitis and plaque. We did not extract extrinsic tooth staining and calculus data reported after rinsing had ceased. </p> </li> <li> <p>Where studies reported mean scores for the Gingival Index at 4 to 6 weeks or 6 months but did not report a measure of variance and a measure of variance could not be obtained from the authors of the studies, the variance was estimated from the standard deviations reported in similar trials that used the same index at the same time point as described in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Where mean scores and measures of variance were reported only in graphs and the data could not be obtained from the authors of the studies, data were estimated by reading the data off the graphs in the published report for inclusion in meta‐analyses. The graphs were enlarged and the data were estimated independently and in duplicate. Any disagreements were resolved by discussion. A sensitivity analysis was conducted to gauge the effects of estimating these outcome data on the overall results. </p> </li> </ul> </p> </section> <section id="CD008676-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors assessed the risk of bias of all included studies, independently and in duplicate, using Cochrane's domain‐based, two‐part tool as described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We contacted study authors for clarification or missing information where necessary and feasible. We tried to resolve any disagreements on risk of bias through discussion but, if this was not possible, an experienced member of the Cochrane Oral Health editorial team (H Worthington) was consulted to achieve consensus. A 'Risk of bias' table was completed for each included study. For each domain of risk of bias, we first described what was reported to have happened in the study in order to provide a rationale for the second part, which involved assigning a judgement of 'low risk' of bias, 'high risk' of bias, or 'unclear risk' of bias. </p> <p>For each included study, we assessed the following seven domains of risk of bias.</p> <p> <ul id="CD008676-list-0008"> <li> <p>Random sequence generation (selection bias): use of simple randomisation (e.g. random number table, computer‐generated randomisation, central randomisation by a specialised unit), restricted randomisation (e.g. random permuted blocks), stratified randomisation and minimisation were assessed as at low risk of bias. Other forms of simple randomisation, such as repeated coin tossing, throwing dice or dealing cards, were also considered as at low risk of bias. If a study report used the phrase 'randomised' or 'random allocation' but with no further information, and if randomisation could not be confirmed, we assessed it as unclear for this domain. </p> </li> <li> <p>Allocation concealment (selection bias): use of centralised/remote allocation, pharmacy‐controlled randomisation (i.e. allocation of sequentially numbered mouthrinse containers of identical appearance) and sequentially numbered, sealed, opaque envelopes were assessed as at low risk of bias. If a study report did not mention allocation concealment, we assessed it as unclear for this domain. </p> </li> <li> <p>Blinding of participants and personnel (performance bias): if blinding was not mentioned, we assessed this domain as at unclear risk of bias. We only considered personnel blinding for studies with supervised mouthrinsing. If a study was described as double blind, we assumed that the intention was for participants and outcome assessors to be blinded to group allocation, however due to the propensity for chlorhexidine to stain the teeth and oral tissues and the association of its use with visible adverse effects such as mucosal desquamation and mucosal lesions, we considered the potential effect of these on blinding as follows. </p> </li> </ul> </p> <p> <ul class="plain" id="CD008676-list-0009"> <li> <ul id="CD008676-list-0010"> <li> <p>Where tooth staining/adverse effects were reported narratively or measured using a scale (where relevant) and were higher in the chlorhexidine rinse arm/s, we considered that participants could have worked out which study arm they were in and this could have affected their oral health behaviours and hence the outcome and assessed this domain as at high risk of bias irrespective of whether participant blinding was indicated. </p> </li> <li> <p>Where tooth staining/adverse effects were reported narratively or measured using a scale (where relevant) but were not higher in the chlorhexidine rinse arm/s and participant blinding was also indicated, we assessed this domain as at low risk of bias. </p> </li> <li> <p>Where tooth staining/adverse effects were not reported, although we considered it likely in this situation that tooth staining or other visible adverse effects could have occurred and been noticeable in the chlorhexidine rinse arm/s after 4 weeks or more of rinsing, we assessed this domain as unclear as there was not enough information upon which to base a judgement. </p> </li> <li> <p>Where it was not possible to blind participants and personnel due to differences in the experimental and comparator interventions this domain was assessed as at high risk of bias. </p> </li> </ul> </li> </ul> </p> <p> <ul id="CD008676-list-0011"> <li> <p>Blinding of outcome assessment (detection bias): if blinding was not mentioned, we assessed this domain as at unclear risk of bias. If a study was described as double blind, we assumed that the intention was for participants and outcome assessors to be blinded to group allocation, however due to the propensity for chlorhexidine to stain the teeth and oral tissues and the association of its use with visible adverse effects such as mucosal desquamation and mucosal lesions, we considered the potential effect of these on blinding as follows. </p> <ul id="CD008676-list-0012"> <li> <p>Where tooth staining/adverse effects such as mucosal desquamation and mucosal lesions that could be visible to the outcome assessor were reported narratively or measured using a scale (where relevant) and were higher in the chlorhexidine arm/s, we considered that outcome assessors could have worked out which study arm participants were in and therefore could not be adequately blinded. In this situation we assessed this domain as at high risk of bias irrespective of whether blinding of outcome assessment was indicated. </p> </li> <li> <p>Where tooth staining/adverse effects such as mucosal desquamation and mucosal lesions that could be visible to the outcome assessor were reported narratively or measured using a scale (where relevant) but were not higher in the chlorhexidine arm/s and blinding of outcome assessment was also indicated, we assessed this domain as at low risk of bias. </p> </li> <li> <p>Where tooth staining/adverse effects such as mucosal desquamation and mucosal lesions that could be visible to the outcome assessor were not reported, although we considered it likely that tooth staining or other visible adverse effects could have occurred and been noticeable in the chlorhexidine arm/s after 4 weeks of more of rinsing, we assessed this domain as unclear as there was not enough information upon which to base a judgement. </p> </li> </ul> </li> <li> <p>Incomplete outcome data (attrition bias): if 10% or less of randomised participants were excluded from the analysis, we assessed this as at low risk of bias. However, when attrition was greater than 10%, assuming the missing participants in one group had a higher mean (e.g. gingivitis score) than those in the other group, as the attrition rate increased, so would the mean difference (MD) between groups, as described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). This situation led to a judgement of high risk of bias if we believed that the attrition was high enough to have resulted in a distortion of the true intervention effect, or if there was considerably greater attrition in one group than another. If attrition was greater than 10%, but with the additional factors of not being reported by group and insufficient reporting of reasons for attrition, this led to a judgement of unclear risk of bias. If it was not clear from the study report how many participants were randomised into each group, we assessed it as at unclear risk of bias for this domain. </p> </li> <li> <p>Selective reporting (reporting bias): if the study either reported outcomes not stated a priori in the methods section or the study protocol (if available) or did not report outcomes stated in the methods section, we assessed this as at high risk of bias. If gingivitis and plaque outcomes were reported with insufficient information to allow us to use the outcome data in a meta‐analysis (e.g. no information on variance), we assessed it as at high risk of bias. We considered the reporting of adverse effects associated with the use of chlorhexidine mouthrinse to be important outcomes. For an assessment of low risk of bias we required either a statement that there were no adverse effects associated with the chlorhexidine rinse or if present, that adverse effects be reported by group. Where tooth staining was not reported or was measured using an index but insufficient data were reported to allow us to use the data in a meta‐analysis we assessed it as at high risk of bias. Where tooth staining was not measured using an index but its presence/absence was reported we assessed this as at low risk of bias, provided that the information was reported for all participants by group. </p> </li> <li> <p>Other bias: any other potential source of bias that may feasibly alter the magnitude of the effect estimate (e.g. baseline imbalances in potentially important prognostic factors between intervention groups and differential diagnostic activity by outcome assessors). </p> </li> </ul> </p> <p>We summarised the risk of bias as follows.</p> <p> <div class="table" id="CD008676-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Risk of bias</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Interpretation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>In outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>In included studies</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plausible bias unlikely to seriously<br/>alter the results </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias for all key domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Most information is from studies at low risk of bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plausible bias that raises some<br/>doubt about the results </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias for one or more key domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Most information is from studies at low or unclear risk of bias</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plausible bias that seriously weakens confidence in the results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias for one or more key domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The proportion of information from studies at high risk of bias is sufficient to affect the interpretation of results </p> </td> </tr> </tbody> </table> </div> </p> </section> <section id="CD008676-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used the methods outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We combined mean differences (MDs) where studies used the same scale and standardised mean differences (SMDs) where studies used different scales for continuous outcomes. For dichotomous outcomes, we reported risk ratios (RR) and 95% confidence intervals. </p> </section> <section id="CD008676-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>The participant was the unit of analysis. We were unable to use data from studies that reported number of sites rather than number of individuals in the meta‐analyses, as failure to take the clustering into account could lead to an overestimate of effect, with narrower confidence intervals and smaller P values. Had we included cluster‐RCTs we would have analysed the results taking account of the clustering present in the data, otherwise we would have used the methods outlined in Section 16.3.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> in order to perform an approximately correct analysis (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> </section> <section id="CD008676-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We attempted, where feasible, to contact the authors of studies to obtain missing data or for clarification. Where appropriate, we used the methods outlined in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> in order to estimate missing standard deviations for the main outcome only (gingivitis) (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We did not use any further statistical methods or carry out any further imputation to account for missing data. Where mean scores and measures of variance were only reported in graphs and could not be obtained from the authors of the studies, data were estimated by reading the data off the graphs in the published report for inclusion in meta‐analyses. The graphs were enlarged and the data were estimated independently and in duplicate. Any disagreements were resolved by discussion. </p> </section> <section id="CD008676-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>If meta‐analyses were performed, we assessed the possible presence of heterogeneity visually by inspecting the point estimates and confidence intervals on the forest plots; if the confidence intervals had poor overlap then heterogeneity was considered to be present. We also assessed heterogeneity statistically using a Chi<sup>2</sup> test, where a P value &lt; 0.1 indicated statistically significant heterogeneity. Furthermore, we quantified heterogeneity using the I<sup>2</sup> statistic. A guide to interpretation of the I<sup>2</sup> statistic given in Section 9.5.2 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> is as follows (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>): </p> <p> <ul id="CD008676-list-0013"> <li> <p>0% to 40%: might not be important;</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity;</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity;</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> </section> <section id="CD008676-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>Assessment of reporting bias within studies has already been described in the section <a href="#CD008676-sec-0029">Assessment of risk of bias in included studies</a>.<br/>Reporting biases can occur when reporting (or not reporting) research findings is related to the results of the research (e.g. a study that did not find a statistically significant difference/result may not be published). Reporting bias can also occur if ongoing studies are missed (but that may be published by the time the systematic review is published), or if multiple reports of the same study are published, or if studies are not included in a systematic review due to not being reported in the language of the review authors. We attempted to limit reporting bias in the first instance by conducting a detailed, sensitive search, including searching for ongoing studies, and any studies not reported in English were translated. If there were more than 10 studies included in a meta‐analysis for the primary outcome (gingivitis), we assessed the possible presence of reporting bias by testing for asymmetry in a funnel plot. We carried out statistical analysis using the methods described by <a href="./references#CD008676-bbs2-0119" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a> for continuous outcomes. </p> </section> <section id="CD008676-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We carried out a meta‐analysis only where studies of similar comparisons reported the same outcomes at the same time interval. We combined mean differences (MDs) where studies used the same scale and standardised mean differences (SMDs) where studies used different scales for continuous outcomes. For dichotomous outcomes, we reported risk ratios (RR) and 95% confidence intervals. Due to anticipated heterogeneity we used random‐effects models for all meta‐analyses. </p> <p>We reported the results from studies not suitable for inclusion in a meta‐analysis both in the results and in additional tables. </p> </section> <section id="CD008676-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where there were sufficient studies, we carried out the following subgroup analyses.</p> <p> <ul id="CD008676-list-0014"> <li> <p>Baseline prophylaxis (scale and polish) versus none.</p> </li> <li> <p>Children versus adults.</p> </li> <li> <p>Different chlorhexidine concentrations.</p> </li> <li> <p>Initial levels of gingivitis.</p> </li> <li> <p>Gingivitis only versus gingivitis + periodontitis.</p> </li> </ul> </p> </section> <section id="CD008676-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>In order to ensure our conclusions were robust, we carried out sensitivity analyses (where there were sufficient studies for each outcome) by excluding studies where outcome data were read from graphs, studies where standard deviations were estimated and studies where periodontal treatment was conducted during the study. </p> <p>We would have carried out sensitivity analyses by excluding studies at high and unclear risk of bias, however this was not possible as apart from one study at unclear risk of bias, all of the included studies were at high risk of bias. </p> </section> <section id="CD008676-sec-0038"> <h4 class="title">Summary of findings and assessment of the quality of the evidence</h4> <p>We produced a 'Summary of findings' table for chlorhexidine mouthrinse compared to placebo/control mouthrinse or no mouthrinse for the following outcomes: gingivitis measured using the Gingival Index at 4 to 6 weeks, plaque at 4 to 6 weeks, tooth staining at 4 to 6 weeks and other adverse effects. We used GRADE methods (<a href="./references#CD008676-bbs2-0125" title="GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">GRADE 2004</a>), and the GRADEpro GDT online tool for developing 'Summary of findings' tables (<a href="http://www.guidelinedevelopment.org" target="_blank">www.guidelinedevelopment.org</a>). We assessed the quality of the body of evidence for each outcome by considering the overall risk of bias of the included studies, the directness of the evidence, the inconsistency of the results, the precision of the estimates, and the risk of publication bias. We categorised the quality of each body of evidence as high, moderate, low, or very low. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008676-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008676-sec-0039"></div> <section id="CD008676-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD008676-sec-0041"> <h4 class="title">Results of the search</h4> <p>The searches resulted in 1520 references after de‐duplication. Two review authors screened the titles against the inclusion criteria for this review, independently and in duplicate, discarding 1424 references in the process. We obtained full‐text copies of the remaining 96 references (94 studies) and examined them independently and in duplicate, excluding 38 studies at this stage. A further four studies are awaiting assessment of their eligibility to be included in the review and one study is ongoing. Therefore, fifty‐one studies (53 records) met the inclusion criteria for this review. This process is presented diagrammatically in <a href="#CD008676-fig-0001">Figure 1</a>. </p> </section> <section id="CD008676-sec-0042"> <h4 class="title">Included studies</h4> <section id="CD008676-sec-0043"> <h5 class="title">Characteristics of the trial designs and settings</h5> <p>Fifty‐one studies met the inclusion criteria for this review. All studies were of parallel‐group design. Sixteen studies had two study arms and compared chlorhexidine rinse with placebo rinse. However, thirty‐five studies had multiple study arms and not all study arms were relevant to this review. Twenty‐two studies had three arms; 10 had four arms and two had five arms. One of the studies with four study arms (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>) had three chlorhexidine rinse groups and one placebo rinse group but presented data only for two groups: the three chlorhexidine study arms combined and the placebo group. One additional study (<a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>) had three main therapeutic arms which were each divided into chlorhexidine rinse and placebo rinse groups using a 2 x 3 factorial design. </p> <p>Sixteen studies were conducted in the USA, six in Brazil, five in the UK, four in Germany, three in India, three in Sweden, two in each of the following countries: Canada, Mexico and Spain, and one in each of the following countries: Argentina, China, Iran, Italy, Norway, Switzerland, the Netherlands and Turkey. The settings of the studies were diverse and often poorly reported. Twenty‐seven studies were conducted in a dental school/university setting and an additional three studies were assumed, based on the information provided, to have been conducted in a dental school/university setting (<a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>). Two studies were conducted under "dental office conditions" (<a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>), two in general dental practices (<a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>; <a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>) and one in a private practice limited to periodontics (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>). Three studies were conducted in a school setting (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>). The remaining studies were conducted in military garrisons (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>); pensioners/nursing homes (<a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>; <a href="./references#CD008676-bbs2-0049" title="WeitzM , BrownsteinC , DeasyM . Effect of a twice daily 0.12% chlorhexidine rinse on the oral health of a geriatric population. Clinical Preventive Dentistry1992;14(3):9-13. ">Weitz 1992</a>); a bone marrow transplant unit (<a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>) and a knitting factory (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>). Three studies were conducted at what we assumed were clinical research facilities (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>) and in four studies the setting of the study was not clear (<a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>). The numbers of centres involved in the studies was often unclear but it appeared that all but two of the studies were conducted at a single centre. One study (<a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>) was conducted at five suburban dental practices in Southern England and another study (<a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>) was conducted at two sites (Manchester and Wirral) in the UK. </p> <p>In 19 studies direct support from industry was explicitly stated. Nine studies received support from P&amp;G; three from GSK; two from Teledyne and one from each of the following companies: GABA, J&amp;J, Oral B, Smithkline Beecham and Warner Lambert. Three studies that did not appear to be funded directly by industry explicitly stated that oral care products used in the study had been provided by industry (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>). Three studies (<a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>) were associated with Biosurface Pharma AB through authorship and another study was associated with 'Dental Products Testing' and Pfizer through authorship (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>). Of the remaining studies that reported a source of support, two appeared to be funded by universities (<a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>); six appeared to be funded by research grants (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>); and in 17 studies there was no statement regarding funding or support. Only one study (<a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) stated that the conduct of the research and final decisions regarding the study report were independent of the funder (GSK). </p> <p>Only 13 of the studies described a sample size calculation. For six of these studies (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>) the sample size required was reported and achieved but for three of these studies the sample size was based on pocket probing depth (PPD) (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>) and clinical attachment loss (CAL) (<a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>) rather than gingivitis. Two studies reported the sample size calculation and number of participants required in each group but the minimum sample size was not achieved at the end of the studies (<a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>). Five of the studies (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) described the sample size calculation but not the required sample size so we were unable to determine if the required sample size was achieved. In one study the sample size calculation was not described but the required sample size was reported and achieved (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>). </p> </section> <section id="CD008676-sec-0044"> <h5 class="title">Characteristics of the participants</h5> <p>A total of 6995 participants provided data for the included studies. The total number of participants providing data for the study arms relevant to this review (excluding the irrelevant study arms) was 5345 with the numbers analysed in each study ranging from 20 to 852. </p> <p>Six studies involved children and adolescents (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>). The age range of the children was 8 to 16 and three of these studies also included some young adults aged 17 and 18 (<a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>). Four studies while predominantly focused on adults, included children and adolescents among the participants: in <a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a> participants were aged 16 to 50 years old; in <a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>no participants under the age of 12 were included; and in <a href="./references#CD008676-bbs2-0037" title="NavarroD , SantosEAT , RochaJCF , BremmLL , JukoskiM , RibeiroPG , et al. Effect of chlorhexidine digluconate, Plantago major and placebo mouth rinse on dental plaque and gingivitis [Efeitos do digluconato de clorexidina, Plantago major e placebo sobre placa dental e gengivite: uma comparacao clinica da eficacia de colutorios]. Revista Brasileira de Plantas Medicinais1998;1(1):28. ">Navarro 1998</a> the age range of participants was 14 to 35 years old. In <a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>, a study involving individuals undergoing bone marrow transplantation and chemoradiotherapy, the age range was 5 to 51 years old. The remaining forty‐one studies involved adults. The age range of adult participants was 17 to 94 years with the mean age ranging from 20 to 83. </p> <p>Twenty‐two studies had a greater proportion of females than males and in four studies, the proportion of males was greater (<a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>; <a href="./references#CD008676-bbs2-0044" title="SouthernEN , McCombsGB , TolleSL , MarinakK . The comparative effects of 0.12% chlorhexidine and herbal oral rinse on dental plaque-induced gingivitis. Journal of Dental Hygiene2006;80(1):12. ">Southern 2006</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>). In five studies there was an equal balance of males to females (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). Five studies involved male participants only (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0037" title="NavarroD , SantosEAT , RochaJCF , BremmLL , JukoskiM , RibeiroPG , et al. Effect of chlorhexidine digluconate, Plantago major and placebo mouth rinse on dental plaque and gingivitis [Efeitos do digluconato de clorexidina, Plantago major e placebo sobre placa dental e gengivite: uma comparacao clinica da eficacia de colutorios]. Revista Brasileira de Plantas Medicinais1998;1(1):28. ">Navarro 1998</a>) and in the remaining 15 studies, the proportion of males to females was not reported. Eight studies included smokers among the participants (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) with the proportion of smokers in each study ranging from 11% to 41%. 10 studies excluded smokers and in the remaining 33 studies, the smoking status of the participants was not reported. </p> <p>Twenty‐four studies reported gingivitis at baseline using the Gingival Index of Löe and Silness (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>). In one study involving dental students (<a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>) where normal gingiva were obtained in a pre‐experimental phase by scaling and polishing and twice daily brushing, the mean baseline gingivitis score was zero. In two other studies (<a href="./references#CD008676-bbs2-0037" title="NavarroD , SantosEAT , RochaJCF , BremmLL , JukoskiM , RibeiroPG , et al. Effect of chlorhexidine digluconate, Plantago major and placebo mouth rinse on dental plaque and gingivitis [Efeitos do digluconato de clorexidina, Plantago major e placebo sobre placa dental e gengivite: uma comparacao clinica da eficacia de colutorios]. Revista Brasileira de Plantas Medicinais1998;1(1):28. ">Navarro 1998</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>) gingivitis at baseline was particularly low, mean gingival index scores were 0.049 and 0.057 respectively. In the remaining 21 studies the mean gingival index ranged from 0.53 to 1.87 with an overall mean of 1.09. </p> <p>In many of the included studies, the periodontal status of the participants was not explicitly described. In 15 studies, the participants appeared to have gingivitis but no periodontitis whereas in nine studies, the participants had periodontitis of varying severity in addition to gingivitis (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>). In three of these studies the periodontitis was untreated at baseline (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>) and in one study the participants required osseous periodontal surgery (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>). In 16 studies it was unclear whether the participants had periodontitis in addition to gingivitis but it was deemed likely that at least some of the participants in these studies had periodontitis; two studies involved older adults (<a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a> (aged &gt; 65 years) and <a href="./references#CD008676-bbs2-0049" title="WeitzM , BrownsteinC , DeasyM . Effect of a twice daily 0.12% chlorhexidine rinse on the oral health of a geriatric population. Clinical Preventive Dentistry1992;14(3):9-13. ">Weitz 1992</a> (mean age 83)) and in the remaining 14 studies, the inclusion criteria allowed for the participants to have deep pockets and clinical attachment loss but the periodontal status of the people actually included in the study was not described. In 11 studies the participants clearly had gingivitis at baseline, but it was unclear whether the participants also had periodontitis. </p> </section> <section id="CD008676-sec-0045"> <h5 class="title">Characteristics of the interventions</h5> <p>Nine studies compared chlorhexidine rinse and mechanical oral hygiene with mechanical oral hygiene alone.Two of these studies had additional chlorhexidine mouthrinse arms that were also included in the analysis (<a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). All of these studies except <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a> also had additional arms that were not relevant to this review. Forty‐two studies compared chlorhexidine rinse with placebo or control rinse. Six of these studies had additional chlorhexidine mouthrinse arms. Data from five of these six studies were included in the analysis (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>). We could not include data from the three separate chlorhexidine arms for <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a> because the authors combined the three arms into one experimental group. Twenty of these 42 studies comparing chlorhexidine rinse with placebo or control rinse also had additional arms that were not relevant to this review. </p> <p>Of the studies with one concentration of chlorhexidine mouthrinse, 10 evaluated 0.2% chlorhexidine mouthrinse; 29 evaluated 0.12% chlorhexidine mouthrinse; two evaluated 0.1% chlorhexidine mouthrinse (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>) and four evaluated 0.05% or 0.06% chlorhexidine mouthrinse (<a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). Four studies had additional arms evaluating different chlorhexidine concentrations (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>) and in two studies, the concentration of the chlorhexidine rinse was not reported (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>). </p> <p>Most of the studies evaluating 0.2% chlorhexidine mouthrinse used a volume of 10 mL twice daily for one minute whereas most of the studies evaluating 0.1% or 0.12% chlorhexidine mouthrinse used a volume of 15 mL twice daily. Duration of rinsing for the studies of 0.1% and 0.12% chlorhexidine mouthrinse varied from 30 seconds to 1 minute but most of the studies employed a 30‐second rinse. The studies of 0.05% and 0.06% chlorhexidine mouthrinse predominantly used a volume of 10 mL once or twice a day for 30 seconds. In some studies with multiple arms different volumes of rinse were used in different arms: in three studies the placebo/control arms and other non‐chlorhexidine active rinse groups rinsed with 20 mL while the chlorhexidine arms rinsed with 10 mL (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>) or 15 mL (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>); in another study the 0.1% chlorhexidine arm rinsed with 15 mL while the two 0.06% chlorhexidine arms used 10 mL of rinse (<a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>). </p> <p>In six studies the volume of rinse used by participants was not reported. In three of these studies participants rinsed twice daily but rinse volume and duration were not reported (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>). In two of the studies, participants rinsed once a day for 30 seconds with an unknown volume of rinse (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). In another study rinse volume, frequency and duration were not reported (<a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>). </p> <p>Of the nine studies that compared chlorhexidine rinse and mechanical oral hygiene with mechanical oral hygiene alone, six involved regular mechanical cleaning using a toothbrush and toothpaste (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). In one study floss and wood points were also used by participants (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>). In another study participants underwent conventional ultrasonic debridement (<a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>) and were given interdental cleaning aids, and participants in a further study used a toothbrush and no toothpaste (<a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>). </p> <p>Thirty‐five of the 51 studies compared chlorhexidine mouthrinse with placebo and seven studies compared chlorhexidine mouthrinse with control. The control rinses were 5% hydroalcohol solution (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>); coloured and flavoured 5% hydroalcohol solution (<a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>); 0.5% benzene alcohol (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>); saline (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>) and water (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>). In one of these studies comparing 0.2% chlorhexidine mouthrinse with placebo rinse, participants were instructed to brush without toothpaste before using the mouthrinse (<a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>). In another study comparing 0.12% chlorhexidine mouthrinse with placebo rinse, all participants used a gum care dentifrice (Blend‐a‐med) (<a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>). </p> <p>Thirty‐six studies reported a baseline prophylaxis to remove plaque and thus assess the potential for chlorhexidine mouthrinse to inhibit plaque accumulation and its ability to reduce gingivitis. In two of the studies that reported a baseline prophylaxis, an additional prophylaxis was also provided 2 weeks before baseline (<a href="./references#CD008676-bbs2-0007" title="BrecxM , MacdonaldLL , LegaryK , CheangM , ForgayMG . Long-term effects of Meridol and chlorhexidine mouthrinses on plaque, gingivitis, staining, and bacterial vitality. Journal of Dental Research1993;72(8):1194-7. ">Brecx 1993</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>). In another study the baseline prophylaxis was conducted during the first week of the study (<a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>). Participants in eight of the nine studies in which some or all of the participants had periodontitis at baseline either had professional prophylaxis at baseline (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>), or adjunctive professional non‐surgical (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>) or surgical periodontal treatment (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) during the study. In the three studies where the participants with periodontitis had a professional prophylaxis at baseline only, scaling and polishing was supragingival (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>) or the extent of the professional cleaning was not clear (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>). </p> <p>Participants in six studies did not have a baseline prophylaxis. These studies were thus designed to assess the potential for chlorhexidine mouthrinse to reduce plaque and gingivitis in individuals who do not obtain professional tooth cleaning or scaling prior to commencing mouthrinse use (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>; <a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>; <a href="./references#CD008676-bbs2-0044" title="SouthernEN , McCombsGB , TolleSL , MarinakK . The comparative effects of 0.12% chlorhexidine and herbal oral rinse on dental plaque-induced gingivitis. Journal of Dental Hygiene2006;80(1):12. ">Southern 2006</a>; <a href="./references#CD008676-bbs2-0049" title="WeitzM , BrownsteinC , DeasyM . Effect of a twice daily 0.12% chlorhexidine rinse on the oral health of a geriatric population. Clinical Preventive Dentistry1992;14(3):9-13. ">Weitz 1992</a>). One of these studies included participants with untreated periodontitis (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>). Participants in this study received no professional prophylaxis and no oral hygiene instructions. In seven studies it was not clear whether a baseline prophylaxis had been carried out (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). In one study (<a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>), the screening examination was followed by calculus removal in the lower front teeth only. In another study, where it was not clear whether the participants had periodontitis in addition to gingivitis, there was no prophylaxis at baseline but supragingival scaling was performed at week 9 and subgingival scaling was performed after 13 weeks (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>). </p> <p>Twenty‐two studies reported that participants received some form of oral hygiene instruction. Where details were reported about the oral hygiene instruction, it usually involved instruction about toothbrushing technique. In two studies, oral hygiene instruction included instruction in the use of interdental cleaning aids (i.e. interdental brushes or dental floss or both) (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>) and in another three studies participants were given interdental cleaning aids; presumably instruction in their use was included in the oral hygiene instruction but this not clear from the text (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>). In two studies participants were advised on duration and frequency of brushing but not technique (<a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>) and in another study, participants were given brief instruction about using the toothbrush they were given but were not given any instructions about duration or technique of toothbrushing (<a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). </p> <p>The participants in 27 studies did not receive any oral hygiene instruction. In 18 of these studies participants were advised to continue their usual oral hygiene practices throughout the duration of the studies. The participants in one of these 18 studies (<a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>) were undergoing bone marrow transplant and chemoradiotherapy and their usual oral hygiene regimen involved oral cleaning with a foam rubber toothbrush substitute and saline solution irrigations. In another of these studies where continuation of usual oral hygiene practices was advised, it was explicitly stated that use of interproximal cleaning devices was permitted if they were part of participants' usual oral hygiene routine (<a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). In two studies it was not clear whether participants received oral hygiene instruction (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>). In one of these studies toothbrushing was supervised Monday to Friday in the mornings but it is not clear if oral hygiene instructions were provided to participants (<a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>). </p> <p>In 38 studies mouthrinsing was unsupervised. Mouthrinsing was fully supervised in only three studies, all conducted in a school setting (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>). In 10 studies mouthrinsing was partially supervised for practical reasons. In five of the studies mouthrinsing was fully supervised on weekdays only (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>); in another two studies, mouthrinsing was supervised once a day on weekdays only (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>). In another three studies the mouthrinsing was supervised except for two weeks during the Chinese New Year (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>); after participants were discharged from hospital (<a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>) and when participants were at military training (<a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>). </p> <p>Thirty studies reported instructing participants to use the mouthrinse after toothbrushing. Three of these studies specified waiting 30 minutes after toothbrushing before using the mouthrinse (<a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). One of these studies specified waiting five timed minutes before mouthrinsing (<a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>). One study reported instructing participants to use mouthrinse at a separate time to toothbrushing (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>). In the remaining 20 studies the timing of mouthrinsing in relation to toothbrushing was not reported. </p> <p>In most of the studies the duration of the intervention (mouthrinsing with chlorhexidine) was 6 months or less broken down as follows: 4 to 6 weeks (15 studies); 2 months (9 studies); 10 weeks (1 study); 3 months (9 studies); 4 months (2 studies) or 6 months (13 studies). In two studies the duration of the intervention was longer than 6 months; one study of 9 months' duration (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>) and another of 24 months' duration (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>). </p> <p>In most studies the final follow‐up assessment was at the end of the intervention phase. However in four studies participants ceased mouthrinsing before the final outcome assessment. In these studies the final assessment of the outcomes was carried out 4 weeks (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>), 4 months (<a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>) and 10 months (<a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>) after mouthrinsing had ceased. For this review, we considered the time that mouthrinsing ceased to be the primary end point for data extraction. </p> </section> <section id="CD008676-sec-0046"> <h5 class="title">Characteristics of the outcomes</h5> <section id="CD008676-sec-0047"> <h6 class="title">Gingivitis</h6> <section id="CD008676-sec-0048"> <p><b>Gingival inflammation</b></p> <p>Thirty‐eight studies included gingival inflammation as an outcome. The most commonly used index for measuring gingival inflammation was the Gingival Index of Löe and Silness (GI) (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>). The following indices were also used to measure gingival inflammation: the Modified Gingival Index (MGI) (<a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>), the Papillary Bleeding Score (PBS) (<a href="./references#CD008676-bbs2-0150" title="LoescheWJ . Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. Journal of Dental Research1979;58(12):2404-12.">Loesche 1979</a>), and the Papillary Marginal Gingival Index (PMGI) (<a href="./references#CD008676-bbs2-0117" title="De la RosaM , SturzenbergerOP . Clinical reduction of gingivitis through the use of a mouthwash containing two quaternary ammonium compounds. Journal of Periodontology1976;47(9):535-7.">de la Rosa and Sturzenberger 1976</a>). Thirty‐one studies measured gingival inflammation using the GI; two studies used the MGI (<a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>); one study used the PBS (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>); and four studies used the PMGI (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>). In one of these studies (<a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>), the PMGI was measured with visual inspection only (no probing) in addition to the GI. One study reported a total mean score for a non‐specific gingival inflammation index (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>). </p> </section> <section id="CD008676-sec-0049"> <p><b>Gingival bleeding</b></p> <p>Thirty‐four studies included gingival bleeding as an outcome. The following indices were used to measure gingival bleeding: the GI (<a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>) scores 2 and 3, the Gingival Bleeding Index of Ainamo and Bay (<a href="./references#CD008676-bbs2-0100" title="AinamoJ , BayI . Problems and proposals for recording gingivitis and plaque. International Dental Journal1975;25(4):229-35.">Ainamo and Bay 1975</a>), the Eastman Interdental Bleeding Index (<a href="./references#CD008676-bbs2-0111" title="CatonJG , PolsonAM . The interdental bleeding index: a simplified procedure for monitoring gingival health. Compendium of Continuing Education in Dentistry1985;6(2):88, 90-2.">Caton and Polson 1985</a>), the Bleeding Index/Bleeding on Marginal Probing (<a href="./references#CD008676-bbs2-0173" title="SaxtonCA , van derOuderaaFJG . The effect of a dentifrice containing zinc citrate and triclosan on developing gingivitis. Journal of Periodontal Research1989;24(1):75-80.">Saxton and van der Ouderaa 1989</a>; <a href="./references#CD008676-bbs2-0184" title="van derWeijdenGA , TimmermanMF , NijboerA , ReijerseE , van derVeldenU . Comparison of different approaches to assess bleeding on probing as indicators of gingivitis. Journal of Clinical Periodontology1994;21(9):589-94.">van der Weijden 1994</a>), a modification of the method described by Cowell et al (<a href="./references#CD008676-bbs2-0114" title="CowellCR , SaxtonCA , SheihamA , WaggBJ . Testing therapeutic measures for controlling gingivitis in man: A suggested protocol. Journal of Clinical Periodontology1975;2:231-40.">Cowell 1975</a>), Papillary Bleeding Score (PBS) (proportion of sites with a PBS ≥ 2) (<a href="./references#CD008676-bbs2-0150" title="LoescheWJ . Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. Journal of Dental Research1979;58(12):2404-12.">Loesche 1979</a>) and the Papillary Bleeding Index (<a href="./references#CD008676-bbs2-0159" title="MuhlemannHR . Psychological and chemical mediators of gingival health. Journal of Preventive Dentistry1977;4(4):6-17.">Muhlemann 1977</a>; <a href="./references#CD008676-bbs2-0172" title="SaxerUP , MühlemannHR . Motivation and education. SSO Schweizerische Monatsschrift fur Zahnheilkunde1975;85(9):905-19.">Saxer 1975</a>). </p> <p>Thirteen studies reported gingival bleeding using scores 2 and 3 from the GI. One of these studies (<a href="./references#CD008676-bbs2-0044" title="SouthernEN , McCombsGB , TolleSL , MarinakK . The comparative effects of 0.12% chlorhexidine and herbal oral rinse on dental plaque-induced gingivitis. Journal of Dental Hygiene2006;80(1):12. ">Southern 2006</a>) also reported bleeding on probing after 15 seconds. Another two studies (<a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>) measured bleeding on probing and the method used suggests that it was based on scores 2 and 3 of the GI. Three studies (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>) measured gingival bleeding using the Gingival Bleeding Index of Ainamo and Bay. Two studies (<a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>) used the Eastman Interdental Bleeding Index. Two studies (<a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>) reported the Bleeding Index/Bleeding on Marginal Probing. One study (<a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>) used a modification of the method described by Cowell et al. One study (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>) reported the proportion of sites with a PBS ≥ 2 and three studies (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) used the Papillary Bleeding Index. A further seven studies measured the proportion of sites with bleeding on probing but were not specific about the index used (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>); three of these studies also reported the mean proportion of sites with gingival bleeding but were not specific about the index used (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>). </p> </section> </section> <section id="CD008676-sec-0050"> <h6 class="title">Plaque</h6> <p>Forty‐eight studies included plaque as an outcome. The majority of the studies measured dental plaque accumulation using the Plaque Index of Silness and Lӧe (<a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) or the Turesky modification of the Quigley and Hein Index (TQH) (<a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>). The following indices were also used to measure plaque: Soparker's modification of the TQH (<a href="./references#CD008676-bbs2-0144" title="LobeneRR , SoparkarPM , NewmanMB . Use of dental floss. Effect on plaque and gingivitis. Clinical Preventive Dentistry1982;4(1):5-8.">Lobene 1982</a>), the Modified Proximal Plaque Index (MPPI) (<a href="./references#CD008676-bbs2-0192" title="ZimmerS , StraussJ , BizhangM , KrageT , RaabWHM , BarthelC . Efficacy of the Cybersonic in comparison with the Braun 3D Excel and a manual toothbrush. Journal of Clinical Periodontology2005;32(4):360-3.">Zimmer 2005</a>), the Quigley and Hein Plaque Index (<a href="./references#CD008676-bbs2-0169" title="QuigleyGA . Comparative cleansing efficiency of manual and power brushing. Journal of the American Dental Association1962;65(1):26-9.">Quigley 1962</a>), the Approximal Plaque Index (API) (<a href="./references#CD008676-bbs2-0141" title="LangeDE , PlagmannHC , EenboomA , PromesbergerA . Clinical methods for the objective evaluation of oral hygiene. Deutsche Zahnarztliche Zeitschrift1977;32(1):44-7.">Lange 1977</a>), a full‐mouth plaque score (FMPS) (<a href="./references#CD008676-bbs2-0164" title="O'LearyTJ , DrakeRB , NaylorJE . The plaque control record. Journal of Periodontology1972;43(1):38.">O'Leary 1972</a>), and the method described by Greene and Vermilion (<a href="./references#CD008676-bbs2-0126" title="GreeneJC , VermillionJR . The Simplified Oral Hygiene Index. Journal of the American Dental Association1964;68:7-13.">Greene and Vermillion 1964</a>). </p> <p>Twenty‐one studies reported using the Plaque Index of Silness and Lӧe. Nineteen studies reported using TQH. One of these studies (<a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>) used Soparker's modification of the TQH, and one of these studies (<a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) reported the MPPI in addition to TQH. Two studies in the same report that used the TQH (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>) did not report any outcome data for plaque. One study (<a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) reported both the MPPI and the Quigley and Hein Plaque Index. The following indices were reported in one study each: the Quigley and Hein Plaque Index (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>), the API (<a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>), FMPS (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>), and the method described by Greene and Vermilion (<a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>). Three studies (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>) measured the presence or absence of plaque accumulation but were not specific about the index used. </p> </section> <section id="CD008676-sec-0051"> <h6 class="title">Adverse effects</h6> <section id="CD008676-sec-0052"> <p><b>Calculus</b></p> <p>Twelve studies reported calculus as an outcome. Seven studies (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>; <a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) reported using the Volpe‐Manhold Calculus Index (<a href="./references#CD008676-bbs2-0153" title="ManholdJH , VolpeAR , ParkerL , AdamsSH . In vivo calculus assessment. II. A comparison of scoring techniques. Journal of Periodontology1965;36:299-304.">Manhold 1965</a>; <a href="./references#CD008676-bbs2-0190" title="VolpeAR , ManholdJH , HazenSP . In vivo calculus assessment. I. A method and its examiner reproducibility. Journal of Periodontology1965;36:292-8.">Volpe 1965</a>). Two studies (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>) reported using the Calculus Surface Index (CSI) (<a href="./references#CD008676-bbs2-0122" title="EnneverJ , SturzenbergerOP , RadikeAW . The calculus surface index method for scoring clinical calculus studies. Journal of Periodontology1961;32:54-7.">Ennever 1961</a>). One study (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>) reported using the Retention Index (<a href="./references#CD008676-bbs2-0106" title="BjorbyA , LöeH . The relative significance of different local factors in the initiation and development of periodontal inflammation. Journal of Periodontal Research1966;2:76-7.">Björby and Löe 1966</a>; <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>). One study (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>) used a calculus index described in the National Institutes of Health (NIH) report 'Oral health of United States adults' (report not available online) and in one study the index used was not specified (<a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>). In two additional studies accumulation of calculus in the chlorhexidine rinse groups was noted but not measured using an index or scale (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>). </p> </section> <section id="CD008676-sec-0053"> <p><b>Extrinsic tooth staining</b></p> <p>Twenty‐one studies included extrinsic tooth staining as an outcome but this was measured and reported in a variety of different ways. In 16 studies, the following indices were used to measure extrinsic tooth staining: the Discolouration Index (<a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a>), the Discolouration Index of Lang and Räber (<a href="./references#CD008676-bbs2-0140" title="LangNP , RäberK . Use of oral irrigators as vehicle for the application of antimicrobial agents in chemical plaque control. Journal of Clinical Periodontology1981;8(3):177-88.">Lang and Räber 1981</a>), the Shaw and Murray Index (<a href="./references#CD008676-bbs2-0177" title="ShawL , MurrayJJ . New index for measuring extrinsic stain in clinical trials. Community Dentistry and Oral Epidemiology1977;5(3):116-20.">Shaw 1977</a>), the Gingival Modification of the Lobene Stain Index (GMSI) (<a href="./references#CD008676-bbs2-0128" title="GrundemannLJ , TimmermanMF , IjzermanY , van derVeldenU , van derWeijdenGA . Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. Journal of Clinical Periodontology2000;27(1):9-15.">Grundemann 2000</a>; <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a>), and Meckels stain grading method (<a href="./references#CD008676-bbs2-0068" title="LangNP , HotzP , GrafH . Effects of supervised chlorhexidine mouthrinses in children. A longitudinal clinical trial. Journal of Periodontal Research1982;17(1):101-11. ">Lang 1982</a>). Seven studies (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>; <a href="./references#CD008676-bbs2-0037" title="NavarroD , SantosEAT , RochaJCF , BremmLL , JukoskiM , RibeiroPG , et al. Effect of chlorhexidine digluconate, Plantago major and placebo mouth rinse on dental plaque and gingivitis [Efeitos do digluconato de clorexidina, Plantago major e placebo sobre placa dental e gengivite: uma comparacao clinica da eficacia de colutorios]. Revista Brasileira de Plantas Medicinais1998;1(1):28. ">Navarro 1998</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>) reported the Lobene Discolouration Index. Five studies (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0007" title="BrecxM , MacdonaldLL , LegaryK , CheangM , ForgayMG . Long-term effects of Meridol and chlorhexidine mouthrinses on plaque, gingivitis, staining, and bacterial vitality. Journal of Dental Research1993;72(8):1194-7. ">Brecx 1993</a>; <a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>) reported the Discolouration Index of Lang and Räber. One study (<a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>) reported the Shaw and Murray Index and another (<a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>) a modification of the Shaw and Murray Index. One study (<a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>) reported the GMSI and one study (<a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>) used Meckels stain grading method. </p> <p>One study (<a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>) reported using the Mean Stain Severity Index that was created at the Case Western Reserve University school of dentistry, to record intensity and area of stain. Another study (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>) reported dividing the buccal surfaces of the eight central incisors into three areas: incisal, approximal and gingival according to <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a> and <a href="./references#CD008676-bbs2-0128" title="GrundemannLJ , TimmermanMF , IjzermanY , van derVeldenU , van derWeijdenGA . Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. Journal of Clinical Periodontology2000;27(1):9-15.">Grundemann 2000</a> and using a Staining Index (SI) to record the dichotomous presence or absence of staining in each area and to calculate the percentage of the total area showing staining. Three studies (<a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) described their method of measuring tooth staining but did not specify a particular index. </p> <p>Sixteen of the other included studies described information regarding tooth staining/discolouration/pigmentation reported by study participants (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>); noted by the clinicians during the clinical examination but not measured using an index or scale (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>); or listed as a reason for participant withdrawal from the studies (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>). In one study (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) the presence or absence of tooth staining was assessed from clinical photographs of the mandibular facial anterior teeth. We included information regarding tooth staining from these studies in meta‐analyses where possible but were unable to include participant‐reported data, data where staining of teeth were reported combined with tongue staining or denture staining or where tooth staining was reported grouped with other adverse effects. </p> </section> </section> <section id="CD008676-sec-0054"> <h6 class="title">Other adverse effects</h6> <p>Fourteen studies did not report any adverse effects apart from extrinsic staining of teeth or oral tissues alone or both (<a href="./references#CD008676-bbs2-0007" title="BrecxM , MacdonaldLL , LegaryK , CheangM , ForgayMG . Long-term effects of Meridol and chlorhexidine mouthrinses on plaque, gingivitis, staining, and bacterial vitality. Journal of Dental Research1993;72(8):1194-7. ">Brecx 1993</a>; <a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>; <a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>; <a href="./references#CD008676-bbs2-0048" title="Van StrydonckDA , TimmermanMF , Van der VeldenU , Van der WeijdenF . Clinical efficacy of a chlorhexidine-delivering toothbrush. Journal of Clinical Periodontology2008;35(7):584-90. ">Van Strydonck 2008</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) or with calculus (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>; <a href="./references#CD008676-bbs2-0022" title="FlemmigTF , NewmanMG , DohertyFM , GrossmanE , MeckelAH , BakdashMB . Supragingival irrigation with 0.06% chlorhexidine in naturally occurring gingivitis. I. 6 month clinical observations. Journal of Periodontology1990;61(2):112-7. ">Flemmig 1990</a>; <a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>). Twenty‐two studies reported at least one adverse effect relating to the chlorhexidine mouthrinse use apart from extrinsic tooth staining/staining of the oral tissues and calculus. Three studies (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>) mentioned a bitter or unacceptable taste associated with the chlorhexidine mouthrinse and no other adverse effects, except for one of the studies (<a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>) which also mentioned tooth staining. Adverse effects were not mentioned in six studies (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0044" title="SouthernEN , McCombsGB , TolleSL , MarinakK . The comparative effects of 0.12% chlorhexidine and herbal oral rinse on dental plaque-induced gingivitis. Journal of Dental Hygiene2006;80(1):12. ">Southern 2006</a>; <a href="./references#CD008676-bbs2-0049" title="WeitzM , BrownsteinC , DeasyM . Effect of a twice daily 0.12% chlorhexidine rinse on the oral health of a geriatric population. Clinical Preventive Dentistry1992;14(3):9-13. ">Weitz 1992</a>). The remaining six studies that did not report any adverse effects or issues with acceptability of the chlorhexidine rinse indicated that there were no oral mucosal lesions (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>); no severe/serious adverse effects/events (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0045" title="StookeyGK , BeiswangerB , MauM , IsaacsRL , WittJJ , GibbR . A 6-month clinical study assessing the safety and efficacy of two cetylpyridinium chloride mouthrinses. American Journal of Dentistry2005;18(Spec No):24A-8A. ">Stookey 2005</a>); or adverse reaction/effect (<a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>); no irreversible pathology (<a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>); or pathology related to the chlorhexidine mouthrinse use (<a href="./references#CD008676-bbs2-0046" title="TallerSH . The effect of baking soda/hydrogen peroxide dentifrice (Mentadent) and a 0.12 percent chlorhexidine gluconate mouthrinse (Peridex) in reducing gingival bleeding. Journal of the New Jersey Dental Association1993;64(4):23-5. ">Taller 1993</a>). </p> </section> </section> </section> <section id="CD008676-sec-0055"> <h4 class="title">Excluded studies</h4> <p>We excluded 38 studies from the review (see '<a href="./references#CD008676-sec-0120" title="">Characteristics of excluded studies</a>' table). Below is a summary of the reasons for excluding these studies. </p> <p> <ul id="CD008676-list-0015"> <li> <p>In seven studies it was not clear whether the studies were randomised and attempts to contact the authors for clarification were unsuccessful (<a href="./references#CD008676-bbs2-0052" title="BayLM , RussellBG . Effect of chlorhexidine on dental plaque and gingivitis in mentally retarded children. Community Dentistry and Oral Epidemiology1975;3(6):267-70. ">Bay 1975</a>; <a href="./references#CD008676-bbs2-0062" title="GouthamBS , ManchandaK , De SarkarA , PrakashR , JhaK , MohammedS . Efficacy of two commercially available oral rinses - Chlorhexidine and Listerine on plaque and gingivitis. Journal of International Oral Health2013;5(4):56-61. ">Goutham 2013</a>; <a href="./references#CD008676-bbs2-0068" title="LangNP , HotzP , GrafH . Effects of supervised chlorhexidine mouthrinses in children. A longitudinal clinical trial. Journal of Periodontal Research1982;17(1):101-11. ">Lang 1982</a>; <a href="./references#CD008676-bbs2-0076" title="OusehalL , LazrakL , Es-saidR , HamdouneH , ElquarsF , KhadijaA . Evaluation of dental plaque control in patients wearing fixed orthodontic appliances: a clinical study. International Orthodontics2011;9:140-55. ">Ousehal 2011</a>; <a href="./references#CD008676-bbs2-0077" title="PaknejadM , JafarzadehTS , ShamlooAM . Comparison of the efficacy of Matrica and %0.2 chlorhexidine mouthwashes on 3-6 mm pockets in patient with chronic periodontitis. Journal of Islamic Dental Association of Iran2006;18(3):16. ">Paknejad 2006</a>; <a href="./references#CD008676-bbs2-0087" title="TodkarR , SheikhS , ByakodG , MuglikarS . Efficacy of chlorhexidine mouthrinses with and without alcohol-A clinical study. Oral Health and Preventive Dentistry2012;10:291-6. ">Todkar 2012</a>; <a href="./references#CD008676-bbs2-0088" title="Vechis-BonS . 0.1% chlorhexidine mouthwash for gingival inflammation in diabetic adults: double blind study. Journal de Parodontologie1989;8(3):299-310. ">Vechis‐Bon 1989</a>). </p> </li> <li> <p>In four studies the mechanical oral hygiene procedures were not the same in the chlorhexidine rinse and comparator arms (<a href="./references#CD008676-bbs2-0054" title="BouwsmaOJ , YostKG , BaronHJ . Comparison of a chlorhexidine rinse and a wooden interdental cleaner in reducing interdental gingivitis. American Journal of Dentistry1992;5(3):143-6. ">Bouwsma 1992</a>; <a href="./references#CD008676-bbs2-0055" title="BrownJB , RosensteinD , MulloolyJ , O'Keeffe RosettiM , RobinsonS , ChiodoG . Impact of intensified dental care on outcomes in human immunodeficiency virus infection. AIDS Patient Care and STDs2002;16(10):479-86. ">Brown 2002</a>; <a href="./references#CD008676-bbs2-0071" title="MaddenTE , HerrigesB , BoydLD , LaughlinG , ChiodoG , RosensteinD . Alterations in HbA1c following minimal or enhanced non-surgical, non-antibiotic treatment of gingivitis or mild periodontitis in type 2 diabetic patients: a pilot trial. Journal of Contemporary Dental Practice2008;9(5):9-16. ">Madden 2008</a>; <a href="./references#CD008676-bbs2-0086" title="SubhashG , DasAK . The effect of chlorhexidine gluconate solution on gingivitis and its best mode of application. Journal of the Indian Dental Association1985;57(12):501-4. ">Subhash 1985</a>). </p> </li> <li> <p>In 11 studies the comparison was with another active rinse and there was no placebo/control or mechanical oral hygiene only group (<a href="./references#CD008676-bbs2-0053" title="BiswasG , AnupN , AcharyaS , KumawatH , VishnaniP , TambiS . Evaluation of the efficacy of 0.2% chlorhexidine versus herbal oral rinse on plaque induced gingivitis- A randomised clinical trial. Journal of Nursing and Health Science2014;3(2):58-63. ">Biswas 2014</a>; <a href="./references#CD008676-bbs2-0058" title="CTRI/2014/10/005145. Comparison of effect of green tea mouthwash and commonly prescribed mouthwash(chlorhexidine) in reducing gum inflammation. www.ctri.nic.in/Clinicaltrials/ (first received 27 October 2014). ">CTRI 2014</a>; <a href="./references#CD008676-bbs2-0059" title="ErnstCP , ProcklK , WillershausenB . The effectiveness and side effects of 0.1% and 0.2% chlorhexidine mouthrinses: a clinical study. Quintessence International1998;29(7):443-8. ">Ernst 1998</a>; <a href="./references#CD008676-bbs2-0060" title="EshwarS , KR , JainV , ManviS , KohliS , BhatiaS . Comparison of dill seed oil mouth rinse and chlorhexidine mouth rinse on plaque levels and gingivitis - A double blind randomized clinical trial. Open Dentistry Journal2016;10:207-13. ">Eshwar 2016</a>; <a href="./references#CD008676-bbs2-0066" title="HaffajeeAD , RobertsC , MurrayL , VeigaN , MartinL , TelesRP , et al. Effect of herbal, essential oil, and chlorhexidine mouthrinses on the composition of the subgingival microbiota and clinical periodontal parameters. Journal of Clinical Dentistry2009;20(7):211-7. ">Haffajee 2009</a>; <a href="./references#CD008676-bbs2-0072" title="McKenzieWT , ForgasL , VerninoAR , ParkerD , LimestallJD . Comparison of a 0.12% chlorhexidine mouthrinse and an essential oil mouthrinse on oral health in institutionalized, mentally handicapped adults: one-year results. Journal of Periodontology1992;63(3):187-93. ">McKenzie 1992</a>; <a href="./references#CD008676-bbs2-0074" title="NCT01750801. Clinical evidence efficacy of a mouthwash containing Propolis for the control of plaque and gingivitis: Phase III, randomized, double-blind comparison with mouthwash chlorhexidine base. http://clinicaltrials.gov/show/NCT01750801 (first received 22 November 2012). ">NCT01750801</a>; <a href="./references#CD008676-bbs2-0075" title="NCT02546804. Evaluate the efficacy of potassium permanganate mouthwash and hot salt water mouthwash and their comparison with chlorhexidine mouthwash on plaque index, gingival index and periodontal probing depth. https://clinicaltrials.gov/show/NCT02546804 (first received 26 August 2015). ">NCT02546804</a>; <a href="./references#CD008676-bbs2-0078" title="PerssonRE , TrueloveEL , LeRescheL , RobinovitchMR . Therapeutic effects of daily or weekly chlorhexidine rinsing on oral health of a geriatric population. Oral Surgery, Oral Medicine and Oral Pathology1991;72(2):184-91. ">Persson 1991</a>; <a href="./references#CD008676-bbs2-0080" title="PriyaBM , GalgaliSR . Comparison of amine fluoride and chlorhexidine mouth rinses in the control of plaque and gingivitis - a randomized controlled clinical trial. Indian Journal of Dental Research2015;26(1):57-62. ">Priya 2015</a>; <a href="./references#CD008676-bbs2-0083" title="RadafsharG , GhotbizadehM , SaadatF , MirfarhadiN . Effects of green tea (Camellia sinensis) mouthwash containing 1% tannin on dental plaque and chronic gingivitis: a double-blinded, randomized, controlled trial. Journal of Investigative and Clinical Dentistry2017;8:(1). ">Radafshar 2017</a>). </p> </li> <li> <p>Four studies were excluded because the chlorhexidine arm included another active agent that the comparator arms did not have. We would have been unable to separate the effect of the chlorhexidine rinse from the effect of the other active agent (<a href="./references#CD008676-bbs2-0057" title="Cortelli SheilaC , Costa FernandoO , RodriguesE , Cota LuisOM , Cortelli JoseR . Periodontal therapy effects on nitrite related to oral bacteria: a 6-month randomized clinical trial. Journal of Periodontology2015;86(8):984-994 11. ">Cortelli 2015</a>; <a href="./references#CD008676-bbs2-0070" title="LuomaH , MurtomaaH , NuujaT . A simultaneous reduction of caries and gingivitis in a group of schoolchildren receiving chlorhexidine-fluoride applications. Caries Research1978;12(5):290-8. ">Luoma 1978</a>; <a href="./references#CD008676-bbs2-0081" title="QuirynenM , SoersC , DesnyderM , DekeyserC , PauwelsM , vanSteenbergheD . A 0.05% cetyl pyridinium chloride/0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. Journal of Clinical Periodontology2005;32(4):390-400. ">Quirynen 2005</a>; <a href="./references#CD008676-bbs2-0082" title="QuirynenM , TeughelsW , vanSteenbergheD . Impact of antiseptics on one-stage, full-mouth disinfection. Journal of Clinical Periodontology2006;33(1):49-52. ">Quirynen 2006</a>). </p> </li> <li> <p>In one study the chlorhexidine arm received a more intensive intervention including cognitive behavioural education (2 hours) compared to the control arm who received standard care (<a href="./references#CD008676-bbs2-0079" title="PerssonRE , PerssonGR , PowellLV , KiyakHA . Periodontal effects of a biobehavioral prevention program. Journal of Clinical Periodontology1998;25(4):322-9. ">Persson 1998</a>). In another study (<a href="./references#CD008676-bbs2-0056" title="CatonJG , BliedenTM , LowenguthRA , FrantzBJ , WagenerCJ , DoblinJM , et al. Comparison between mechanical cleaning and an antimicrobial rinse for the treatment and prevention of interdental gingivitis. Journal of Clinical Periodontology1993;20(3):172-8. ">Caton 1993</a>) the chlorhexidine arm received oral hygiene instructions but the control arm did not. The mechanical oral hygiene procedures were potentially not the same in both arms in these two studies. </p> </li> <li> <p>One study was unpublished and we were unable to obtain a copy of the study despite following up several lines of enquiry (<a href="./references#CD008676-bbs2-0085" title="SegretoV , CollinsE . A clinical investigation to assess the effects on plaque, gingivitis, and staining potential of an experimental mouthrinse (research report on file). Cincinnati: Procter &amp; Gamble; 1993. Report No: 002392. ">Segreto 1993</a>). </p> </li> <li> <p>In one study, it was not clear from the published report whether the study was a randomised trial. Additional information obtained from the contact author indicated quasi‐randomisation (participants were assigned to groups according to the order that they came to the University) (<a href="./references#CD008676-bbs2-0069" title="Leyes BorrajoJL , GarciaVL , LopezCG , Rodriguez-NunezI , GarciaFM , GallasTM . Efficacy of chlorhexidine mouthrinses with and without alcohol: a clinical study [Erratum appears in Journal of Periodontology 2006;77(5):931]. Journal of Periodontology2002;73(3):317-21. ">Leyes Borrajo 2002</a>). </p> </li> <li> <p>One study was reported in an abstract. The authors were contacted but they did not have access to the data (<a href="./references#CD008676-bbs2-0084" title="SaltiniC , SanzM , NewmanMG , DohertyF . Clinical efficacy of a 0.12% chlorhexidine mouthrinse in periodontal maintenance patients with persistent disease. Journal of Dental Research1988;67(Spec Iss, IADR, AADR, CADR March 9-13 1988):183 (Abs No 567). ">Saltini 1988</a>). </p> </li> <li> <p>One study compared chlorhexidine, zinc and placebo mouthrinses but each rinse arm was further split into those who received a professional prophylaxis prior to the start of the study and those that did not. The study outcomes were not reported in a format that could be used in the review and the authors of the study were unable to provide any additional data (<a href="./references#CD008676-bbs2-0061" title="FischmanS , PicozziA , CancroL , PaderM . Influence of a chlorhexidine and a zinc mouthrinse on gingivitis. Journal of Periodontology1975;46(12):710-4. ">Fischman 1975</a>). </p> </li> <li> <p>In one study (<a href="./references#CD008676-bbs2-0073" title="NadkernyPV , RavishankarPL , PramodV , AgarwalLA , BhandariS . A comparative evaluation of the efficacy of probiotic and chlorhexidine mouthrinses on clinical inflammatory parameters of gingivitis: A randomized controlled clinical study. Journal of Indian Society of Periodontology2015;19(6):633-9. ">Nadkerny 2015</a>) the duration of rinsing was only 15 days and this was not apparent until the full text of the paper was reviewed. </p> </li> <li> <p>In three studies we had concerns about the duplication of outcome data in different studies from the same research group (<a href="./references#CD008676-bbs2-0063" title="GuptaD , BhaskarDJ , GuptaRK , KarimB , JainA , SinghR , et al. A randomized controlled clinical trial of Ocimum sanctum and chlorhexidine mouthwash on dental plaque and gingival inflammation. Journal of Ayurveda and Integrative Medicine2014;5(2):109-16. ">Gupta 2014</a>; <a href="./references#CD008676-bbs2-0064" title="GuptaD , GuptaRK , BhaskarDJ , GuptaV . Comparative evaluation of terminalia chebula extract mouthwash and chlorhexidine mouthwash on plaque and gingival inflammation - 4-week randomised control trial. Oral Health and Preventive Dentistry2015;13(1):5-12. ">Gupta 2015</a>; <a href="./references#CD008676-bbs2-0067" title="KarimB , BhaskarDJ , AgaliC , GuptaD , GuptaRK , JainA , et al. Effect of aloe vera mouthwash on periodontal health: triple blind randomized control trial. Oral Health and Dental Management2014;13(1):14-9. ">Karim 2014</a>) and contact with the authors failed to provide an adequate explanation or reassurance. Another study from this research group was excluded due to these concerns (<a href="./references#CD008676-bbs2-0065" title="GuptaD , JainA . Effect of cinnamon extract and chlorhexidine gluconate (0.2%) on the clinical level of dental plaque and gingival health: a 4-week, triple-blind randomized controlled trial. Journal of the International Academy of Periodontology2015;17(3):91-8. ">Gupta 2015a</a>). </p> </li> <li> <p>One study was excluded because the chlorhexidine mouthrinse was not used as an adjunct to regular mechanical oral hygiene (<a href="./references#CD008676-bbs2-0089" title="YatesR , ShearerBH , HuntingtonE , AddyM . A method to compare four mouthrinses: time to gingivitis level as the primary outcome variable. Journal of Clinical Periodontology2002;29(6):519-23. ">Yates 2002</a>). </p> </li> </ul> </p> </section> </section> <section id="CD008676-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD008676-sec-0057"> <h4 class="title">Allocation</h4> <section id="CD008676-sec-0058"> <h5 class="title">Random sequence generation</h5> <p>Nineteen studies reported sufficient details of the method of random sequence generation to allow us to assign a judgement of low risk of bias. The remaining 32 studies either stated that participants were randomised to groups, with no further details, or gave an inadequate description of the method. For these studies, we assigned a judgement of unclear risk of bias. </p> </section> <section id="CD008676-sec-0059"> <h5 class="title">Allocation concealment</h5> <p>Eleven studies described various methods of allocation concealment which implied that the random sequence was adequately protected and administered as it was generated, thus we assigned a judgement of low risk of bias. Two studies were rated as being at high risk of bias because personnel involved in the studies used a random number table to assign participants to groups, and could have foreseen upcoming assignments (<a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>). The remaining 38 studies did not report sufficient information on the randomisation process to allow a judgement of either low or high risk of bias, so we assigned a judgement of unclear risk of bias to them. </p> <p>Overall, seven studies had a rating of low risk of bias for the two above domains, and therefore were at low risk of selection bias. The two studies that had a rating of high risk of bias for allocation concealment were therefore at high risk of selection bias. The remaining 42 studies were at unclear risk of bias. </p> </section> </section> <section id="CD008676-sec-0060"> <h4 class="title">Blinding</h4> <p>The majority of studies contained a placebo arm with the intention of blinding participants and personnel. However, we considered blinding unlikely to be successful due to the propensity for chlorhexidine to stain the teeth and oral tissues and the association of its use with clinically apparent adverse effects such as mucosal desquamation and mucosal lesions. </p> <section id="CD008676-sec-0061"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>Forty‐one studies were assigned a judgement of high risk of bias either because staining or adverse events were reported at a higher rate in the chlorhexidine arms, or because a placebo comparison was not used and therefore no blinding was attempted. In these studies, participants could be aware of their allocated intervention and this could have affected their motivation and oral health behaviour. Two studies were assigned a judgement of low risk of bias as there was no difference in staining between the groups, so the blinding appeared to have been maintained (<a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>; <a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>). In the remaining eight studies, blinding was intended through the use of placebo but staining was not reported, so there was insufficient information on which to base a judgement. We rated these studies as being at unclear risk of bias. </p> </section> <section id="CD008676-sec-0062"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>Thirty‐three studies were assigned a judgement of high risk of bias because the outcomes assessors could have noticed the higher rates of staining or adverse events or both in the chlorhexidine arms. Five studies were rated as having low risk of bias. Two of these studies showed no difference in staining between groups (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>). Two studies used masking strategies (whereby a subset of participants were assessed with and without plastic tooth covers and painting of the tongue with food dyes) which revealed that measurements of gingivitis were no different when an examiner thought the participant had received chlorhexidine or not (<a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>). One study performed a sensitivity analysis on participants with no visible side effects, which showed no difference to the analysis including all participants, and we judged that bias had not affected the results (<a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). We rated the remaining 13 studies at unclear risk of bias because extrinsic tooth staining was not reported. These studies either implied that the outcome assessors were blinded, or did not discuss it, but in any case it was not possible to judge whether or not any blinding could have been successful. </p> </section> </section> <section id="CD008676-sec-0063"> <h4 class="title">Incomplete outcome data</h4> <p>We did not have any concerns regarding attrition bias in 23 studies, so we rated them as at low risk of bias. Nineteen studies were assigned a judgement of high risk of bias due to either a high overall proportion of attrition, differences in the proportion of attrition between groups, or because the reasons for attrition differed between groups and were linked to the intervention. The remaining nine studies were rated as unclear because the numbers per group at either baseline or evaluation were not reported, thus preventing us from calculating the attrition. </p> </section> <section id="CD008676-sec-0064"> <h4 class="title">Selective reporting</h4> <p>Fourteen studies adequately reported all expected and planned outcomes, so we rated them as having low risk of bias. The remaining 37 studies were rated at high risk of bias, mainly due to lack of reporting of measures of variance along with the means for each group, and no reporting of tooth staining and other adverse effects. </p> </section> <section id="CD008676-sec-0065"> <h4 class="title">Other potential sources of bias</h4> <p>Eleven studies were assigned a judgement of low risk of bias. Three studies were assigned a judgement of high risk of bias due to baseline imbalances between groups in important prognostic factors or outcomes of the review or both (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>). The remaining 37 studies were rated as unclear due to a lack of reporting of details of either calibration of outcome assessment or baseline measurements, meaning that we were unable to assess the potential for differential measurement of outcomes or baseline imbalances respectively. </p> <section id="CD008676-sec-0066"> <h5 class="title">Overall risk of bias</h5> <p>Fifty studies were at high risk of bias overall as they had at least one domain rated at high risk of bias. One study was rated at unclear risk of bias overall as it had at least one domain rated at unclear risk of bias, but with no domains rated at high risk of bias (<a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>). A summary of the risk of bias of the included studies is presented in <a href="#CD008676-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD008676-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008676-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> </section> </section> <section id="CD008676-sec-0067"> <h3 class="title" id="CD008676-sec-0067">Effects of interventions</h3> <p>See: <a href="./full#CD008676-tbl-0001"><b>Summary of findings 1</b> Summary of findings</a> </p> <section id="CD008676-sec-0068"> <h4 class="title">Chlorhexidine rinse versus placebo/control rinse or no intervention</h4> <section id="CD008676-sec-0069"> <h5 class="title">Gingivitis</h5> <section id="CD008676-sec-0070"> <h6 class="title">Gingival Index of Löe and Silness</h6> <p>At 4 to 6 weeks, eight studies analysing 466 participants (seven at high and one at unclear risk of bias) comparing chlorhexidine rinse with placebo or control rinse and two studies analysing 339 participants (both at high risk of bias) comparing chlorhexidine with no rinse, presented data using the Gingival Index (GI) of Löe and Silness (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>) (<a href="./references#CD008676-fig-0003" title="">Analysis 1.1</a>). The mean GI score across the control groups ranged from 0.17 to 1.4 with a mean of 0.93 and a median of 1. There was no clear difference between the placebo/control and no rinse control subgroups (P = 0.33). The pooled effect estimate of the comparison for all trials showed a reduction in gingivitis in favour of chlorhexidine rinse (mean difference (MD) ‐0.21, 95% confidence interval (CI) ‐0.31 to ‐0.11, P &lt; 0.0001) demonstrating a moderate effect (GI on 0 to 3 increasing scale). There was substantial heterogeneity between the studies (P = 0.001; I<sup>2</sup> = 67%). </p> <p>There was no clear difference between the different control group subgroups at 6 months (P = 0.11). The overall effect estimate showed a reduction in gingivitis in favour of the chlorhexidine rinse (MD ‐0.20, 95% CI ‐0.30 to ‐0.11, P &lt; 0.0001, 13 high risk of bias studies, 2616 participants) (<a href="./references#CD008676-fig-0004" title="">Analysis 1.2</a>). The mean GI score across the control groups ranged from 0.1 to 1.25 with a mean of 0.8 and a median of 0.7. There was considerable heterogeneity (P &lt; 0.00001; I<sup>2</sup> = 96%). </p> <p>There were insufficient data to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with higher mean GI scores of 1.1 to 3 (moderate or severe levels of gingival inflammation). </p> <section id="CD008676-sec-0071"> <p><b>Investigation of heterogeneity</b></p> <p>We undertook an investigation of the reasons for heterogeneity for the GI scores, at both 4 to 6 weeks and 6 months, for the following subgroups: adults compared to children; baseline gingivitis alone compared to gingivitis and periodontitis at baseline; prophylaxis/scale and polish at baseline compared to none; baseline mean gingivitis score &lt; 1 versus scores ≥ 1, by undertaking metaregression in Stata version 14 (<a href="./references#CD008676-bbs2-0180" title="Stata Data Analysis and Statistical Software: release 14. StataCorp LP, 2015.">Stata 2015</a>) (Additional <a href="#CD008676-tbl-0002">Table 1</a>; <a href="#CD008676-tbl-0003">Table 2</a>). The only subgroup analysis that was significant (P = 0.045) was for prophylaxis or not at 6 months, where the trials including a prophylaxis had a lesser effect for the chlorhexidine rinse than those without. This may explain some of the heterogeneity at 6 months. </p> <div class="table" id="CD008676-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 4 to 6 weeks</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Characteristic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope estimate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope interpretation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults versus children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 ‐ no studies with just children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gingivitis alone versus gingivitis with perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 to 0.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for gingivitis and perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis or not</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.22 to 0.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.66</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline gingivitis &lt; 1 versus &gt; 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.25 to 0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for higher baseline score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI = confidence interval.</p> </div> </div> <div class="table" id="CD008676-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 6 months</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Characteristic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope estimate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope interpretation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults versus children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.42 to 0.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.185</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gingivitis alone versus gingivitis with perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 to 0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for gingivitis and perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis or not</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.25 to ‐0.004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for no prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.045</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline gingivitis</p> <p>&lt; 1 versus &gt; 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.39 to 0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decrease in GI effect estimate for higher baseline score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI = confidence interval.</p> </div> </div> </section> <section id="CD008676-sec-0072"> <p><b>Chlorhexidine concentration and frequency of rinsing</b></p> <p>At 4 to 6 weeks there was no difference between the studies with concentrations of 0.2% and 0.1%/0.12% chlorhexidine, and there was an insufficient number of studies in the concentration subgroups at 6 months to undertake the analysis (Additional <a href="#CD008676-tbl-0004">Table 3</a>). Participants in one study included in the meta‐analysis for 4 to 6 weeks for the GI rinsed once a day, participants in the other studies rinsing twice per day so we were unable to undertake an analysis. Participants in two studies at 6 months rinsed once per day compared with 11 rinsing twice but there was no difference between these subgroups (P = 0.56, Additional <a href="#CD008676-tbl-0005">Table 4</a>). </p> <div class="table" id="CD008676-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Chlorhexidine concentration: all trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine concentration</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants</b>) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% C</b>I </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Subgroup P value</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (552)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.27 (‐0.46 to ‐0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.003 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (253)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.19 (‐0.27 to ‐0.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.12 (‐0.20 to ‐0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (2352)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.22 (‐0.33 to ‐0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (150)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.04 (‐0.11 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (472)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.71 (‐0.90 to ‐0.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (127)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.32 (‐0.85 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (155)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.20 (‐2.48 to 0.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (977)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.57 (‐0.79 to ‐0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (685)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.75 (‐2.45 to ‐1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (215)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.95 (‐1.23 to ‐0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.26 (‐1.61 to ‐0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours Chx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1898)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.38 (‐1.75 to ‐1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 (‐0.21 to 0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (159)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.03 (‐0.43 to 0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (266)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.52 (0.13 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.10</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.41 (0.09 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (174)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.17 (0.76 to 1.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (116)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.45 (1.04 to 1.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.96 (0.68 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (181)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.38 (1.05 to 1.71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (361)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.2 (0.96 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.59 (‐0.05 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.79 (1.41 to 2.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.08</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (174)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.33 (1.00 to 1.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; CI = confidence interval; MD = mean difference; SMD = standardised mean difference. </p> <p>Studies where the concentration of the chlorhexidine mouthrinse was not reported (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>) and where data relate to a combination of different chlorhexidine concentrations (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>) were excluded from this analysis. Therefore, in certain analyses, the number of studies and participants presented in the table are different from the data presented in the main analysis. </p> </div> </div> <div class="table" id="CD008676-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Chlorhexidine rinse frequency of use: all trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine frequency</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants</b>) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% C</b>I </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Subgroup P value</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (785)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.22 (‐0.33 to ‐0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.13 (‐0.31 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (1614)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.17 (‐0.20 to ‐0.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (1002)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.34 (‐0.93 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (649)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.56 (‐0.79 to ‐0.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1132)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.72 (‐1.02 to ‐0.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (930)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.49 (‐1.97 to ‐1.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.92 (‐1.86 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (1223)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.34 (‐1.66 to ‐1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once a day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (852)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐2.10 (‐2.27 to ‐1.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.03 (‐0.11 to 0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (373)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.33 (‐0.11 to 0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (323)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.80 (0.33 to 1.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.55 (0.76 to 2.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (310)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.18 (0.93 to 1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1(20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.39 (‐0.5 to 1.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.77 (0.06 to 1.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (496)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.26 (1.04 to 1.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (323)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.54 (1.22 to 1.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI = confidence interval; MD = mean difference; SMD = standardised mean difference.</p> </div> </div> </section> <section id="CD008676-sec-0073"> <p><b>Other data</b></p> <p>Meta‐analyses of studies comparing chlorhexidine rinse with placebo or control rinse after 7 to 12 weeks and &gt; 6 months of rinsing (all at high risk of bias), using the GI of Löe and Silness (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>), showed an effect size similar to the 4 to 6 weeks and 6 month studies (MD ‐0.47, 95% CI ‐0.76 to ‐0.18 and MD ‐0.50, 95% CI ‐1.11 to 0.11 respectively). The uncertainty around the effect estimate at &gt; 6 months (two studies of 9 and 24 months duration) is reflected in the 95% CI. Furthermore, there was considerable heterogeneity in both meta‐analyses (P &lt; 0.0001, I<sup>2</sup> = 86%; P &lt; 0.0001, I<sup>2</sup> = 99% respectively) (Additional <a href="#CD008676-tbl-0006">Table 5</a>). </p> <div class="table" id="CD008676-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results for gingivitis and plaque at 7 to 12 weeks, &gt; 6 months and long term (after cessation of mouthrinsing)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine conc (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Heterogeneity</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results for studies with no rinse control arms</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (196)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.07 (‐0.16 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.19, I<sup>2</sup> = 40% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (196)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.77 (‐1.07 to ‐0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.61, I<sup>2</sup> = 0% </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results for studies with placebo/control rinse arms</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (144)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.47 (‐0.76 to ‐0.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.0001, I<sup>2</sup> = 86% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (1124)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.50 (‐1.11 to 0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.0001, I<sup>2</sup> = 99% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 and &lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (182)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.29 (‐1.85 to ‐0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.02, I<sup>2</sup> = 64% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.12 (‐0.2 to ‐0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.003 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.33, I<sup>2</sup> = 11% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2, 0.12 and &lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (423)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.74 (‐2.51 to ‐0.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.00001, I<sup>2</sup> = 91% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (852)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.55 (‐1.79 to ‐1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (132)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.10 (‐1.18 to ‐0.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.002 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.02, I<sup>2</sup> = 71% </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; CI = confidence interval; conc = concentration; MD = mean difference; N/A = not applicable; SMD = standardised mean difference. </p> <p>There were no subgroup differences between the different chlorhexidine concentrations, therefore the overall effect for all concentrations combined is reported. </p> </div> </div> <p>One 4‐week study (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>) at high risk of bias that was not included in the meta‐analysis found no statistically significant differences in Papillary Bleeding Score (<a href="./references#CD008676-bbs2-0150" title="LoescheWJ . Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. Journal of Dental Research1979;58(12):2404-12.">Loesche 1979</a>) between the chlorhexidine (0.12%) and placebo group. Three studies (<a href="./references#CD008676-bbs2-0021" title="FinePD . A clinical trial to compare the effect of two antiseptic mouthwashes on gingival inflammation. Journal of Hospital Infection1985;6(Suppl A):189-93. ">Fine 1985</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>) at high risk of bias, reporting gingival inflammation at 4 to 6 months were not included in the meta‐analysis. Two of the three studies found a reduction in the GI (P = 0.043) (<a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>) and the modified GI (P &lt; 0.001) (<a href="./references#CD008676-bbs2-0038" title="OverholserCD , MeillerTF , DePaolaLG , MinahGE , NiehausC . Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. Journal of Clinical Periodontology1990;17(8):575-9. ">Overholser 1990</a>) for the 0.1% and 0.12% chlorhexidine groups respectively compared to the control rinse (Additional <a href="#CD008676-tbl-0007">Table 6</a>). Results for 7 to 12 weeks studies not included in meta‐analyses are supportive of a reduction in gingival inflammation associated with chlorhexidine mouthrinse use (Additional <a href="#CD008676-tbl-0007">Table 6</a>). </p> <div class="table" id="CD008676-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Studies with a gingival inflammation outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anauate‐Netto 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PBS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI. Quote: "..no statistically significant differences were detected among groups" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported mean GI by surface + SD. No overall SD. We calculated overall mean. Quote: "The means of the …gingival indices did not show any significant differences (P&lt;0.05) 1 or 2 months after baseline. However there were significant differences (P&lt;0.05) in the changes recorded at 30 and 60 days at all sites in…..the experimental group" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1888b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI severity (mean score of all sites graded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2902</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI or a SD. Quote: "..the effect of the chlorhexidine rinse on the occurrence and severity of gingivitis amounted to a 51% reduction of the disease compared to the placebo rinse…differences were statistically significant" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1988a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI severity (mean score of all sites graded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI or a SD. Quote: "..the gingivitis reductions were 34% and 36% for occurrence and severity respectively…differences were statistically significant" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Eaton 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mGI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (0.383)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.382)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI. Quote: "..the pooled mean mGI score improved by 25% from 0.56 at baseline to 0.42 at 12 weeks in the ChD (CHX) group but showed no change (0.54 to 0.55) in the placebo group" </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ferretti 1987</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI and SD depicted in graph but not reported. Quote: "Significant reductions in …gingivitis scores were seen on days 33 (P&lt;0.0001) and 60… (P&lt;0.001) for those patients using chlorhexidine rinse" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% vs 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4112/0.3640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5039</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Gingivitis severity by the GI method was… significantly lower at 3 months for both chlorhexidine groups compared to the placebo group. Differences ranged from 28‐46% and averaged 37% for the 0.12% group. Differences ranged from 18‐40% for the 0.20% group and averaged 29%" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weitz 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "…the active (CHX) groups had significantly lower… gingivitis scores than the respective control groups. Overall, the active group had a 10.27% reduction in the gingival index…compared to insignificant changes in the control groups" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fine 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear. Quote: "a gingival inflammation Index"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes reported in graphs which are difficult to decipher. Quote: "Whilst there was a general improvement in all… groups of patients, no one group was statistically significantly different from the other…" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%, CHX 0.06%, CHX 0.06%+F vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.15/0.29/0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No SD. At 3 months "..only the 0.1% CHX was different from the control". At 6 months "…the 0.1% CHX showed significant differences…in the GI…when compared to the 0.06% CHX/F" (P = 0.043) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overholser 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mGI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (SE 0.065)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.166 (SE 0.063)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "PX (CHX) inhibited gingivitis development by 26.8% (P&lt;0.001) at 3 months and by 30.5% (P&lt;0.001) at 6 months, compared to the control" </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; F = fluoride; NR = not reported; OH = oral hygiene; SD = standard deviation; SE = standard error. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>PBS (Papillary Bleeding Score, <a href="./references#CD008676-bbs2-0150" title="LoescheWJ . Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. Journal of Dental Research1979;58(12):2404-12.">Loesche 1979</a>) is measured on a 0‐5 increasing scale. </p> <p>GI (Gingival Index, <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>) is measured on a 0‐3 increasing scale. </p> <p>PMGI (Papillary Marginal Gingivitis Index, <a href="./references#CD008676-bbs2-0117" title="De la RosaM , SturzenbergerOP . Clinical reduction of gingivitis through the use of a mouthwash containing two quaternary ammonium compounds. Journal of Periodontology1976;47(9):535-7.">de la Rosa and Sturzenberger 1976</a>) is measured on a 0‐3 increasing scale. </p> <p>mGI (modified Gingival Index, <a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>) is measured on a 0‐4 increasing scale. </p> </div> </div> </section> </section> <section id="CD008676-sec-0074"> <h6 class="title">Gingival bleeding</h6> <p>A variety of different indices were used to measure gingival bleeding, therefore standardised mean differences (SMD) are presented. There was no clear difference between the placebo/control and the no rinse subgroups at either 4 to 6 weeks or 6 months (<a href="./references#CD008676-fig-0005" title="">Analysis 1.3</a>; <a href="./references#CD008676-fig-0006" title="">Analysis 1.4</a>). At 4 to 6 weeks, eight studies analysing 649 participants (all at high risk of bias) comparing chlorhexidine rinse with placebo/control or with no rinse that reported gingival bleeding were combined in a meta‐analysis. The overall effect estimate for all studies, both placebo/control and no rinse controls, was moderate at 4 to 6 weeks (SMD ‐0.56, 95% CI ‐0.79 to ‐0.33) showing a reduction in gingival bleeding in favour of the chlorhexidine rinse (P &lt; 0.00001). There was evidence of moderate heterogeneity (P = 0.16; I<sup>2</sup> = 34%). </p> <p>At 6 months, eight studies analysing 1132 participants (all at high risk of bias) reported gingival bleeding and were combined in a meta‐analysis. The overall effect estimate for all studies was also moderate at 6 months (SMD ‐0.72, 95% CI ‐1.02 to ‐0.42), showing a reduction in gingival bleeding in favour of the chlorhexidine rinse (P &lt; 0.00001). There was evidence of considerable heterogeneity between the studies at 6 months (P &lt; 0.00001; I<sup>2</sup> = 81%). </p> <section id="CD008676-sec-0075"> <p><b>Chlorhexidine concentration and frequency of rinsing</b></p> <p>No statistically significant differences were found between the subgroups with different chlorhexidine concentrations, at 4 to 6 weeks and 6 months (Additional <a href="#CD008676-tbl-0004">Table 3</a>). At both 4 to 6 weeks and 6 months all participants in the included studies for gingival bleeding were instructed to rinse twice per day, so no analysis for the effect of frequency of rinsing could be undertaken (Additional <a href="#CD008676-tbl-0005">Table 4</a>). </p> </section> <section id="CD008676-sec-0076"> <p><b>Other data</b></p> <p>A meta‐analysis of two studies (both at high risk of bias) analysing 196 participants comparing chlorhexidine rinse with no rinse controls using the Papillary Bleeding Index (<a href="./references#CD008676-bbs2-0159" title="MuhlemannHR . Psychological and chemical mediators of gingival health. Journal of Preventive Dentistry1977;4(4):6-17.">Muhlemann 1977</a>; <a href="./references#CD008676-bbs2-0172" title="SaxerUP , MühlemannHR . Motivation and education. SSO Schweizerische Monatsschrift fur Zahnheilkunde1975;85(9):905-19.">Saxer 1975</a>) after 8 weeks of rinsing showed no evidence of a difference in gingival bleeding (MD ‐0.07, 95% CI ‐0.16 to 0.02) (Additional <a href="#CD008676-tbl-0006">Table 5</a>). </p> <p>Another meta‐analysis of five studies (all at high risk of bias) analysing 182 participants comparing chlorhexidine rinse with placebo rinse using a variety of different gingival bleeding indices after 7 to 12 weeks of rinsing showed a strong effect in favour of the chlorhexidine rinse (SMD ‐1.29, 95% CI ‐1.85 to ‐0.72, P &lt; 0.00001). There was evidence of substantial heterogeneity (P = 0.02; I<sup>2</sup> = 64%) (Additional <a href="#CD008676-tbl-0006">Table 5</a>). </p> <p>Three studies analysing 99 participants (all at high risk of bias) comparing chlorhexidine rinse with placebo rinse, using bleeding on probing, presented longer‐term data 1, 4 and 10 months after chlorhexidine mouthrinsing had ceased and were combined in a meta‐analysis that showed a small retained effect in favour of chlorhexidine (MD ‐0.12, 95% CI ‐0.20 to ‐0.04) (Additional <a href="#CD008676-tbl-0006">Table 5</a>). </p> <p>Three studies (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) at high risk of bias reporting gingival bleeding at 4 to 6 weeks were not included in the meta‐analysis (Additional <a href="#CD008676-tbl-0008">Table 7</a>). All three studies reported a reduction in gingival bleeding for 0.1%, 0.12% and 0.2% chlorhexidine rinses compared to placebo or control rinse. </p> <div class="table" id="CD008676-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Studies with a gingival bleeding outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Axelsson 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs CHX 0.1% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % of gingival units with GI score 2 or 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%/11%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "In all…study groups, the % of gingival units scored GI 2+3 was reduced between baseline..and end of trial" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graziani 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%+Alc vs CHX 0.2% no Alc vs CHX+ADS vs control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FMBS /BOP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.47%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partial reporting of outcome data. Quote: "Statistically significant decreases in mean full‐mouth scores of gingival inflammation were noted for all experimental study groups at day 35 compared to baseline. Between‐group changes in FMBS…were statistically significant only when CHX2 (mean difference of 43.4 ± 22.4, P = 0.05) and CHX 3 (mean difference of 46.1 ± 23.1, P = 0.05) were compared to the CTRL group" (note: CHX 2 = CHX no Alc, CHX 3 = CHX + ADS) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.78%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Beginning at 4 weeks of rinsing, gingival bleeding was significantly lower in the CHX group compared to the placebo group by an average of 41.6% (P &lt; 0.05). At 6 weeks that reduction was 40%, (P &lt; 0.05)" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corbet 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27%(anterior)</p> <p>42%(posterior)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52%(anterior)</p> <p>75%(posterior)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "The difference between the mean percentage of GB of the test and control groups at 3 months was highly significant (P &lt; 0.001)" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Examiner A: 3.4%/2%</p> <p>Examiner B: 7.2%/6.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Examiner A: 3.81%</p> <p>Examiner B: 14.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD.</p> <p><b>O.2%</b> Quote: "Bleeding was 31% lower (range 11‐52%) compared to the placebo group" (P &gt; 0.05) </p> <p><b>0.12%</b> Quote: "..gingival bleeding was significantly lower by an average of 53% for both examiners (range 48‐59%)" (P ≤ 0.05) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign=""> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Regarding outcomes at 6 months to 2 years: Quote: "Subjects in the treatment group…displayed between 42% and 51% fewer sites with moderate to severe gingivitis (GI scores of 2 or 3) compared with subjects in the control group" (P &lt; 0.0001) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.01%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.65%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1156 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% of bleeding sites in each group is presented. There is a unit of analysis error (number of sites rather than number of subjects). Quote: "There was a considerable reduction in percent bleeding sites in the chlorhexidine…groups at 6 months compared with both control and baseline" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lucas 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Although the percentage of bleeding surfaces in the chlorhexidine group was less than in the placebo group on days 90 (33%) and 180 (76%), the differences were not significant" (P = 0.07) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% bleeding sites reported incompletely in text and also in a graph. Did not report a SD. </p> <p>Quote: "At 6 months…the positive control group had significantly fewer bleeding sites than the control group (.. 23%...)" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.88%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Regarding outcomes at 6 months to 2 years: Quote: "Subjects in the treatment group…displayed between 42% and 51% fewer sites with moderate to severe gingivitis (GI scores of 2 or 3) compared with subjects in the control group" (P &lt; 0.0001) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ADS = antidiscolouration system; Alc = alcohol; BOP = bleeding on probing; CHX = chlorhexidine; FMBS = Full‐Mouth Bleeding Score; GI = Gingival Index; SD = standard deviation. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> </div> </div> <p>Four studies (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) at high risk of bias reporting gingival bleeding at 6 months were not included in the meta‐analysis (Additional <a href="#CD008676-tbl-0008">Table 7</a>). Three of these studies reported a reduction in gingival bleeding for 0.12% chlorhexidine rinse compared to placebo or control rinse. <a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a> demonstrated a reduction in gingival bleeding at 2 years for 0.12% chlorhexidine compared to placebo (P &lt; 0.0001). Results for 7 to 12 weeks studies not included in meta‐analyses are supportive of a reduction in gingival bleeding associated with chlorhexidine mouthrinse use (Additional <a href="#CD008676-tbl-0008">Table 7</a>). </p> </section> </section> </section> <section id="CD008676-sec-0077"> <h5 class="title">Plaque</h5> <p>A variety of different indices were used to measure plaque, therefore SMDs are presented. There was no difference between the placebo/control or no rinse control subgroups for plaque at 4 to 6 weeks (P = 0.93) (<a href="./references#CD008676-fig-0007" title="">Analysis 1.5</a>). The overall effect was based on 12 trials analysing 950 participants, 11 at high and one at unclear risk of bias, and showed a large effect in favour of chlorhexidine rinse (SMD ‐1.45, 95% CI ‐1.90 to ‐1.00). Four of these trials analysing 223 participants reported the Plaque Index (0 to 3 increasing scale) (<a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) and showed a reduction in plaque in favour of chlorhexidine rinse (MD ‐0.58, 95% CI ‐0.78 to ‐0.39) (<a href="./references#CD008676-fig-0008" title="">Analysis 1.6</a>); five of these trials analysing 546 participants reported the Turesky modification of the Quigley Hein Index (0 to 5 increasing scale) (<a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>) and also showed a reduction in plaque in favour of chlorhexidine rinse (MD ‐0.78, 95% CI ‐0.85 to ‐0.70) (<a href="./references#CD008676-fig-0009" title="">Analysis 1.7</a>). </p> <p>At 6 months, although both subgroups showed a reduction in plaque favouring the chlorhexidine rinse (<a href="./references#CD008676-fig-0010" title="">Analysis 1.8</a>), there was a difference between the size of the effect estimates for the placebo/control and no rinse subgroups (P = 0.02). The higher estimate for the chlorhexidine rinse compared to placebo/control rinse based on nine trials analysing 1933 participants (all at high risk of bias) with a large effect (SMD ‐1.59, 95% CI ‐1.89 to ‐1.29) is compared with a moderate effect for the chlorhexidine rinse compared to no rinse control groups based on 2 trials analysing 142 participants (both at high risk of bias) (SMD ‐0.68, 95% CI ‐1.35 to ‐0.01). There was substantial heterogeneity among the studies in each subgroup (P &lt; 0.00001; I<sup>2</sup> = 84%; P = 0.06; I<sup>2</sup> = 72% for placebo/control and no rinse subgroups respectively). Five studies analysing 1108 participants reported data for the Plaque Index at 6 months. There was no clear difference between the placebo/control and no rinse subgroups, and the overall effect was ‐0.62 (95% CI ‐1.12 to ‐0.12) (<a href="./references#CD008676-fig-0011" title="">Analysis 1.9</a>). Six trials, all with placebo/no treatment controls, analysing 967 participants reported the Turesky modification of the Quigley Hein Index at 6 months and also showed a reduction in plaque in favour of chlorhexidine rinse (MD ‐0.73, 95% CI ‐0.88 to ‐0.57) (<a href="./references#CD008676-fig-0012" title="">Analysis 1.10</a>). </p> <section id="CD008676-sec-0078"> <h6 class="title">Chlorhexidine concentration and frequency of rinsing</h6> <p>No differences were found between the subgroups with different chlorhexidine concentrations (Additional <a href="#CD008676-tbl-0004">Table 3</a>). At 4 to 6 weeks the participants in one trial were instructed to rinse once per day compared with twice a day in the other 11 trials so no analysis for the effect of frequency of rinsing could be undertaken. Similarly at 6 months the participants in one trial were instructed to rinse once per day compared with twice a day in the other 10 trials so no analysis for the effect of frequency of rinsing could be undertaken (Additional <a href="#CD008676-tbl-0005">Table 4</a>). </p> </section> <section id="CD008676-sec-0079"> <h6 class="title">Other data</h6> <p>Meta‐analyses of studies that compared chlorhexidine mouthrinse with placebo (10 studies all at high risk of bias analysing 423 participants) or no rinse control (two studies both at high risk of bias analysing 196 participants) at 7 to 12 weeks showed a reduction in plaque (using various indices) in favour of chlorhexidine rinse (SMD ‐1.74, 95% CI ‐2.51 to ‐0.98 and SMD ‐0.77, 95% CI ‐1.07 to ‐0.47 respectively, Additional <a href="#CD008676-tbl-0006">Table 5</a>) both indicating a strong effect. There was considerable heterogeneity among the 10 placebo‐controlled studies P &lt; 0.00001; I<sup>2</sup> = 91%. </p> <p>One large 9‐month study (at high risk of bias) (<a href="./references#CD008676-bbs2-0004" title="BajajN , TandonS . The effect of Triphala and Chlorhexidine mouthwash on dental plaque, gingival inflammation, and microbial growth. International Journal of Ayurveda Research2011;2(1):29-36. ">Bajaj 2011</a>) analysing 852 participants comparing 0.1% chlorhexidine rinse with distilled water found a large reduction in plaque (0 to 3 increasing scale) in the chlorhexidine rinse group (MD ‐1.55, 95% CI ‐1.79 to ‐1.31, Additional <a href="#CD008676-tbl-0006">Table 5</a>). </p> <p>Four studies analysing 132 participants (all at high risk of bias) comparing chlorhexidine rinse with placebo rinse presented data 1, 4 and 10 months after rinsing had ceased, using a variety of indices, and were combined in a meta‐analysis that showed a large retained effect in favour of chlorhexidine (SMD ‐1.10, 95% CI ‐1.18 to ‐0.40, Additional <a href="#CD008676-tbl-0006">Table 5</a>). However, there was substantial heterogeneity between the studies (P = 0.02; I<sup>2</sup> = 71%). </p> <p>One study (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) at high risk of bias reporting a plaque outcome at 6 weeks that was not included in the meta‐analysis showed a reduction in plaque for 0.12% chlorhexidine rinse compared to placebo rinse (Additional <a href="#CD008676-tbl-0009">Table 8</a>). </p> <div class="table" id="CD008676-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Studies with a plaque outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.3175*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8425*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean GI by surface + SD reported. We calculated the overall mean. No overall SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1888b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The reductions in dental plaque were not statistically significant.."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1988a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The reductions in dental plaque were not statistically significant.."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% vs 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14/1.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weitz 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "Subjects in the treatment group had significantly lower mean plaque scores than those in the control group at six months, and at one and two years. The difference between the groups ranged from 35% to 46%" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%/CHX 0.06%/CHX 0.06%+F vs control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.13/0.25/0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median only. Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jayaprakash 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.05%/ CHX 0.05%+F vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0813/0.0459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lucas 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OHI‐S</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "…reductions in Plaque Index...were statistically significant for the positive control group…compared with the reduction obtained with the control group.. These reductions were 41% (positive control)…after 3 months and 35%..after 6 months.." </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "Subjects in the treatment group had significantly lower mean plaque scores than those in the control group at six months, and at one and two years. The difference between the groups ranged from 35% to 46%" </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; F = Fluoride; NR = not reported; SD = standard deviation.</p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>PI (Plaque Index, <a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) is measured on a 0‐3 increasing scale. </p> <p>TQH (Turesky modification of the Quigley and Hein Index, <a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>) is measured on a 0‐5 increasing scale. </p> <p>OHI‐S (Simplified Oral Hygiene Index, <a href="./references#CD008676-bbs2-0126" title="GreeneJC , VermillionJR . The Simplified Oral Hygiene Index. Journal of the American Dental Association1964;68:7-13.">Greene and Vermillion 1964</a>) is measured on a 0‐3 increasing scale. </p> </div> </div> <p>Five studies at high risk of bias reporting a plaque outcome at 6 months that were not included in the meta‐analysis also showed a reduction in plaque for 0.12%, 0.1%, 0.05% and 0.06% chlorhexidine rinse compared to placebo or control rinse (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) (Additional <a href="#CD008676-tbl-0009">Table 8</a>). </p> <p><a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>, which was not included in the meta‐analysis demonstrated a reduction in plaque at 2 years for 0.12% chlorhexidine compared to placebo. Results for 7 to 12 weeks studies not included in meta‐analyses were generally supportive of a reduction in plaque associated with chlorhexidine mouthrinse use (Additional <a href="#CD008676-tbl-0009">Table 8</a>). </p> </section> </section> <section id="CD008676-sec-0080"> <h5 class="title">Adverse effects</h5> <section id="CD008676-sec-0081"> <h6 class="title">Calculus</h6> <p>Two studies analysing 102 participants, both at high risk of bias, and with placebo/control rinses, presented data on calculus at 4 to 6 weeks. There was insufficient evidence to determine whether using chlorhexidine rinse for 4 to 6 weeks was associated with increased calculus formation (SMD 0.02, 95% CI ‐0.09 to 0.14) (<a href="./references#CD008676-fig-0013" title="">Analysis 1.11</a>). </p> <p>At 7 to 12 weeks, five studies (all high risk of bias) analysing 330 participants, with a placebo/control rinse presented calculus data, along with one study analysing 95 participants with a no rinse control also at high risk of bias (<a href="./references#CD008676-fig-0014" title="">Analysis 1.12</a>). There was a difference between the subgroups for control type, with there being insufficient evidence to determine an effect on calculus for chlorhexidine rinse compared to placebo/control rinse (SMD 0.14, 95% CI ‐0.08 to 0.36). The single study in the no rinse control group, however, showed more calculus in the chlorhexidine rinse group compared to the no rinse control group (SMD 1.02, 95% CI 0.59 to 1.45) demonstrating a large effect. There was evidence of substantial heterogeneity (P =0.004; I<sup>2</sup> = 71%). </p> <p>At 6 months there was a difference between the subgroups for control type. There was only one study (at high risk of bias), analysing 91 participants, with a no rinse control group which showed an increase in calculus in the chlorhexidine rinse group (SMD 1.39, 95% CI 0.93 to 1.85) demonstrating a large effect (<a href="./references#CD008676-fig-0015" title="">Analysis 1.13</a>). The pooled result for the three studies (at high risk of bias) analysing 232 participants with placebo/control rinses showed an increase in calculus associated with chlorhexidine rinse (SMD 0.60, 95% CI 0.24 to 0.96) demonstrating a moderate effect. There was evidence of moderate heterogeneity (P = 0.16; I<sup>2</sup> = 46%). </p> <section id="CD008676-sec-0082"> <p><b>Chlorhexidine concentration and frequency of rinsing</b></p> <p>No statistically significant difference was found between the subgroups with different chlorhexidine concentrations at 7 to 12 weeks, however the data at 6 months indicated a larger effect (increased calculus formation in the chlorhexidine rinse group) for the lower concentration chlorhexidine mouthrinse (Additional <a href="#CD008676-tbl-0004">Table 3</a>). Participants in all the included trials with calculus data at 4 to 6, 7 to 12 weeks and 6 months were asked to use the mouthrinse twice a day, so no analysis of frequency could be undertaken (Additional <a href="#CD008676-tbl-0005">Table 4</a>). </p> </section> <section id="CD008676-sec-0083"> <p><b>Other data</b></p> <p>Five studies at high risk of bias reporting interim and end scores for calculus at various time points from 4 weeks to 2 years (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) that were not included in the meta‐analysis all found increased supragingival calculus in the 0.12% chlorhexidine rinse groups compared to the placebo and control rinse groups (Additional <a href="#CD008676-tbl-0010">Table 9</a>). Increased calculus was noted in two other studies but not measured using an index or scale (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>). </p> <div class="table" id="CD008676-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Studies with a calculus outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0475</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean RI by surface + SD reported. We calculated overall mean. No overall SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean RI by surface + SD reported. We calculated overall mean. No overall SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in graph. Did not report a SD. Quote: "All groups developed calculus after the initial cleaning at baseline. This increase was only statistically significant for the positive control group compared with the control group at 6 months" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign="middle"> <p><b>Calculus 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results reported at 24 months only. See results at &gt; 6 months below</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.21 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Supragingival calculus was higher in the group using chlorhexidine but this increase in calculus did not diminish the therapeutic effects of chlorhexidine since subjects with significant increases in calculus also had significant decreases in gingivitis" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "All groups developed calculus after the initial cleaning at baseline. This increase was only statistically significant for the positive control group compared with the control group at 6 months" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 24 months subjects in the treatment group had higher mean supragingival calculus scores, but at the same time more subjects were free of subgingival calculus </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; NR = not reported; SD = standard deviation.</p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>RI (Retention Index, <a href="./references#CD008676-bbs2-0106" title="BjorbyA , LöeH . The relative significance of different local factors in the initiation and development of periodontal inflammation. Journal of Periodontal Research1966;2:76-7.">Björby and Löe 1966</a>) is measured on a 0‐3 increasing scale. </p> <p>VM (Volpe‐Manhold Calculus Index, <a href="./references#CD008676-bbs2-0153" title="ManholdJH , VolpeAR , ParkerL , AdamsSH . In vivo calculus assessment. II. A comparison of scoring techniques. Journal of Periodontology1965;36:299-304.">Manhold 1965</a>; <a href="./references#CD008676-bbs2-0190" title="VolpeAR , ManholdJH , HazenSP . In vivo calculus assessment. I. A method and its examiner reproducibility. Journal of Periodontology1965;36:292-8.">Volpe 1965</a>) measures calculus present on the lingual surface of the lower 6 anterior teeth. Calculus is measured in 3 planes using a standard periodontal probe.The greatest value allowed for any 1 plane is 3 units, therefore the maximum score per tooth is 9 units or 54 units per subject. The mean per subject score is obtained by dividing the total calculus score by the number of lower anterior teeth. A mean calculus score for the group is then calculated. </p> </div> </div> </section> </section> <section id="CD008676-sec-0084"> <h6 class="title">Extrinsic tooth staining</h6> <p>Different dichotomous and continuous indices were used to measure tooth staining. At 4 to 6 weeks both the dichotomous data (two studies at high risk of bias, 156 participants) and the continuous data (eight studies at high risk of bias, 415 participants) showed more tooth staining in the chlorhexidine rinse group. A large effect estimate was found for both the dichotomous data (risk ratio (RR) 5.41, 95% CI 2.03 to 14.47, <a href="./references#CD008676-fig-0016" title="">Analysis 1.14</a>) and continuous data (SMD 1.07, 95% CI 0.80 to 1.34, <a href="./references#CD008676-fig-0018" title="">Analysis 1.16</a>). There was no strong evidence of heterogeneity between the trials reporting continuous data (P = 0.14, I<sup>2</sup> = 36%). </p> <p>Only one study, analysing 118 participants, reported dichotomous data for tooth staining at 7 to 12 weeks, with more tooth staining in the chlorhexidine group (RR 2.50, 95% CI 1.29 to 4.83) (<a href="./references#CD008676-fig-0017" title="">Analysis 1.15</a>). Eleven studies, analysing 581 participants (at high risk of bias) reported data on different continuous scales showing an increase in tooth staining associated with chlorhexidine rinse at 7 to 12 weeks (SMD 1.19, 95% CI 0.98 to 1.40), demonstrating a large effect (<a href="./references#CD008676-fig-0019" title="">Analysis 1.17</a>). </p> <p>Four studies analysing 323 participants, at high risk of bias, reported continuous data at 6 months using different tooth staining indices. The pooled effect estimate indicated a large effect for tooth staining due to the chlorhexidine rinse (SMD 1.54, 95% CI 1.22 to 1.86) (<a href="./references#CD008676-fig-0020" title="">Analysis 1.18</a>). There was no strong evidence of heterogeneity (P = 0.19; I<sup>2</sup> = 36%). </p> <section id="CD008676-sec-0085"> <p><b>Chlorhexidine concentration and frequency of rinsing</b></p> <p>Subgroup comparisons for chlorhexidine concentration were not significant (Additional <a href="#CD008676-tbl-0004">Table 3</a>). In one study providing tooth staining data at both 4 to 6 weeks and 7 to 12 weeks, participants rinsed three times a day, and in one of the studies at 4 to 6 weeks participants rinsed only once per day, whereas in all the other studies participants rinsed twice per day (Additional <a href="#CD008676-tbl-0005">Table 4</a>). There were insufficient studies in the subgroups to make a meaningful comparison on frequency at any time point. </p> </section> <section id="CD008676-sec-0086"> <p><b>Other data</b></p> <p>Thirteen studies reported information about tooth staining that could not be included in meta‐analyses. Eight studies that reported data on extrinsic tooth staining could not be included in meta‐analyses because no measure of variance was reported (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>), no outcome data were reported (<a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>) or because the mean value in the control groups was zero (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>). All of these studies reported higher levels of extrinsic tooth staining in the chlorhexidine compared to control arms at 4 to 6 weeks (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>); 7 to 12 weeks (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>); and at 6 months (<a href="./references#CD008676-bbs2-0009" title="CharlesCH , MostlerKM , BartelsLL , MankodiSM . Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. Journal of Clinical Periodontology2004;31(10):878-84. ">Charles 2004</a>; <a href="./references#CD008676-bbs2-0025" title="GrossmanE , ReiterG , SturzenbergerOP . Six-month study of the effects of a chlorhexidine mouthrinse on gingivitis in adults. Journal of Periodontal Research1986;21(Suppl 16):33-43. ">Grossman 1986</a>; <a href="./references#CD008676-bbs2-0026" title="GrossmanE , MeckelAH , IsaacsRL , FerrettiGA , SturzenbergerOP , BollmerBW , et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. Journal of Periodontology1989;60(8):435-40. ">Grossman 1989</a>; <a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>). In five other studies tooth staining was reported combined with either denture staining (<a href="./references#CD008676-bbs2-0035" title="Lopez-JornetP , Plana-RamonE , LestonJS , Pons-FusterA . Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study. Gerodontology2012;29(4):292-8. ">Lopez‐Jornet 2012</a>), discolouration of oral tissues (<a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) or was reported as 'discolouration' and it was not clear whether this related to teeth, oral tissues or both (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>). In four of these five studies staining/discolouration was higher in the chlorhexidine rinse groups at 4 to 6 weeks (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) and 7 to 12 weeks (<a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) (Additional <a href="#CD008676-tbl-0011">Table 10</a>). </p> <div class="table" id="CD008676-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Studies with a staining outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD/SE) or n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="8" scope="col" valign="middle"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Axelsson 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%/0.1% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1171 (0.297)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not included in meta‐analysis as control mean is 0. We combined data from the 0.2% and 0.1% CHX groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bhat 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported number and proportion of participants with mild or moderate 'discolouration' in text </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 (91%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear whether discolouration relates to teeth or oral tissues or both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Flotra 1972 &amp; 1971 (4‐month study that reports this outcome at 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%/0.1%/0.1% (acetate) vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No index</p> <p>Reported narratively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12% of tooth surfaces without fillings</p> <p>62% of silicate fillings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 (at 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "..12% of the tooth surfaces without fillings became discolored within the first 4 weeks of the experiment…this happened more frequently on the interproximal surfaces than on the labial surfaces (ratio2:1). Sixty‐two per cent of the silicate fillings in these areas were discolored.." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graziani 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2228 (0.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not included in meta‐analysis as control mean is 0. We combined data from the 3 CHX groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hase 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective of participants regarding staining of teeth and/or tongue using VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (SE 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (SE 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Teeth and/or tongue staining reported together. Data estimated from a graph</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>López‐Jornet 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Registration of side effects including denture/dental staining (n and %)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (5.71%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (8.57%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denture and dental staining reported together</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Turkoglu 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX (conc not reported) vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No index</p> <p>Reported narratively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (56%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assumed 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Of the 25 subjects who rinsed their mouth with CHX mouthrinse..14 showed discolouration of teeth and/or tongue" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimmer 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.06%+F+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staining of teeth and tongue registered at final examination (n)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stain on teeth/tongue reported together. If more than 1 side effect was present, only the most relevant was listed i.e. side effects were reported with no double counting </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.61 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.66 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.59 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph at 6 months only See 6‐month results below</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimmer 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.06% +F+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staining of teeth and tongue registered at final examination (n)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stain on teeth/tongue reported together. If more than 1 side effect was present, only the most relevant was listed i.e. side effects were reported with no double counting </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.08 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome data not reported. Quote: "Some extrinsic tooth staining was observed in the chlorhexidine group" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.15 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.75 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%/ 0.06%/0.06%+F vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lang and Räber)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13/1.02/1.06 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median only. Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in graph Did not report a SD</p> <p>Quote: "Statistically significant more overall staining, more intense staining and stain coverage per tooth were detected for the positive control group…compared with the control group" </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHX = chlorhexidine; conc = concentration; F = fluoride; NR = not reported; OH = oral hygiene; SD = standard deviation; SE = standard error; VAS = visual analogue scale. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>DI (Discolouration Index, <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a>): gingival and body regions of the tooth are scored for intensity (0‐3 increasing scale) and severity (0‐3 increasing scale). </p> <p>DI (Discolouration Index, <a href="./references#CD008676-bbs2-0140" title="LangNP , RäberK . Use of oral irrigators as vehicle for the application of antimicrobial agents in chemical plaque control. Journal of Clinical Periodontology1981;8(3):177-88.">Lang and Räber 1981</a>) is measured on a 0‐3 increasing scale. </p> <p>SI (Staining Index): the buccal surfaces of the 8 central incisors were divided into 3 areas: incisal, approximal and gingival according to <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a> and <a href="./references#CD008676-bbs2-0128" title="GrundemannLJ , TimmermanMF , IjzermanY , van derVeldenU , van derWeijdenGA . Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. Journal of Clinical Periodontology2000;27(1):9-15.">Grundemann 2000</a> and a SI was used to record the dichotomous presence or absence of staining in each area and to calculate the percentage of the total area showing staining. </p> </div> </div> <p>In five additional studies, increased tooth staining (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>), 'pigmentation' (<a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>) and 'yellow teeth' (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>) were reported in relation to the chlorhexidine rinse arms. In two studies staining of teeth in the chlorhexidine rinse arm was listed as a reason for participant withdrawal from the studies (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>). </p> </section> </section> </section> <section id="CD008676-sec-0087"> <h5 class="title">Other adverse effects</h5> <p>Twenty‐two studies reported at least one adverse effect apart from extrinsic tooth staining and calculus formation in the chlorhexidine rinse arms. Apart from extrinsic tooth staining, the adverse effects most commonly reported in the chlorhexidine rinse arms of the included studies were taste disturbance/alteration (reported in 11 studies), effects on the oral mucosa (reported in 13 studies) and a general burning sensation or a burning tongue or both (reported in nine studies). </p> <p>Taste disturbance/alteration was reported in 11 studies (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>; <a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). The proportion of participants experiencing taste disturbance/alteration was reported in eight of these studies and was consistently higher in the chlorhexidine rinse arms (3% to 30%) than in the placebo/control/oral hygiene (OH) only arms (0% to 7%) with one exception (<a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>) where a higher proportion of participants in the saline control arm experienced taste disturbances (45.4% versus 63.6%). </p> <p>A general burning sensation (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) and/or a burning tongue (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>) was reported in the chlorhexidine rinse arms in nine studies. The proportion of participants affected was reported in four of the nine studies (<a href="./references#CD008676-bbs2-0002" title="AndersonGB , BowdenJ , MorrisonEC , CaffesseRG . Clinical effects of chlorhexidine mouthwashes on patients undergoing orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics1997;111(6):606-12. ">Anderson 1997</a>; <a href="./references#CD008676-bbs2-0006" title="BhatN , MitraR , OzaS , Mantu VinayakK , BishnoiS , GohilM , et al. The antiplaque effect of herbal mouthwash in comparison to chlorhexidine in human gingival disease: a randomized placebo controlled clinical trial. Journal of Complementary and Integrative Medicine2014;11(2):129-37. ">Bhat 2014</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>) and ranged from 4.6% to 50% in the chlorhexidine arms compared to 0% in the placebo/control/OH only arms. <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a> reported 'burning sensation' rated by participants on a visual analogue scale from none (0) to 100 (very much). The mean visual analogue scale score for the chlorhexidine rinse arm was approximately 18 compared to 8 for the placebo arm. </p> <p>Effects on the oral mucosa of participants in the chlorhexidine rinse arms were reported in 13 studies. Specific effects were described as mucosal irritation (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0015" title="EmlingRC , LevinS , ShiX , WeinbergS , YankellSL . Rembrandt toothpaste stain prevention with and without the use of Peridex. Journal of Clinical Dentistry1992;3(2):59-65. ">Emling 1992</a>), sensitivities of the oral mucosa (<a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>), mucosal soreness (<a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>), mild desquamation (<a href="./references#CD008676-bbs2-0012" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988</a>; <a href="./references#CD008676-bbs2-0013" title="dela RosaM , SturzenbergerOP , MooreDJ . The use of chlorhexidine in the management of gingivitis in children. Journal of Periodontology1988;59(6):387-9. ">de la Rosa 1988b</a>; <a href="./references#CD008676-bbs2-0037" title="NavarroD , SantosEAT , RochaJCF , BremmLL , JukoskiM , RibeiroPG , et al. Effect of chlorhexidine digluconate, Plantago major and placebo mouth rinse on dental plaque and gingivitis [Efeitos do digluconato de clorexidina, Plantago major e placebo sobre placa dental e gengivite: uma comparacao clinica da eficacia de colutorios]. Revista Brasileira de Plantas Medicinais1998;1(1):28. ">Navarro 1998</a>), mucosal ulceration (<a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>), mucosal erosions (<a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>), soft tissue conditions (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>), oral mucosal lesions (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>) and adverse mucosal reaction (<a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>). Where it was reported, the proportion of participants experiencing effects on the oral mucosa was generally low. For example, clinically apparent mucosal ulceration was reported in 12% (n = 3) of participants in the chlorhexidine rinse arm of one study (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>) and mucosal erosions affected 4% (n = 2) of participants in the chlorhexidine rinse arm of another study (<a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>). However one study reported a high proportion of oral mucosal lesions in participants in the chlorhexidine (0.2%) rinse arm (25%, n = 6) (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>). </p> <p>Discolouration/pigmentation of the oral soft tissues was reported in seven studies and was consistently higher in the chlorhexidine rinse arms ranging from 9% to 88% compared to 0% to 7% in the placebo/control/OH only arms (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>; <a href="./references#CD008676-bbs2-0039" title="PereiraSL , deOliveiraJW , AngeloKK , da CostaAM , CostaF . Clinical effect of a mouth rinse containing Ocimum gratissimum on plaque and gingivitis control. Journal of Contemporary Dental Practice2011;12:350-5. ">Pereira 2011</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>; <a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). Coated tongue was reported as an adverse effect in one study (<a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>). </p> <p>Less commonly reported adverse effects included transient anaesthetic sensation, hypoaesthesia and paraesthesia; affecting 5% to 18% of participants in the chlorhexidine rinse arms (<a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0028" title="HaseJC , AttstromR , EdwardssonS , KeltyE , KischJ . 6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo. (I). Effect on plaque formation and gingivitis. Journal of Clinical Periodontology1998;25(9):746-53. ">Hase 1998</a>; <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>; <a href="./references#CD008676-bbs2-0032" title="JoseA , ButlerA , PayneD , MaclureR , RimmerP , BosmaML . A randomised clinical study to evaluate the efficacy of alcohol-free or alcohol-containing mouthrinses with chlorhexidine on gingival bleeding. British Dental Journal2015;219(3):125-30, 6. ">Jose 2015</a>; <a href="./references#CD008676-bbs2-0034" title="LangNP , HaseJC , GrassiM , HammerleCH , WeigelC , KeltyE , et al. Plaque formation and gingivitis after supervised mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 6 months. Oral Diseases1998;4(2):105-13. ">Lang 1998</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>). </p> <p>Lastly, in relation to acceptability, an unacceptable or unpleasant taste was reported by participants in the chlorhexidine rinse arms of eight studies (<a href="./references#CD008676-bbs2-0001" title="Anauate-NettoC , Anido-AnidoA , LeegoyHR , MatsumotoR , AlonsoRC , MarcucciMC , et al. Randomized, double-blind, placebo-controlled clinical trial on the effects of propolis and chlorhexidine mouthrinses on gingivitis. Brazilian Dental Science2014;17(1):11-5. ">Anauate‐Netto 2014</a>; <a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0014" title="EatonKA , RiminiFM , ZakE , BrookmanDJ , HopkinsLM , CannellPJ , et al. The effects of a 0.12% chlorhexidine-digluconate-containing mouthrinse versus a placebo on plaque and gingival inflammation over a 3-month period. A multicentre study carried out in general dental practices. Journal of Clinical Periodontology1997;24(3):189-97. ">Eaton 1997</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0027" title="HaseJC , AinamoJ , EtemadzadehH , AstromM . Plaque formation and gingivitis after mouthrinsing with 0.2% delmopinol hydrochloride, 0.2% chlorhexidine digluconate and placebo for 4 weeks, following an initial professional tooth cleaning. Journal of Clinical Periodontology1995;22(7):533-9. ">Hase 1995</a>; <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>). </p> </section> <section id="CD008676-sec-0088"> <h5 class="title">Sensitivity analysis</h5> <p>We undertook a sensitivity analysis for the GI at both 4 to 6 weeks and 6 months, excluding trials where we had to estimate the standard deviation from similar studies, or had to read the data from graphs. The pooled estimate for 4 to 6 weeks (excluding <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a> and <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) was: MD ‐0.23 (95% CI ‐0.36 to ‐0.10), and at 6 months (excluding <a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) MD ‐0.25 (95% CI ‐0.39 to ‐0.10). These estimates are similar to those for the overall pooling of the studies. </p> <p>We undertook a sensitivity analysis for the GI at both 4 to 6 weeks and 6 months excluding trials where professional periodontal treatment was carried out during the study (i.e. <a href="./references#CD008676-bbs2-0017" title="FaveriM , GurskyLC , FeresM , ShibliJA , SalvadorSL , deFigueiredoLC . Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. Journal of Clinical Periodontology2006;33(11):819-28. ">Faveri 2006</a>; <a href="./references#CD008676-bbs2-0018" title="FeresM , GurskyLC , FaveriM , TsuzukiCO , FigueiredoLC . Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology2009;36(10):857-67. ">Feres 2009</a>; <a href="./references#CD008676-bbs2-0019" title="FeresM , SoaresGM , MendesJA , SilvaMP , FaveriM , TelesR , et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. Journal of Clinical Periodontology2012;39(12):1149-58. ">Feres 2012</a>; <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>; <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a>; <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>). The pooled estimate for 4 to 6 weeks (excluding <a href="./references#CD008676-bbs2-0040" title="RahmaniME , RadvarM . Effects of chlorhexidine (0.2%) as irrigant during ultrasonic debridement: A clinical study. International Journal of Pharmacology2006;2(1):89-92. ">Rahmani 2006</a> and <a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a> ) was: MD ‐0.21 (95% CI ‐0.32 to ‐0.10), and at 6 months (excluding <a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>) MD ‐0.19 (95% CI ‐0.29 to ‐0.10). These estimates are similar to those for the overall pooling of the studies. </p> </section> <section id="CD008676-sec-0089"> <h5 class="title">Assessment of reporting biases</h5> <p>The meta‐analysis for GI at 4 to 6 weeks included 10 trials. Testing for asymmetry in a funnel plot using the methods described by <a href="./references#CD008676-bbs2-0119" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>, using "metabias" command in Stata (P = 0.019), although significant, the estimate of bias was negative indicating that the bias was lack of large studies (not small studies). The meta‐analysis for GI at 6 months included 13 trials, and there was no evidence of publication bias from the funnel plot and this was confirmed by testing for asymmetry in a funnel plot using the same methods (P = 0.95). Two of the plaque meta‐analyses at 4 to 6 weeks and 6 months had more than 10 studies but funnel plots cannot be investigated when SMD models are used. All the other meta‐analyses had less than 10 trials, so we were unable to assess reporting bias for these. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008676-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008676-sec-0090"></div> <section id="CD008676-sec-0091"> <h3 class="title" id="CD008676-sec-0091">Summary of main results</h3> <p>There was high‐quality evidence that using chlorhexidine mouthrinse as an adjunct to regular mechanical oral hygiene procedures for 4 to 6 weeks and 6 months results in a moderate reduction in gingivitis compared to placebo, control or mechanical oral hygiene alone. This reduction in gingivitis, in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 Gingival Index (GI) scale) is not considered to be clinically important. Heterogeneity was considerable in the meta‐analyses at 4 to 6 weeks and 6 months and subgroup analysis was only able to explain some of the heterogeneity at 6 months, due to whether or not a prophylaxis or scale and polish was conducted at the start of the study. The standardised mean differences (SMDs) for gingival bleeding at 4 to 6 weeks and 6 months also indicate that chlorhexidine mouthrinse has a moderate effect on gingival bleeding compared to placebo, control or mechanical oral hygiene alone. There was insufficient evidence to determine the reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with mean GI scores of 1.1 to 3 indicating moderate or severe levels of gingival inflammation. </p> <p>There was also high‐quality evidence that chlorhexidine mouthrinse reduces plaque at 4 to 6 weeks and 6 months. SMDs for plaque for both control subgroups at 4 to 6 weeks and at 6 months indicate a large effect. The four studies that used the Plaque Index (0 to 3 increasing scale) and the four studies that used the Turesky Modification of the Quigley and Hein Index (0 to 5 increasing scale) at 4 to 6 weeks indicate a reduction in plaque in favour of the chlorhexidine mouthrinse. </p> <p>There was no evidence that one concentration of chlorhexidine rinse was more effective than another in reducing gingivitis and plaque. Participants in most of the studies included in the meta‐analyses used a rinse frequency of twice daily, limiting our ability to analyse the effect of rinse frequency on gingivitis and plaque. We were only able to evaluate the effect of rinse frequency for gingivitis measured at 6 months using the GI, however, no difference in effect was observed. </p> <p>There was moderate‐quality evidence that chlorhexidine rinse causes a large amount of extrinsic tooth staining when used for periods of 4 weeks or longer. Comparison of subgroups with different chlorhexidine concentrations was not statistically significant. </p> <p>There was insufficient evidence to determine whether using chlorhexidine rinse for 1 to 3 months was associated with increased calculus formation. There was some evidence of increased calculus formation related to rinsing with chlorhexidine mouthrinse for a period of 6 months. However, overall evidence for the effect of chlorhexidine mouthrinse on calculus formation was inconclusive. </p> <p>Twenty‐two of the 51 studies included in this review reported at least one adverse effect apart from extrinsic tooth staining and calculus formation in the chlorhexidine rinse arms. The adverse effects most commonly reported in the chlorhexidine rinse arms of the included studies were taste disturbance/alteration (reported in 11 studies), effects on the oral mucosa including mucosal irritation, soreness, mild desquamation, mucosal ulceration/erosions and oral mucosal lesions (reported in 13 studies) and a general burning sensation or a burning tongue or both (reported in nine studies). </p> </section> <section id="CD008676-sec-0092"> <h3 class="title" id="CD008676-sec-0092">Overall completeness and applicability of evidence</h3> <p>Chlorhexidine mouthrinse is effective in reducing gingivitis and plaque when used as an adjunct to regular mechanical oral hygiene procedures for 4 weeks or longer. The consistency of effect for chlorhexidine mouthrinse on gingivitis and plaque across studies included in this review was remarkable though not surprising considering that chlorhexidine mouthrinse has long been regarded as the gold standard of antimicrobial mouthrinses.The primary outcome of this review was gingivitis which can be measured using a variety of different indices. The clinical features of gingivitis can be assessed non‐invasively by visual assessment of colour, contour and gingival bleeding or invasively using an instrument to provoke bleeding or both (<a href="./references#CD008676-bbs2-0151" title="LorenzK , BruhnG , NetuschilL , HeumannC , HoffmannT . How to select study designs and parameters to investigate the effect of mouthrinses? Part I: rationale and background. Journal of Physiology and Pharmacology2009;60 Suppl 8:77-83.">Lorenz 2009</a>). Our review clearly demonstrates the many different indices that can be used to measure gingivitis. While these many indices were developed to provide a standardised reproducible method of quantifying gingivitis for descriptive or comparative purposes in epidemiology and clinical trials respectively, the subjectivity involved in their use remains problematic. The presence/absence of bleeding on provocation would appear to be the more objective approach (<a href="./references#CD008676-bbs2-0113" title="CiancioSG . Current status of indices of gingivitis. Journal of Clinical Periodontology1986;13(5):375-8, 381-2.">Ciancio 1986</a>; <a href="./references#CD008676-bbs2-0151" title="LorenzK , BruhnG , NetuschilL , HeumannC , HoffmannT . How to select study designs and parameters to investigate the effect of mouthrinses? Part I: rationale and background. Journal of Physiology and Pharmacology2009;60 Suppl 8:77-83.">Lorenz 2009</a>; <a href="./references#CD008676-bbs2-0167" title="PolsonAM , CatonJG . Current status of bleeding in the diagnosis of periodontal diseases. Journal of Periodontology1985;56(11 Suppl):1-3.">Polson and Caton 1985</a>). However, the probing technique, the depth to which the instrument is inserted, the force with which it is applied, the time allowed to elapse between applying the stimulus and recording the outcome and even the angulation of the instrument can have an effect on the bleeding response (<a href="./references#CD008676-bbs2-0151" title="LorenzK , BruhnG , NetuschilL , HeumannC , HoffmannT . How to select study designs and parameters to investigate the effect of mouthrinses? Part I: rationale and background. Journal of Physiology and Pharmacology2009;60 Suppl 8:77-83.">Lorenz 2009</a>; <a href="./references#CD008676-bbs2-0167" title="PolsonAM , CatonJG . Current status of bleeding in the diagnosis of periodontal diseases. Journal of Periodontology1985;56(11 Suppl):1-3.">Polson and Caton 1985</a>; <a href="./references#CD008676-bbs2-0184" title="van derWeijdenGA , TimmermanMF , NijboerA , ReijerseE , van derVeldenU . Comparison of different approaches to assess bleeding on probing as indicators of gingivitis. Journal of Clinical Periodontology1994;21(9):589-94.">van der Weijden 1994</a>). Moreover, calibration of examiners and demonstrating inter‐ and intraexaminer reliability are hampered by the inability to obtain the same response upon repeated application of the stimulus to provoke gingival bleeding at the same site (<a href="./references#CD008676-bbs2-0151" title="LorenzK , BruhnG , NetuschilL , HeumannC , HoffmannT . How to select study designs and parameters to investigate the effect of mouthrinses? Part I: rationale and background. Journal of Physiology and Pharmacology2009;60 Suppl 8:77-83.">Lorenz 2009</a>; <a href="./references#CD008676-bbs2-0167" title="PolsonAM , CatonJG . Current status of bleeding in the diagnosis of periodontal diseases. Journal of Periodontology1985;56(11 Suppl):1-3.">Polson and Caton 1985</a>). In synthesising the evidence from primary research studies evaluating chlorhexidine mouthrinse as an adjunctive treatment for gingival health, the many different approaches to measuring gingivitis, particularly gingival bleeding, presented difficulties in combining the study results to produce a summary of the effect of the mouthrinse. </p> <p>To facilitate the analysis, we grouped the indices into those that measured principally gingival inflammation visually and invasively (e.g. the Gingival Index (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>)) or visually only (e.g. the Modified Gingival Index (<a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>)) and those that measured gingival bleeding (e.g. bleeding on probing (BOP) (<a href="./references#CD008676-bbs2-0100" title="AinamoJ , BayI . Problems and proposals for recording gingivitis and plaque. International Dental Journal1975;25(4):229-35.">Ainamo and Bay 1975</a>) or the Eastman Interdental Bleeding Index (<a href="./references#CD008676-bbs2-0111" title="CatonJG , PolsonAM . The interdental bleeding index: a simplified procedure for monitoring gingival health. Compendium of Continuing Education in Dentistry1985;6(2):88, 90-2.">Caton and Polson 1985</a>)). We endeavoured to include both types of index for measuring gingivitis in the review, therefore where both were reported within a study, both were data extracted. Our main analysis was based on the studies that reported gingival inflammation using the Gingival Index (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>) at 4 to 6 weeks and 6 months to reflect both the short‐ and long‐term effect of chlorhexidine mouthrinse. Our results showed that after 4 to 6 weeks of use, chlorhexidine mouthrinse reduced gingivitis by a mean of 0.21 of a unit on the Gingival Index (GI) scale when compared to a placebo/control mouthrinse or mechanical oral hygiene alone. Based on these studies, a reduction in gingivitis of 0.11 to 0.31 of a unit on the GI scale could be expected with use of chlorhexidine mouthrinse for a period of 4 to 6 weeks in individuals with mild gingival inflammation on average (mean score of 1 on the 0 to 3 GI scale). A similar mean effect size of 0.20 of a unit reduction on the GI scale was found for gingivitis at 6 months also in individuals with mild gingival inflammation on average. </p> <p>The GI is measured on a 0 to 3 increasing scale with 0 indicating normal gingivae. However, each one unit increase on the scale does not indicate the same proportionate deterioration in gingival condition and a low mean GI score could mask the presence of a small number of sites with moderate or severe levels of gingival inflammation. With this in mind, depending on the average gingivitis level in an individual, a one unit reduction could indicate a shift from severe inflammation and a tendency for spontaneous bleeding to moderate inflammation and BOP or from moderate inflammation and BOP to mild inflammation but no BOP. As previously mentioned, the participants who contributed data to the meta‐analyses of the GI at 4 to 6 weeks had a low mean gingival index score at baseline. The clinical relevance of a mean reduction of one fifth of a unit on the GI scale is therefore not clear. Our results for gingival bleeding indicate that using chlorhexidine mouthrinse for 4 to 6 weeks or 6 months has a moderate effect on gingival bleeding. Although these meta‐analyses included some studies where participants appeared to have a high proportion of sites with BOP at baseline, the variety of different gingival bleeding indices employed meant that we were unable to determine the mean reduction in gingivitis associated with chlorhexidine mouthrinse use in individuals with moderate or severe levels of gingival inflammation. When the SMDs for gingival bleeding were expressed in the units of the bleeding aspect of the GI (GI ≥ 2) the effect size was equivalent to a 7% reduction in the percentage of sites with BOP at 4 to 6 weeks and a 4% reduction in the percentage of sites with BOP at 6 months. Use of chlorhexidine mouthrinse was associated with a large reduction in plaque at 4 to 6 weeks and 6 months. The mean reduction in plaque associated with chlorhexidine mouthrinse use at 4 to 6 weeks was equivalent to approximately half a unit on the 0 to 3 Plaque Index scale (<a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) or three quarters of a unit on the 0 to 5 Turesky modification of the Quigley and Hein Index (TQH) scale (<a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>). </p> <p>Statistical heterogeneity was evident in many of our meta‐analyses and was likely due to variation in the characteristics of the individual included studies. Investigation of the observed heterogeneity was conducted for our main outcome, measured using the GI at 4 to 6 weeks and 6 months using prespecified characteristics. There was a decrease in the effect estimate for the GI at 6 months when a prophylaxis or scale and polish was conducted at the start of the study compared to studies where no prophylaxis or scale and polish was undertaken. This is not consistent with our knowledge of the mechanism of action of chlorhexidine mouthrinse which would appear to be more effective in preventing plaque accumulation when applied to a clean tooth surface than reducing pre‐existing plaque (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>). Nonetheless, the results indicate that some of the heterogeneity for the GI at 6 months was due to whether or not a prophylaxis or scale and polish was conducted at the beginning of the study. We have presented all of the meta‐analyses despite the high heterogeneity due to the remarkable consistency of the direction of effect across the different analyses. </p> <p>We included studies that evaluated chlorhexidine mouthrinse use in individuals with gingivitis only or gingivitis and periodontitis. Where it was reported, the level of gingivitis in the included studies at baseline was generally low. The majority of the studies that evaluated chlorhexidine mouthrinse use in individuals with periodontitis evaluated its effect as an adjunct to surgical or non‐surgical periodontal treatment. In a small number of the studies that evaluated chlorhexidine mouthrinse use in individuals with periodontitis, it was difficult to ascertain whether the professional tooth cleaning provided was appropriate for the level of disease present. For example, in two of these studies it was reported that professional cleaning was undertaken at baseline but no further details were provided (<a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0016" title="ErnstCP , CanbekK , DillenburgerA , WillershausenB . Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence International2005;36(8):641-52. ">Ernst 2005</a>). In another study where 17% to 50% of participants in the study groups were diagnosed with periodontitis, supragingival scaling and polishing only was provided at baseline (<a href="./references#CD008676-bbs2-0024" title="GrazianiF , GabrieleM , D'AiutoF , SuvanJ , TonelliM , CeiS . Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health and Preventive Dentistry2015;13(2):101-11. ">Graziani 2015</a>). In one study a proportion of the participants clearly had periodontitis and abundant calculus, however no professional treatment or oral hygiene instructions were provided to the participants (<a href="./references#CD008676-bbs2-0011" title="CorbetEF , TamJO , ZeeKY , WongMC , LoEC , MombelliAW , et al. Therapeutic effects of supervised chlorhexidine mouthrinses on untreated gingivitis. Oral Diseases1997;3(1):9-18. ">Corbet 1997</a>). The inclusion of these studies could be criticised because antimicrobials such as chlorhexidine have limited capacity to penetrate subgingivally and are therefore suggested for use as an adjunct to mechanical debridement rather than as an alternative therapy (<a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>; <a href="./references#CD008676-bbs2-0165" title="OhrnK , SanzM . Prevention and therapeutic approaches to gingival inflammation. Journal of Clinical Periodontology2009;36 Suppl 10:20-6.">Ohrn 2009</a>). Furthermore, self‐medication with an effective antimicrobial agent such as chlorhexidine mouthrinse "may mask more serious underlying periodontal disease" (<a href="./references#CD008676-bbs2-0182" title="TonettiMS , ChappleILC , JepsenS , SanzM . Primary and secondary prevention of periodontal and peri-implant diseases - Introduction to, and objectives of the 11th European workshop on periodontology consensus conference. Journal of Clinical Periodontology2015;42(16):S1-S4.">Tonetti 2015</a>). It is well recognised that control of supragingival plaque alone will not be sufficient to treat periodontitis (<a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>; <a href="./references#CD008676-bbs2-0132" title="HullPS . Chemical inhibition of plaque. Journal of Clinical Periodontology1980;7(6):431-42.">Hull 1980</a>), disruption of the subgingival plaque by mechanical debridement will also be required (<a href="./references#CD008676-bbs2-0138" title="KornmanKC . The role of supragingival plaque in the prevention and treatment of periodontal diseases. Journal of Periodontal Research1986;21:5-22.">Kornman 1986</a>; <a href="./references#CD008676-bbs2-0165" title="OhrnK , SanzM . Prevention and therapeutic approaches to gingival inflammation. Journal of Clinical Periodontology2009;36 Suppl 10:20-6.">Ohrn 2009</a>). </p> <p>We would have liked to investigate how the effect of chlorhexidine mouthrinse on gingival health varies depending on the level of underlying periodontal disease. However, the periodontal status of the participants in the included studies often was not clearly reported at baseline. In many cases, the inclusion criteria allowed for individuals to have pocket probing depths and clinical attachment loss consistent with periodontitis but the periodontal status of the people actually enrolled in the study was not described. Furthermore, where participants were advised to continue their regular oral hygiene practices during the study, no information about their frequency of toothbrushing or their use of interdental cleaning aids was reported. Therefore, our ability to explore the effect of the adjunctive use of chlorhexidine mouthrinse on gingivitis in individuals with different levels of periodontal disease at baseline and in individuals with treated and untreated periodontitis was hampered both by the small number of studies available at each time point and by poor reporting of the relevant information in the included studies. </p> <p>We were able to conduct a metaregression analysis of 4 to 6 week and 6‐month studies where participants had gingivitis only compared to studies where participants had gingivitis and periodontitis (both treated and untreated during the study). The results did not disclose any statistically significant difference in the effect of the chlorhexidine mouthrinse on the gingival index at either time point, however only eight studies were included in the metaregression at 4 to 6 weeks and only nine studies were included in the metaregression at 6 months. We cannot specifically comment on the effect of chlorhexidine used adjunctively during periodontal treatment on periodontal outcomes such as pocket probing depth and clinical attachment loss because the focus of this review was gingivitis and therefore periodontal outcomes were outside the scope of the review. </p> <p>Retention of chlorhexidine in the oral cavity is key to its effectiveness as an antimicrobial agent (<a href="./references#CD008676-bbs2-0107" title="BonesvollP , LokkenP , RollaG . Influence of concentration, time, temperature and pH on the retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(11):1025-9.">Bonesvoll 1974</a>; <a href="./references#CD008676-bbs2-0108" title="BonesvollP , LokkenP , RollaG , PausPN . Retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(3):209-12.">Bonesvoll 1974a</a>; <a href="./references#CD008676-bbs2-0109" title="BonesvollP , GjermoP . A comparison between chlorhexidine and some quaternary ammonium compounds with regard to retention, salivary concentration and plaque-inhibiting effect in the human mouth after mouth rinses. Arch Oral Biol1978;23(4):289-94. [0003-9969: (Print)]">Bonesvoll 1978</a>; <a href="./references#CD008676-bbs2-0133" title="JenkinsS , AddyM , WadeW . The mechanism of action of chlorhexidine. A study of plaque growth on enamel inserts in vivo. Journal of Clinical Periodontology1988;15(7):415-24.">Jenkins 1988</a>; <a href="./references#CD008676-bbs2-0170" title="RollaG , LoeH , SchiottCR . Retention of chlorhexidine in the human oral cavity. Archives of Oral Biology1971;16(9):1109-16.">Rolla 1971</a>) and is dependant on a number of different factors including concentration and duration of application (<a href="./references#CD008676-bbs2-0181" title="TomásI , CousidoMC , Garcia-CaballeroL , RubidoS , LimeresJ , DizP . Substantivity of a single chlorhexidine mouthwash on salivary flora: Influence of intrinsic and extrinsic factors. Journal of Dentistry2010;38(7):541-6.">Tomás 2010</a>). In relation to concentration, the effect of chlorhexidine on plaque is dose‐dependant and a similar effect can be achieved with larger volumes of lower concentration solutions providing the optimal dose of approximately 20 mg twice a day is delivered (<a href="./references#CD008676-bbs2-0109" title="BonesvollP , GjermoP . A comparison between chlorhexidine and some quaternary ammonium compounds with regard to retention, salivary concentration and plaque-inhibiting effect in the human mouth after mouth rinses. Arch Oral Biol1978;23(4):289-94. [0003-9969: (Print)]">Bonesvoll 1978</a>). All but four of the included studies evaluated either 0.2%, 0.12% or 0.1% chlorhexidine mouthrinse and only two of these studies provided data for 0.2% compared to 0.1% (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>) or 0.12% (<a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>) chlorhexidine mouthrinse within the same study. Most of the studies that evaluated 0.2% chlorhexidine mouthrinse employed a rinse volume of 10 mL twice a day while most of the studies that evaluated 0.12% or 0.1% chlorhexidine mouthrinse employed a rinse volume of 15 mL twice a day. Therefore regardless of the concentration of chlorhexidine mouthrinse used, the dose of chlorhexidine was effectively the same in the majority of the studies and corresponded to the optimal dose of 18 mg to 20 mg twice a day. It has been demonstrated that increasing the duration of rinsing with 0.12% or 0.2% chlorhexidine mouthrinse from 30 to 60 seconds results in greater substantivity of the rinse (<a href="./references#CD008676-bbs2-0181" title="TomásI , CousidoMC , Garcia-CaballeroL , RubidoS , LimeresJ , DizP . Substantivity of a single chlorhexidine mouthwash on salivary flora: Influence of intrinsic and extrinsic factors. Journal of Dentistry2010;38(7):541-6.">Tomás 2010</a>). The longer duration of rinsing employed by most of the studies in this review that evaluated 0.2% chlorhexidine mouthrinse could be expected to translate into greater retention of chlorhexidine in these studies and hence a greater effect on gingivitis and plaque. However, 75% of the chlorhexidine that is retained after rinsing for 60 seconds with 0.2% chlorhexidine rinse is retained after the first 30 seconds of rinsing (<a href="./references#CD008676-bbs2-0107" title="BonesvollP , LokkenP , RollaG . Influence of concentration, time, temperature and pH on the retention of chlorhexidine in the human oral cavity after mouth rinses. Archives of Oral Biology1974;19(11):1025-9.">Bonesvoll 1974</a>) and a rinse duration of 30 seconds for 0.12% chlorhexidine mouthrinse has been shown to be both effective and acceptable (<a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). Therefore, most of the studies included in this review used the optimal dose of chlorhexidine for at least 30 seconds which may partly explain why we did not find any difference in effect between the different concentration rinses. The two included studies that provided data for a direct comparison between 0.2% and 0.1%/0.12% chlorhexidine rinse found no difference in effect between the different concentration rinses used with the same volume and duration of rinsing (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>). </p> <p>Studies that evaluated the effectiveness of chlorhexidine mouthrinse on gingivitis using a cross‐over study design were excluded from this review. This was due to concerns that the duration of the washout phase between the trial periods might not be sufficient to rule out a carry‐over effect due to chlorhexidine mouthrinse. Carry‐over can threaten the internal validity of a cross‐over study and is of particular concern in studies involving chlorhexidine mouthrinse due to the established substantivity or prolonged effect of chlorhexidine mouthrinse. Evidence‐based guidance on the appropriate duration of washout phase is absent from the literature and the washout periods commonly used appear to range from 2 days to 3 weeks (<a href="./references#CD008676-bbs2-0105" title="BerchierCE , SlotDE , Van der WeijdenGA . The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. Journal of Clinical Periodontology2010;37(9):829-39.">Berchier 2010</a>; <a href="./references#CD008676-bbs2-0161" title="NewcombeRG , AddyM , McKeownS . Residual effect of chlorhexidine gluconate in 4-day plaque regrowth crossover trials, and its implications for study design. Journal of Periodontal Research1995;30(5):319-24.">Newcombe 1995</a>). The very limited data we have in this review regarding gingivitis and plaque outcomes recorded after cessation of chlorhexidine mouthrinsing suggest a residual effect on these outcomes weeks or months after rinsing with chlorhexidine has ceased. Although no firm conclusions can be drawn regarding the appropriateness of using a cross‐over study design when the study includes a chlorhexidine mouthrinse arm, the uncertainty surrounding carry‐over in relation to chlorhexidine mouthrinse warrants further investigation. </p> <p>Low concentration (0.05%/0.06%) chlorhexidine mouthrinses are currently marketed for long‐term daily use. Side‐effects associated with chlorhexidine mouthrinse use are dose‐dependant and tend to decrease when the concentration is lowered (<a href="./references#CD008676-bbs2-0115" title="CummingBR , LöeH . Optimal dosage and method of delivering chlorhexidine solutions for the inhibition of dental plaque. Journal of Periodontal Research1973;8(2):57-62.">Cumming and Löe 1973</a>; <a href="./references#CD008676-bbs2-0123" title="FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25.">Flotra 1971</a>). Therefore in lowering the concentration of chlorhexidine, it is hoped that side effects will be reduced while maintaining the effect on gingivitis and plaque (<a href="./references#CD008676-bbs2-0137" title="KeijserJAM , VerkadeH , TimmermanMF , van derWeijdenFA . Comparison of 2 commercially available chlorhexidine mouthrinses. Journal of Periodontology2003;74(2):214-8.">Keijser 2003</a>). Only five studies that evaluated chlorhexidine concentrations less than 0.1% met the inclusion criteria for this review. Two studies evaluated 0.05% (<a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>) and three studies evaluated 0.06% chlorhexidine mouthrinse (<a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). Although all of these studies demonstrated a reduction in plaque, the effect on gingivitis was not clear. This might be explained by the lower concentration rinses having a mainly bacteriostatic action that may produce an effect below the threshold required to produce a corresponding reduction in gingivitis. Despite the reduced concentration of chlorhexidine, extrinsic tooth staining occurred in all four studies of low concentration chlorhexidine mouthrinse that reported a staining outcome (<a href="./references#CD008676-bbs2-0029" title="HoffmannT , BruhnG , RichterS , NetuschilL , BrecxM . Clinical controlled study on plaque and gingivitis reduction under long-term use of low-dose chlorhexidine solutions in a population exhibiting good oral hygiene. Clinical Oral Investigations2001;5(2):89-95. ">Hoffmann 2001</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>; <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>; <a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>). There has been some debate about the mechanism by which chlorhexidine mouthrinse produces extrinsic tooth staining. However, it is currently understood to be a result of precipitation of anionic dietary chromogens onto adsorbed chlorhexidine cations (<a href="./references#CD008676-bbs2-0191" title="WattsA , AddyM . Tooth discolouration and staining: a review of the literature. British Dental Journal2001;190(6):309-16.">Watts 2001</a>) and thus the mechanism by which chlorhexidine mouthrinse produces extrinsic tooth staining appears to be closely linked to its mechanism of action. Therefore lack of staining is likely to indicate lack of effectiveness (<a href="./references#CD008676-bbs2-0099" title="AddyM , SharifN , MoranJ . A non-staining chlorhexidine mouthwash? Probably not: a study in vitro. International Journal of Dental Hygiene2005;3(2):59-63.">Addy 2005</a>; <a href="./references#CD008676-bbs2-0120" title="EleyBM . Antibacterial agents in the control of supragingival plaque - a review. British Dental Journal1999;186(6):286-96.">Eley 1999</a>). Some degree of tooth staining can therefore be expected to feature even with low chlorhexidine concentration rinses. However, with the exception of <a href="./references#CD008676-bbs2-0050" title="ZimmerS , KolbeC , KaiserG , KrageT , OmmerbornM , BarthelC . Clinical efficacy of flossing versus use of antimicrobial rinses. Journal of Periodontology2006;77(8):1380-5. ">Zimmer 2006</a>, there were no reports of other adverse effects relating to the low concentration chlorhexidine mouthrinse apart from staining of the teeth and oral tissues. </p> <p>Use of chlorhexidine mouthrinse is associated with a number of adverse effects, the most common being extrinsic staining of the teeth and oral soft tissues (<a href="./references#CD008676-bbs2-0098" title="AddyM . Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology1986;13(10):957-64.">Addy 1986</a>). In many of the studies included in this review, adverse effects were inadequately reported or not reported at all. It is important that adverse effects due to chlorhexidine mouthrinse use are reported alongside evidence for effectiveness with enough detail to allow health professionals and the public to make an informed decision about recommending, prescribing or using the mouthrinse. </p> <p>From our included studies it was clear that rinsing with any concentration of chlorhexidine mouthrinse for 4 weeks or longer was associated with an increase in extrinsic tooth staining. A number of the included studies reported higher levels of calculus in the chlorhexidine rinse arms but the meta‐analyses were inconclusive. Other adverse effects such as taste disturbance/alteration, burning sensation and pigmentation of the oral soft tissues were also reported in a number of included studies. Effects on the oral mucosa such as mucosal ulceration, lesions or erosions and a transient anaesthetic sensation, hypoaesthesia and paraesthesia were also reported in a number of included studies and can be considered more severe but the proportion of participants experiencing these adverse effects in any study tended to be low. While extrinsic tooth staining and calculus build‐up due to chlorhexidine mouthrinse use must be removed by professional tooth cleaning incurring the costs associated with a visit to a dental professional, the other associated adverse effects are known to be transient in nature and to resolve once mouthrinsing ceases (<a href="./references#CD008676-bbs2-0123" title="FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25.">Flotra 1971</a>; <a href="./references#CD008676-bbs2-0127" title="GreensteinG , BermanC , JaffinR . Chlorhexidine. An adjunct to periodontal therapy. Journal of Periodontology1986;57(6):370-7.">Greenstein 1986</a>). However, these adverse effects, although transient, can be severe and development of extrinsic tooth staining with short‐term use of the mouthrinse is an obvious deterrent to using chlorhexidine mouthrinse. </p> </section> <section id="CD008676-sec-0093"> <h3 class="title" id="CD008676-sec-0093">Quality of the evidence</h3> <p>Although all the included studies were randomised controlled trials (RCTs), 50 of the 51 included studies were assessed as at high risk of bias overall, as they had at least one domain rated at high risk of bias. The reason many of the studies were assessed as at high risk of bias was due to problems with the blinding of participants, personnel, and outcome assessors. The majority of studies contained a placebo arm with the intention of blinding participants and personnel. However, we considered blinding unlikely to be successful due to the propensity for chlorhexidine to stain the teeth and oral tissues and the association of its use with clinically visible adverse effects such as mucosal desquamation and mucosal lesions. This also applied to the blinding of outcome assessors, in trials with either a placebo, control, or mechanical oral hygiene alone. This was not the fault of the investigators who in many studies went to great lengths to try to ensure blinding. Consequently we assessed 42 (82%) studies as at high risk of bias for either sort of blinding bias (performance bias or detection bias). </p> <p>Thirty‐seven studies were rated at high risk of selective reporting bias, mainly due to lack of reporting of measures of variance along with the means for each group, and no reporting of tooth staining and other adverse effects. </p> <p>It is worth mentioning that 22 of the included studies were published prior to the first publication of the first iteration of the CONSORT Statement in 1996 (<a href="./references#CD008676-bbs2-0103" title="BeggC , ChoM , EastwoodS , HortonR , MoherD , OlkinI , et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA1996;276(8):637-9.">Begg 1996</a>) and their quality was therefore partly judged according to reporting standards that did not exist at the time of their publication. An additional nine studies were published prior to the publication of the revised CONSORT Statement in 2001 (<a href="./references#CD008676-bbs2-0157" title="MoherD , SchulzKF , AltmanDG . The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet2001;357(9263):1191-4.">Moher 2001</a>). However, disappointingly, instances of poor reporting were not confined to the studies that predated widespread awareness of the CONSORT Statement. </p> <p>Despite most studies included in the meta‐analyses being assessed as at high risk of bias we did not downgrade the GRADE assessments for gingivitis and plaque for this reason. This is because we believe that further research is very unlikely to change our confidence in the estimate of effect for these outcomes. The grade assessments for the body of evidence for chlorhexidine mouthrinse compared with placebo, control or mechanical oral hygiene alone for gingivitis measured using the Löe and Silness Gingival Index and for plaque measured using various indices were therefore rated as high quality. Although there was high heterogeneity for some of these meta‐analyses we did not downgrade for this due to consistency of the direction of effect. </p> <p>Over half of the included studies were either funded directly, received support for the study or were affiliated in some way with industry. Although a high level of industry funding is far from ideal, the reality is that without industry funding few trials evaluating the effectiveness of chlorhexidine mouthrinse would have been conducted. However, it is noteworthy that of the 19 included studies funded directly by industry, only one study (<a href="./references#CD008676-bbs2-0051" title="ZimmerS , KorteP , VerdeP , OhmannC , NaumovaE , JordanRA . Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks. International Journal of Dental Hygiene2015;13(2):110-6. ">Zimmer 2015</a>) stated that the conduct of the research and final decisions regarding the study report were independent of the company funding the research. </p> </section> <section id="CD008676-sec-0094"> <h3 class="title" id="CD008676-sec-0094">Potential biases in the review process</h3> <p>In order to prevent judgements about the eligibility criteria for studies being influenced by prior knowledge of the study results, the methods to be used in the review should be established and documented in advance of the review being undertaken (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We made a number of changes to the protocol in relation to the types of studies and types of participants to be included in the review. We also clarified additional criteria for the inclusion of studies based on type of intervention that were implicit but not explicitly stated in the protocol. We amended the assessment of the blinding domains in the 'Risk of bias' tool to allow studies to obtain a judgement of 'low' or 'unclear' risk of bias in certain circumstances compared to the blanket judgement of high risk of bias that was stated in the published protocol. </p> <p>A hierarchy to guide data extraction for gingivitis and plaque data was developed to facilitate data extraction and analysis. The main analysis however, was based on the main prespecified gingivitis index: the Gingival Index of Löe and Silness (<a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>). Full details of the changes to the protocol are described in the <a href="#CD008676-sec-0116">Differences between protocol and review</a> section. It is acknowledged that it may not always be appropriate to adhere to the published protocol (<a href="./references#CD008676-bbs2-0131" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Therefore, while these changes to the protocol could introduce a risk of bias, the changes were made in the early stages of the review before any analyses of the results were undertaken and are therefore considered unlikely to have been influenced by knowledge of the study results or the results of the review. Furthermore, each decision was appropriately justified and was made to improve the scientific quality and clinical applicably of the review. </p> <p>We estimated the standard deviations for four studies that measured the Gingival Index at 6 months (<a href="./references#CD008676-bbs2-0005" title="BantingD , BosmaM , BollmerB . Clinical effectiveness of a 0.12% chlorhexidine mouthrinse over two years. Journal of Dental Research1989;68(Spec Iss):1716-8. ">Banting 1989</a>; <a href="./references#CD008676-bbs2-0030" title="JayaprakashK , VeereshaKL , HiremathSS . A comparative study of two mouthrinses on plaque and gingivitis in school children in the age group of 13-16 years in Bangalore city. Journal of the Indian Society of Pedodontics and Preventive Dentistry2007;25(3):126-9. ">Jayaprakash 2007</a>; <a href="./references#CD008676-bbs2-0036" title="LucasGQ , LucasON . Preventive action of short-term and long-term chlorhexidine rinses. Acta Odontologica Latinoamericana1999;12(1):45-58. ">Lucas 1999</a>; <a href="./references#CD008676-bbs2-0042" title="SanzM , VallcorbaN , FabreguesS , MullerI , HerkstroterF . The effect of a dentifrice containing chlorhexidine and zinc on plaque, gingivitis, calculus and tooth staining. Journal of Clinical Periodontology1994;21(6):431-7. ">Sanz 1994</a>) and one study that measured the Gingival Index at 4 to 6 weeks (<a href="./references#CD008676-bbs2-0041" title="SanzM , NewmanMG , AndersonL , MatoskaW , Otomo-CorgelJ , SaltiniC . Clinical enhancement of post-periodontal surgical therapy by a 0.12% chlorhexidine gluconate mouthrinse. Journal of Periodontology1989;60(10):570-6. ">Sanz 1989</a>) using data from the same outcomes measured at the same time point in other similar studies so that we could include these data in meta‐analyses. Where mean scores or measures of variance of the mean scores or both were not reported in the text or in tabular form, and could not be obtained from the authors of the studies, data were estimated by reading them off the graphs in the published report for inclusion in meta‐analyses for six studies (<a href="./references#CD008676-bbs2-0007" title="BrecxM , MacdonaldLL , LegaryK , CheangM , ForgayMG . Long-term effects of Meridol and chlorhexidine mouthrinses on plaque, gingivitis, staining, and bacterial vitality. Journal of Dental Research1993;72(8):1194-7. ">Brecx 1993</a>; <a href="./references#CD008676-bbs2-0008" title="BrightmanLJ , TerezhalmyGT , GreenwellH , JacobsM , EnlowDH . The effects of a 0.12% chlorhexidine gluconate mouthrinse on orthodontic patients aged 11 through 17 with established gingivitis. American Journal of Orthodontics and Dentofacial Orthopedics1991;100(4):324-9. ">Brightman 1991</a>; <a href="./references#CD008676-bbs2-0010" title='ChavesES , KornmanKS , ManwellMA , JonesAA , NewboldDA , WoodRC . Mechanism of irrigation effects on gingivitis. Journal of Periodontology1994;65(11):1016-21. ChavesES , WoodRC , JonesAA , NewboldDA , ManwellMA , KornmanKS . Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. Journal of Clinical Periodontology1993;20(2):139-43. '>Chaves 1994</a>; <a href="./references#CD008676-bbs2-0020" title="FerrettiGA , AshRC , BrownAT , LargentBM , KaplanA , LillichTT . Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. Journal of the American Dental Association1987;114(4):461-7. ">Ferretti 1987</a>; <a href="./references#CD008676-bbs2-0031" title="JenkinsS , AddyM , NewcombeR . Evaluation of a mouthrinse containing chlorhexidine and fluoride as an adjunct to oral hygiene. Journal of Clinical Periodontology1993;20(1):20-5. ">Jenkins 1993</a>; <a href="./references#CD008676-bbs2-0033" title="Joyston-BechalS , HernamanN . The effect of a mouthrinse containing chlorhexidine and fluoride on plaque and gingival bleeding. Journal of Clinical Periodontology1993;20(1):49-53. ">Joyston‐Bechal 1993</a>). The graphs were enlarged and the data were estimated independently and in duplicate. A sensitivity analysis for the Gingival Index at both 4 to 6 weeks and 6 months, excluding trials where we had to estimate the standard deviation from similar studies, or had to read the data from graphs, showed that the effect estimates were similar to those for the overall pooling of the studies. </p> </section> <section id="CD008676-sec-0095"> <h3 class="title" id="CD008676-sec-0095">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a> conducted a comprehensive review of the effect of chlorhexidine mouthrinse on plaque, gingival inflammation and tooth staining in studies of 4 weeks or longer. This review was very similar to our review but slight differences in the inclusion criteria and the dates of the literature searches meant that a slightly different group of studies were reviewed by Van Strydonck et al. The review focused on healthy adults only, considered chlorhexidine mouthrinse used as a monotherapy or as an adjunct, and excluded patients with periodontitis or dentures as well as orthodontic and implant patients. In addition, apart from tooth staining, adverse effects although reported in the review, were not prespecified outcomes. Of the 30 studies included in this review, 27 are common to our review. The results of the meta‐analysis of studies reporting the GI at all time points included data from seven studies, six of which were included in our meta‐analyses at either 4 to 6 weeks, 7 to 12 weeks or 6 months. The weighted mean difference for the GI in this review was ‐0.32 which is similar to the mean difference for the GI reported in our review. Extrinsic tooth staining, increased calculus formation and change of taste sensation were also noted to have frequently occurred in the included studies. Considerable heterogeneity in the design, study duration and rinse regimen were also noted to be present. </p> <p><a href="./references#CD008676-bbs2-0110" title="BoyleP , KoechlinA , AutierP . Mouthwash use and the prevention of plaque, gingivitis and caries. Oral Disease2014;20 Suppl 1:1-68.">Boyle 2014</a> systematically reviewed the evidence relating to the efficacy of the most frequently used mouthrinses for the control of supragingival plaque and gingivitis. Both the scope of the literature search and the inclusion criteria were narrower than in our review. Of the 17 trials involving chlorhexidine mouthrinse included in this review 16 are common to our review. The reported 'summary relative differences' facilitated comparison between the different mouthrinse preparations being reviewed. Results for the chlorhexidine mouthrinse studies are supportive of the effectiveness of chlorhexidine mouthrinse primarily for the control of both gingivitis and plaque relative to control but also relative to other active mouthrinse preparations. </p> <p>A systematic review by <a href="./references#CD008676-bbs2-0176" title="SerranoJ , EscribanoM , RoldánS , MartínC , HerreraD . Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. Journal of Clinical Periodontology2015;42(16):S106-38.">Serrano 2015</a> evaluated the effectiveness of adjunctive antiplaque chemical agents including chlorhexidine mouthrinse in RCTs of at least 6 months duration. The review included 14 studies evaluating chlorhexidine mouthrinse. Due to differences in inclusion criteria, 12 of these studies are common to our review. The authors reported a significant benefit for rinsing with 0.1% to 0.2% chlorhexidine mouthrinse based on a meta‐analysis of four studies (weighted mean difference on the GI ‐0.185) but a non‐significant effect for chlorhexidine mouthrinse at concentrations of ≤ 0.06%. In common with our review was the presence of high heterogeneity which made it difficult to pool the data and was an acknowledged limitation of the review. </p> <p><a href="./references#CD008676-bbs2-0129" title="GunsolleyJC . A meta-analysis of six-month studies of antiplaque and antigingivitis agents. Journal of the American Dental Association2006;137(12):1649-57.">Gunsolley 2006</a> conducted a meta‐analysis of 6‐month mouthrinse studies for the control of gingivitis and plaque. Six of the included studies evaluated the effect of 0.12% chlorhexidine mouthrinse using the GI and all six were common to our review. The analysis indicated a moderate effect for gingivitis and a large effect for plaque. A subsequent metareview also conducted by Gunsolley drew on the data from the earlier meta‐analysis and found a weighted mean percentage reduction of 28.7% for the GI and 40.4% for the Plaque Index (<a href="./references#CD008676-bbs2-0130" title="GunsolleyJC . Clinical efficacy of antimicrobial mouthrinses. Journal of Dentistry2010;38 Suppl 1:S6-10.">Gunsolley 2010</a>) based on the same six studies. </p> <p>The efficacy of 0.12% chlorhexidine mouthrinse compared to 0.2% on plaque and periodontal parameters was systematically reviewed by <a href="./references#CD008676-bbs2-0105" title="BerchierCE , SlotDE , Van der WeijdenGA . The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. Journal of Clinical Periodontology2010;37(9):829-39.">Berchier 2010</a>. The review included eight studies with rinse duration from 3 days to 3 months that directly compared 0.12% with 0.2% chlorhexidine mouthrinse. The review found no difference in the effect on gingivitis between the two concentrations of chlorhexidine. The small significant difference in plaque inhibition in favour of 0.2% chlorhexidine was thought to be of negligible clinical relevance. Our review included two studies that provided data for a direct comparison between 0.2% and 0.1%/0.12% chlorhexidine rinse (<a href="./references#CD008676-bbs2-0003" title="AxelssonP , LindheJ . Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. Journal of Clinical Periodontology1987;14(4):205-12. ">Axelsson 1987</a>; <a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>), one of which was also included in the Berchier review (<a href="./references#CD008676-bbs2-0043" title="SegretoVA , CollinsEM , BeiswangerBB . A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research1986;21(Suppl 16):23-32. ">Segreto 1986</a>). There was no difference in effect between the different concentration rinses used with the same volume and duration of rinsing in these two studies. Similarly our subgroup analysis found no evidence that one concentration of chlorhexidine rinse was more effective than another in reducing gingivitis and plaque. </p> <p><a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a> conducted a metareview of the evidence regarding the efficacy and safety of chemical agents in mouthrinses to manage gingivitis and plaque. The evidence for chlorhexidine mouthrinse was drawn from the systematic reviews (<a href="./references#CD008676-bbs2-0176" title="SerranoJ , EscribanoM , RoldánS , MartínC , HerreraD . Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. Journal of Clinical Periodontology2015;42(16):S106-38.">Serrano 2015</a>; <a href="./references#CD008676-bbs2-0189" title="Van StrydonckDA , SlotDE , van derVeldenU , van derWeijdenF . Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology2012;39(11):1042-55.">Van Strydonck 2012</a>) and meta‐analyses (<a href="./references#CD008676-bbs2-0129" title="GunsolleyJC . A meta-analysis of six-month studies of antiplaque and antigingivitis agents. Journal of the American Dental Association2006;137(12):1649-57.">Gunsolley 2006</a>; <a href="./references#CD008676-bbs2-0130" title="GunsolleyJC . Clinical efficacy of antimicrobial mouthrinses. Journal of Dentistry2010;38 Suppl 1:S6-10.">Gunsolley 2010</a>) described above. <a href="./references#CD008676-bbs2-0105" title="BerchierCE , SlotDE , Van der WeijdenGA . The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. Journal of Clinical Periodontology2010;37(9):829-39.">Berchier 2010</a> contributed data for the comparison of active ingredients. This review reaffirmed the effectiveness of chlorhexidine mouthrinse for reducing plaque and gingivitis. The body of evidence resulting from these three reviews was rated as 'strong'. Due to the heterogeneity in the meta‐analyses, the authors advised caution in interpreting the difference of means as it "may not provide an exact measure of the results" (<a href="./references#CD008676-bbs2-0188" title="van derWeijdenFA , van derSluijsE , CiancioSG , SlotDE . Can chemical mouthwash agents achieve plaque/gingivitis control?Dental Clinics of North America2015;59(4):799-829.">van der Weijden 2015</a>). Although the authors concluded that chlorhexidine is the "first choice", they also acknowledged that the development of taste disturbance, tooth staining and calculus formation prohibit long‐term adjunctive use of the mouthrinse. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008676-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD008676-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008676-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 1: Gingival Index (0‐3) 4‐6 weeks" data-id="CD008676-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 1: Gingival Index (0‐3) 4‐6 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 2: Gingival Index (0‐3) 6 months" data-id="CD008676-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 2: Gingival Index (0‐3) 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 3: Gingival bleeding 4‐6 weeks" data-id="CD008676-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 3: Gingival bleeding 4‐6 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 4: Gingival bleeding 6 months" data-id="CD008676-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 4: Gingival bleeding 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 5: Plaque 4‐6 weeks" data-id="CD008676-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 5: Plaque 4‐6 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 6: Plaque 4‐6 weeks PI (0‐3)" data-id="CD008676-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 6: Plaque 4‐6 weeks PI (0‐3) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 7: Plaque 4‐6 weeks TQH (0‐5)" data-id="CD008676-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 7: Plaque 4‐6 weeks TQH (0‐5) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 8: Plaque 6 months" data-id="CD008676-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 8: Plaque 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 9: Plaque 6 months PI (0‐3)" data-id="CD008676-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 9: Plaque 6 months PI (0‐3) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 10: Plaque 6 months TQH (0‐5)" data-id="CD008676-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 10: Plaque 6 months TQH (0‐5) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 11: Calculus 4‐6 weeks" data-id="CD008676-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 11: Calculus 4‐6 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 12: Calculus 7‐12 weeks" data-id="CD008676-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 12: Calculus 7‐12 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 13: Calculus 6 months" data-id="CD008676-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 13: Calculus 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 14: Tooth staining 4‐6 weeks dichotomous" data-id="CD008676-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 14: Tooth staining 4‐6 weeks dichotomous </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 15: Tooth staining 7‐12 weeks dichotomous" data-id="CD008676-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 15: Tooth staining 7‐12 weeks dichotomous </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 16: Tooth staining 4‐6 weeks" data-id="CD008676-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 16: Tooth staining 4‐6 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 17: Tooth staining 7‐12 weeks" data-id="CD008676-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 17: Tooth staining 7‐12 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008676-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/urn:x-wiley:14651858:media:CD008676:CD008676-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 18: Tooth staining 6 months" data-id="CD008676-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_t/tCD008676-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: CHX versus placebo/control mouthrinse or no mouthrinse, Outcome 18: Tooth staining 6 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/media/CDSR/CD008676/image_n/nCD008676-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008676-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Chlorhexidine mouthrinse compared with placebo/control mouthrinse/no mouthrinse for gingival health</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults and children with gingivitis </p> <p><b>Settings:</b> any </p> <p><b>Intervention:</b> chlorhexidine mouthrinse </p> <p><b>Comparison:</b> placebo/control mouthrinse or no mouthrinse </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Number of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gingival Index 4 to 6 weeks</b> (Löe and Silness Gingival Index) (0 to 3 on an increasing scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean gingivitis scores ranged across control groups from 0.17 to 1.40<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean gingivitis score in the chlorhexidine group was 0.21 lower (0.11 to 0.31 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>805</p> <p>(10 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>2,3</sup><br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect size at 6 months was similar</p> <p>Insufficient evidence for differences in effect size for different chlorhexidine concentration or frequency of use </p> <p>Insufficient evidence to determine the effect size in individuals with moderate or severe levels of gingival inflammation on average (mean GI scores 1.1 to 3) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Plaque 4 to 6 weeks</b> </p> <p>(various increasing scales including Plaque Index (0 to 3 scale) and Turesky Modification of the Quigley and Hein Index (0 to 5 scale)) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Plaque Index ranged from 0.75 to 1.06</p> <p>Turesky Modification of the Quigley and Hein Index ranged from 1.2 to 3.3</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The SMD was 1.45 lower in the chlorhexidine group indicating a large reduction in plaque from 1.00 to 1.90 standard deviations </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>950</p> <p>(12 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<sup>2,3</sup><br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect for the Plaque Index (4 trials; 223 participants) was 0.58 (95% CI 0.39 to 0.78) lower </p> <p>The effect for the Turesky Modification of the Quigley and Hein Index (5 trials; 546 participants) was 0.78 (95% CI 0.70 to 0.85) lower </p> <p>There were also large effects for the plaque at 6 months</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tooth staining 4 to 6 weeks</b> </p> <p>(various increasing scales)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean tooth staining score was measured on different scales</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The SMD for tooth staining in the chlorhexidine group was<br/>1.07 (0.80 to 1.34) standard deviations higher </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>415</p> <p>(8 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>4</sup><br/><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data have not been converted to original scale as many different scales are used. The SMD effect size is considered large </p> <p>There were also 2 trials presenting dichotomous data showing large significant effect RR 5.41 (95% CI 2.03 to 14.47) </p> <p>There was also a large effect for tooth staining for chlorhexidine at 7 to 12 weeks and 6 months </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>22 trials reported at least 1 adverse effect apart from extrinsic tooth staining and calculus formation in the chlorhexidine rinse arms. The adverse effects most commonly reported were taste disturbance/alteration (reported in 11 trials), effects on the oral mucosa including mucosal irritation, soreness, mild desquamation, mucosal ulceration/erosions, oral mucosal lesions (reported in 13 trials) and a general burning sensation and/or a burning tongue (reported in 9 trials) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across trials) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/><b>CI:</b> confidence interval; <b>GI:</b> Gingival Index; <b>RR:</b> risk ratio; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/><b>Very low quality:</b> we are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The mean gingivitis score for the control group was 0.93 (median is 1.0).<br/><sup>2</sup>Although most trials included in the meta‐analyses were assessed as at high risk of bias we did not downgrade the GRADE assessments for this reason because we believe that further research is very unlikely to change our confidence in the estimate of effect.<br/><sup>3</sup>Not downgraded for high heterogeneity as results consistent.<br/><sup>4</sup>Downgraded as 8 trials at high risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 4 to 6 weeks</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Characteristic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope estimate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope interpretation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults versus children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 ‐ no studies with just children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gingivitis alone versus gingivitis with perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 to 0.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for gingivitis and perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis or not</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.22 to 0.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.66</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline gingivitis &lt; 1 versus &gt; 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.25 to 0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for higher baseline score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CI = confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 4 to 6 weeks</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 6 months</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Characteristic</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope estimate</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Slope interpretation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adults versus children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.42 to 0.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.185</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Gingivitis alone versus gingivitis with perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 to 0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for gingivitis and perio</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prophylaxis or not</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.25 to ‐0.004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Increase in GI effect estimate for no prophylaxis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.045</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Baseline gingivitis</p> <p>&lt; 1 versus &gt; 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.39 to 0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Decrease in GI effect estimate for higher baseline score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CI = confidence interval.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Random‐effects metaregression analyses of Gingival Index (GI) at 6 months</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Chlorhexidine concentration: all trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine concentration</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants</b>) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% C</b>I </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Subgroup P value</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (552)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.27 (‐0.46 to ‐0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.003 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.41</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (253)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.19 (‐0.27 to ‐0.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.12 (‐0.20 to ‐0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (2352)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.22 (‐0.33 to ‐0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (150)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.04 (‐0.11 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (472)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.71 (‐0.90 to ‐0.51)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (127)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.32 (‐0.85 to 0.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.23</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (155)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.20 (‐2.48 to 0.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (977)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.57 (‐0.79 to ‐0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (685)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.75 (‐2.45 to ‐1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.04</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (215)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.95 (‐1.23 to ‐0.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.26 (‐1.61 to ‐0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours Chx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1898)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.38 (‐1.75 to ‐1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.01 (‐0.21 to 0.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (159)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.03 (‐0.43 to 0.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (266)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.52 (0.13 to 0.91)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.10</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.41 (0.09 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.005</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (174)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.17 (0.76 to 1.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (116)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.45 (1.04 to 1.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.96 (0.68 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (181)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.38 (1.05 to 1.71)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>0.10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 (361)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.2 (0.96 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.59 (‐0.05 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.07</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (149)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.79 (1.41 to 2.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.08</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (174)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.33 (1.00 to 1.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours control</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CHX = chlorhexidine; CI = confidence interval; MD = mean difference; SMD = standardised mean difference. </p> <p>Studies where the concentration of the chlorhexidine mouthrinse was not reported (<a href="./references#CD008676-bbs2-0047" title="TurkogluO , BecerikS , EmingilG , KutukculerN , BaylasH , AtillaG . The effect of adjunctive chlorhexidine mouthrinse on clinical parameters and gingival crevicular fluid cytokine levels in untreated plaque-associated gingivitis. Inflammation Research2009;58(5):277-83. ">Turkoglu 2009</a>) and where data relate to a combination of different chlorhexidine concentrations (<a href="./references#CD008676-bbs2-0023" title="FlotraL , GjermoP , RollaG , WaerhaugJ . A 4-month study on the effect of chlorhexidine mouth washes on 50 soldiers. Scandinavian Journal of Dental Research1972;80(1):10-7. FlotraL , GjermoP , RollaG , WaerhaugJ . Side effects of chlorhexidine mouth washes. Scandinavian Journal of Dental Research1971;79(2):119-25. ">Flotra 1972</a>) were excluded from this analysis. Therefore, in certain analyses, the number of studies and participants presented in the table are different from the data presented in the main analysis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Chlorhexidine concentration: all trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Chlorhexidine rinse frequency of use: all trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine frequency</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants</b>) </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% C</b>I </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Subgroup P value</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (785)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.22 (‐0.33 to ‐0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.13 (‐0.31 to 0.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.18</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (1614)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.17 (‐0.20 to ‐0.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>0.56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (1002)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.34 (‐0.93 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (649)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.56 (‐0.79 to ‐0.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1132)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.72 (‐1.02 to ‐0.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 (930)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.49 (‐1.97 to ‐1.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.92 (‐1.86 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (1223)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.34 (‐1.66 to ‐1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once a day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (852)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐2.10 (‐2.27 to ‐1.93)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.03 (‐0.11 to 0.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (373)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.33 (‐0.11 to 0.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (323)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.80 (0.33 to 1.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>4 to 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.55 (0.76 to 2.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (310)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.18 (0.93 to 1.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Once per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1(20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.39 (‐0.5 to 1.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.39</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.77 (0.06 to 1.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Too few studies in subgroup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (496)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.26 (1.04 to 1.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Tooth staining</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (323)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.54 (1.22 to 1.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.0001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CI = confidence interval; MD = mean difference; SMD = standardised mean difference.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Chlorhexidine rinse frequency of use: all trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results for gingivitis and plaque at 7 to 12 weeks, &gt; 6 months and long term (after cessation of mouthrinsing)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcome (index)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Chlorhexidine conc (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Studies (participants)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>MD/SMD 95% CI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Effect P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Heterogeneity</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results for studies with no rinse control arms</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (196)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.07 (‐0.16 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.13 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.19, I<sup>2</sup> = 40% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (196)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.77 (‐1.07 to ‐0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.61, I<sup>2</sup> = 0% </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Results for studies with placebo/control rinse arms</b> </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (144)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.47 (‐0.76 to ‐0.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.0001, I<sup>2</sup> = 86% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival inflammation (Gingival Index)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1 and 0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (1124)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.50 (‐1.11 to 0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.0001, I<sup>2</sup> = 99% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12 and &lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (182)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.29 (‐1.85 to ‐0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.02, I<sup>2</sup> = 64% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.12 (‐0.2 to ‐0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.003 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.33, I<sup>2</sup> = 11% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 to 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2, 0.12 and &lt; 0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 (423)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.74 (‐2.51 to ‐0.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P &lt; 0.00001, I<sup>2</sup> = 91% </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (852)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.55 (‐1.79 to ‐1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.00001 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (132)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐1.10 (‐1.18 to ‐0.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 0.002 favours CHX</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.02, I<sup>2</sup> = 71% </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>CHX = chlorhexidine; CI = confidence interval; conc = concentration; MD = mean difference; N/A = not applicable; SMD = standardised mean difference. </p> <p>There were no subgroup differences between the different chlorhexidine concentrations, therefore the overall effect for all concentrations combined is reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Results for gingivitis and plaque at 7 to 12 weeks, &gt; 6 months and long term (after cessation of mouthrinsing)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Studies with a gingival inflammation outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anauate‐Netto 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PBS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.7 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI. Quote: "..no statistically significant differences were detected among groups" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="7" scope="col" valign=""> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported mean GI by surface + SD. No overall SD. We calculated overall mean. Quote: "The means of the …gingival indices did not show any significant differences (P&lt;0.05) 1 or 2 months after baseline. However there were significant differences (P&lt;0.05) in the changes recorded at 30 and 60 days at all sites in…..the experimental group" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1888b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI severity (mean score of all sites graded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2902</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI or a SD. Quote: "..the effect of the chlorhexidine rinse on the occurrence and severity of gingivitis amounted to a 51% reduction of the disease compared to the placebo rinse…differences were statistically significant" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1988a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI severity (mean score of all sites graded)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2892</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI or a SD. Quote: "..the gingivitis reductions were 34% and 36% for occurrence and severity respectively…differences were statistically significant" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Eaton 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mGI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (0.383)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55 (0.382)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI. Quote: "..the pooled mean mGI score improved by 25% from 0.56 at baseline to 0.42 at 12 weeks in the ChD (CHX) group but showed no change (0.54 to 0.55) in the placebo group" </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ferretti 1987</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PMGI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report GI and SD depicted in graph but not reported. Quote: "Significant reductions in …gingivitis scores were seen on days 33 (P&lt;0.0001) and 60… (P&lt;0.001) for those patients using chlorhexidine rinse" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% vs 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4112/0.3640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5039</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Gingivitis severity by the GI method was… significantly lower at 3 months for both chlorhexidine groups compared to the placebo group. Differences ranged from 28‐46% and averaged 37% for the 0.12% group. Differences ranged from 18‐40% for the 0.20% group and averaged 29%" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weitz 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "…the active (CHX) groups had significantly lower… gingivitis scores than the respective control groups. Overall, the active group had a 10.27% reduction in the gingival index…compared to insignificant changes in the control groups" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fine 1985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear. Quote: "a gingival inflammation Index"</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcomes reported in graphs which are difficult to decipher. Quote: "Whilst there was a general improvement in all… groups of patients, no one group was statistically significantly different from the other…" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%, CHX 0.06%, CHX 0.06%+F vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.15/0.29/0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No SD. At 3 months "..only the 0.1% CHX was different from the control". At 6 months "…the 0.1% CHX showed significant differences…in the GI…when compared to the 0.06% CHX/F" (P = 0.043) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overholser 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>mGI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (SE 0.065)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.166 (SE 0.063)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "PX (CHX) inhibited gingivitis development by 26.8% (P&lt;0.001) at 3 months and by 30.5% (P&lt;0.001) at 6 months, compared to the control" </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CHX = chlorhexidine; F = fluoride; NR = not reported; OH = oral hygiene; SD = standard deviation; SE = standard error. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>PBS (Papillary Bleeding Score, <a href="./references#CD008676-bbs2-0150" title="LoescheWJ . Clinical and microbiological aspects of chemotherapeutic agents used according to the specific plaque hypothesis. Journal of Dental Research1979;58(12):2404-12.">Loesche 1979</a>) is measured on a 0‐5 increasing scale. </p> <p>GI (Gingival Index, <a href="./references#CD008676-bbs2-0147" title="LöeH . The Gingival Index, the Plaque Index and the Retention Index Systems. Journal of Periodontology1967;38(6):Suppl:610-6.">Löe 1967</a>; <a href="./references#CD008676-bbs2-0149" title="LöeH , SilnessJ . Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontologica Scandinavica1963;21:533-51.">Löe and Silness 1963</a>) is measured on a 0‐3 increasing scale. </p> <p>PMGI (Papillary Marginal Gingivitis Index, <a href="./references#CD008676-bbs2-0117" title="De la RosaM , SturzenbergerOP . Clinical reduction of gingivitis through the use of a mouthwash containing two quaternary ammonium compounds. Journal of Periodontology1976;47(9):535-7.">de la Rosa and Sturzenberger 1976</a>) is measured on a 0‐3 increasing scale. </p> <p>mGI (modified Gingival Index, <a href="./references#CD008676-bbs2-0145" title="LobeneRR , WeatherfordT , RossNM , LammRA , MenakerL . A modified gingival index for use in clinical trials. Clinical Preventive Dentistry1986;8(1):3-6.">Lobene 1986</a>) is measured on a 0‐4 increasing scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Studies with a gingival inflammation outcome not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Studies with a gingival bleeding outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Axelsson 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs CHX 0.1% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % of gingival units with GI score 2 or 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12%/11%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "In all…study groups, the % of gingival units scored GI 2+3 was reduced between baseline..and end of trial" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graziani 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%+Alc vs CHX 0.2% no Alc vs CHX+ADS vs control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FMBS /BOP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13.47%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Partial reporting of outcome data. Quote: "Statistically significant decreases in mean full‐mouth scores of gingival inflammation were noted for all experimental study groups at day 35 compared to baseline. Between‐group changes in FMBS…were statistically significant only when CHX2 (mean difference of 43.4 ± 22.4, P = 0.05) and CHX 3 (mean difference of 46.1 ± 23.1, P = 0.05) were compared to the CTRL group" (note: CHX 2 = CHX no Alc, CHX 3 = CHX + ADS) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18.78%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31.31%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Beginning at 4 weeks of rinsing, gingival bleeding was significantly lower in the CHX group compared to the placebo group by an average of 41.6% (P &lt; 0.05). At 6 weeks that reduction was 40%, (P &lt; 0.05)" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign=""> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Corbet 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27%(anterior)</p> <p>42%(posterior)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52%(anterior)</p> <p>75%(posterior)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "The difference between the mean percentage of GB of the test and control groups at 3 months was highly significant (P &lt; 0.001)" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Examiner A: 3.4%/2%</p> <p>Examiner B: 7.2%/6.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Examiner A: 3.81%</p> <p>Examiner B: 14.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD.</p> <p><b>O.2%</b> Quote: "Bleeding was 31% lower (range 11‐52%) compared to the placebo group" (P &gt; 0.05) </p> <p><b>0.12%</b> Quote: "..gingival bleeding was significantly lower by an average of 53% for both examiners (range 48‐59%)" (P ≤ 0.05) </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign=""> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.12%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Regarding outcomes at 6 months to 2 years: Quote: "Subjects in the treatment group…displayed between 42% and 51% fewer sites with moderate to severe gingivitis (GI scores of 2 or 3) compared with subjects in the control group" (P &lt; 0.0001) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11.01%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20.65%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1156 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% of bleeding sites in each group is presented. There is a unit of analysis error (number of sites rather than number of subjects). Quote: "There was a considerable reduction in percent bleeding sites in the chlorhexidine…groups at 6 months compared with both control and baseline" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lucas 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.2%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Quote: "Although the percentage of bleeding surfaces in the chlorhexidine group was less than in the placebo group on days 90 (33%) and 180 (76%), the differences were not significant" (P = 0.07) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>% bleeding sites reported incompletely in text and also in a graph. Did not report a SD. </p> <p>Quote: "At 6 months…the positive control group had significantly fewer bleeding sites than the control group (.. 23%...)" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gingival bleeding &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean % sites GI score 2 and 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.41%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.88%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD. Regarding outcomes at 6 months to 2 years: Quote: "Subjects in the treatment group…displayed between 42% and 51% fewer sites with moderate to severe gingivitis (GI scores of 2 or 3) compared with subjects in the control group" (P &lt; 0.0001) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>ADS = antidiscolouration system; Alc = alcohol; BOP = bleeding on probing; CHX = chlorhexidine; FMBS = Full‐Mouth Bleeding Score; GI = Gingival Index; SD = standard deviation. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Studies with a gingival bleeding outcome not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Studies with a plaque outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.452</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.9907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.3175*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8425*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean GI by surface + SD reported. We calculated the overall mean. No overall SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1888b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The reductions in dental plaque were not statistically significant.."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>de la Rosa 1988a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "The reductions in dental plaque were not statistically significant.."</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Segreto 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2% vs 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.14/1.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weitz 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "Subjects in the treatment group had significantly lower mean plaque scores than those in the control group at six months, and at one and two years. The difference between the groups ranged from 35% to 46%" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%/CHX 0.06%/CHX 0.06%+F vs control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.13/0.25/0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median 0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median only. Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jayaprakash 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.05%/ CHX 0.05%+F vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0813/0.0459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lucas 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OHI‐S</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "…reductions in Plaque Index...were statistically significant for the positive control group…compared with the reduction obtained with the control group.. These reductions were 41% (positive control)…after 3 months and 35%..after 6 months.." </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Plaque &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TQH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "Subjects in the treatment group had significantly lower mean plaque scores than those in the control group at six months, and at one and two years. The difference between the groups ranged from 35% to 46%" </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CHX = chlorhexidine; F = Fluoride; NR = not reported; SD = standard deviation.</p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>PI (Plaque Index, <a href="./references#CD008676-bbs2-0178" title="SilnessJ , LöeH . Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica1964;22:121-35.">Silness and Löe 1964</a>) is measured on a 0‐3 increasing scale. </p> <p>TQH (Turesky modification of the Quigley and Hein Index, <a href="./references#CD008676-bbs2-0183" title="TureskyS , GilmoreND , GlickmanI . Reduced plaque formation by the chloromethyl analogue of victamin C. Journal of Periodontology1970;41(1):41-3.">Turesky 1970</a>) is measured on a 0‐5 increasing scale. </p> <p>OHI‐S (Simplified Oral Hygiene Index, <a href="./references#CD008676-bbs2-0126" title="GreeneJC , VermillionJR . The Simplified Oral Hygiene Index. Journal of the American Dental Association1964;68:7-13.">Greene and Vermillion 1964</a>) is measured on a 0‐3 increasing scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Studies with a plaque outcome not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Studies with a calculus outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0475</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean RI by surface + SD reported. We calculated overall mean. No overall SD</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Anderson 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.0525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean RI by surface + SD reported. We calculated overall mean. No overall SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.37 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.11 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in graph. Did not report a SD. Quote: "All groups developed calculus after the initial cleaning at baseline. This increase was only statistically significant for the positive control group compared with the control group at 6 months" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign="middle"> <p><b>Calculus 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results reported at 24 months only. See results at &gt; 6 months below</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.45 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.21 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Supragingival calculus was higher in the group using chlorhexidine but this increase in calculus did not diminish the therapeutic effects of chlorhexidine since subjects with significant increases in calculus also had significant decreases in gingivitis" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph. Did not report a SD. Quote: "All groups developed calculus after the initial cleaning at baseline. This increase was only statistically significant for the positive control group compared with the control group at 6 months" </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Calculus &gt; 6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Banting 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>VM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At 24 months subjects in the treatment group had higher mean supragingival calculus scores, but at the same time more subjects were free of subgingival calculus </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CHX = chlorhexidine; NR = not reported; SD = standard deviation.</p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>RI (Retention Index, <a href="./references#CD008676-bbs2-0106" title="BjorbyA , LöeH . The relative significance of different local factors in the initiation and development of periodontal inflammation. Journal of Periodontal Research1966;2:76-7.">Björby and Löe 1966</a>) is measured on a 0‐3 increasing scale. </p> <p>VM (Volpe‐Manhold Calculus Index, <a href="./references#CD008676-bbs2-0153" title="ManholdJH , VolpeAR , ParkerL , AdamsSH . In vivo calculus assessment. II. A comparison of scoring techniques. Journal of Periodontology1965;36:299-304.">Manhold 1965</a>; <a href="./references#CD008676-bbs2-0190" title="VolpeAR , ManholdJH , HazenSP . In vivo calculus assessment. I. A method and its examiner reproducibility. Journal of Periodontology1965;36:292-8.">Volpe 1965</a>) measures calculus present on the lingual surface of the lower 6 anterior teeth. Calculus is measured in 3 planes using a standard periodontal probe.The greatest value allowed for any 1 plane is 3 units, therefore the maximum score per tooth is 9 units or 54 units per subject. The mean per subject score is obtained by dividing the total calculus score by the number of lower anterior teeth. A mean calculus score for the group is then calculated. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Studies with a calculus outcome not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008676-tbl-0011"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Studies with a staining outcome not included in meta‐analyses</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Time</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Index</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CHX mean (SD/SE) or n (%)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Total n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Notes</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="8" scope="col" valign="middle"> <p><b>4 to 6 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Axelsson 1987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%/0.1% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.1171 (0.297)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not included in meta‐analysis as control mean is 0. We combined data from the 0.2% and 0.1% CHX groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bhat 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported number and proportion of participants with mild or moderate 'discolouration' in text </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 (91%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not clear whether discolouration relates to teeth or oral tissues or both</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Flotra 1972 &amp; 1971 (4‐month study that reports this outcome at 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2%/0.1%/0.1% (acetate) vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No index</p> <p>Reported narratively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12% of tooth surfaces without fillings</p> <p>62% of silicate fillings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48 (at 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "..12% of the tooth surfaces without fillings became discolored within the first 4 weeks of the experiment…this happened more frequently on the interproximal surfaces than on the labial surfaces (ratio2:1). Sixty‐two per cent of the silicate fillings in these areas were discolored.." </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graziani 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.2228 (0.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not included in meta‐analysis as control mean is 0. We combined data from the 3 CHX groups </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hase 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subjective of participants regarding staining of teeth and/or tongue using VAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (SE 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9 (SE 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Teeth and/or tongue staining reported together. Data estimated from a graph</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>López‐Jornet 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.2% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Registration of side effects including denture/dental staining (n and %)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (5.71%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (8.57%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Denture and dental staining reported together</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Turkoglu 2009</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX (conc not reported) vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No index</p> <p>Reported narratively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (56%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Assumed 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quote: "Of the 25 subjects who rinsed their mouth with CHX mouthrinse..14 showed discolouration of teeth and/or tongue" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimmer 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.06%+F+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staining of teeth and tongue registered at final examination (n)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stain on teeth/tongue reported together. If more than 1 side effect was present, only the most relevant was listed i.e. side effects were reported with no double counting </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="4" scope="col" valign="middle"> <p><b>7 to 12 weeks</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.61 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.66 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.59 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in a graph at 6 months only See 6‐month results below</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Zimmer 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.06% +F+OH vs OH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Staining of teeth and tongue registered at final examination (n)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stain on teeth/tongue reported together. If more than 1 side effect was present, only the most relevant was listed i.e. side effects were reported with no double counting </p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="5" scope="col" valign="middle"> <p><b>6 months</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Charles 2004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lobene)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.08 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome data not reported. Quote: "Some extrinsic tooth staining was observed in the chlorhexidine group" </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grossman 1989</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.15 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.75 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hoffmann 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.1%/ 0.06%/0.06%+F vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DI (Lang and Räber)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.13/1.02/1.06 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.38 (SD NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median only. Did not report a SD</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sanz 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CHX 0.12% vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not specified Quote: "Photographs of facial surfaces of the 12 anterior teeth (maxillary and mandibular, cuspid to cuspid) were graded for stain intensity and coverage" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Graph</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data presented in graph Did not report a SD</p> <p>Quote: "Statistically significant more overall staining, more intense staining and stain coverage per tooth were detected for the positive control group…compared with the control group" </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CHX = chlorhexidine; conc = concentration; F = fluoride; NR = not reported; OH = oral hygiene; SD = standard deviation; SE = standard error; VAS = visual analogue scale. </p> <p>Total n is the number of participants analysed in the study arms relevant to the review.</p> <p>DI (Discolouration Index, <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a>): gingival and body regions of the tooth are scored for intensity (0‐3 increasing scale) and severity (0‐3 increasing scale). </p> <p>DI (Discolouration Index, <a href="./references#CD008676-bbs2-0140" title="LangNP , RäberK . Use of oral irrigators as vehicle for the application of antimicrobial agents in chemical plaque control. Journal of Clinical Periodontology1981;8(3):177-88.">Lang and Räber 1981</a>) is measured on a 0‐3 increasing scale. </p> <p>SI (Staining Index): the buccal surfaces of the 8 central incisors were divided into 3 areas: incisal, approximal and gingival according to <a href="./references#CD008676-bbs2-0143" title="LobeneRR . Effect of dentifrices on tooth stains with controlled brushing. Journal of the American Dental Association1968;77(4):849-55.">Lobene 1968</a> and <a href="./references#CD008676-bbs2-0128" title="GrundemannLJ , TimmermanMF , IjzermanY , van derVeldenU , van derWeijdenGA . Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. Journal of Clinical Periodontology2000;27(1):9-15.">Grundemann 2000</a> and a SI was used to record the dichotomous presence or absence of staining in each area and to calculate the percentage of the total area showing staining. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Studies with a staining outcome not included in meta‐analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/full#CD008676-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008676-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHX versus placebo/control mouthrinse or no mouthrinse</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Gingival Index (0‐3) 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>805</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.31, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.31, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.34, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Gingival Index (0‐3) 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.30, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.18, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2474</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.33, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Gingival bleeding 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.56 [‐0.79, ‐0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.69 [‐0.89, ‐0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.77, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Gingival bleeding 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.02, ‐0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.83, ‐0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.16, ‐0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Plaque 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐1.90, ‐1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐2.39, ‐0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.48 [‐2.07, ‐0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Plaque 4‐6 weeks PI (0‐3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐0.78, ‐0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐0.94, ‐0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐0.97, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Plaque 4‐6 weeks TQH (0‐5) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>546</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐0.85, ‐0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.83 [‐1.00, ‐0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐0.85, ‐0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Plaque 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2075</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐1.76, ‐1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐1.35, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1933</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.59 [‐1.89, ‐1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Plaque 6 months PI (0‐3) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐1.12, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.42, ‐0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.46, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Plaque 6 months TQH (0‐5) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐0.88, ‐0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐0.88, ‐0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Calculus 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.09, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Calculus 7‐12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [‐0.04, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.59, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.08, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Calculus 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.33, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.93, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.24, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Tooth staining 4‐6 weeks dichotomous <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.41 [2.03, 14.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.44 [1.43, 13.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.88 [1.37, 71.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Tooth staining 7‐12 weeks dichotomous <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.50 [1.29, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Tooth staining 4‐6 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.08, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.73, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Tooth staining 7‐12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.98, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.88, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.93, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Tooth staining 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.22, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 CHX versus no rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.73, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.2 CHX versus placebo/control rinse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [1.38, 1.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">CHX versus placebo/control mouthrinse or no mouthrinse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008676.pub2/references#CD008676-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008676.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008676-note-0016">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008676-note-0023">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008676-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="ko#CD008676-note-0019">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD008676-note-0020">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008676-note-0022">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD008676-note-0018">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008676-note-0017">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008676\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008676\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008676\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008676\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008676\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008676.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008676.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008676.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008676.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008676.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716870539"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008676.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716870543"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008676.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918daa0e5b361be3',t:'MTc0MDcxNjg3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 